
<html lang="en"     class="pb-page"  data-request-id="3eeef1c8-3896-4504-a790-d6e68287776b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b00624;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-15"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies" /></meta><meta name="dc.Creator" content="Irene  Sola" /></meta><meta name="dc.Creator" content="Ester  Aso" /></meta><meta name="dc.Creator" content="Daniela  Frattini" /></meta><meta name="dc.Creator" content="Irene  López-González" /></meta><meta name="dc.Creator" content="Alba  Espargaró" /></meta><meta name="dc.Creator" content="Raimon  Sabaté" /></meta><meta name="dc.Creator" content="Ornella  Di Pietro" /></meta><meta name="dc.Creator" content="F. Javier  Luque" /></meta><meta name="dc.Creator" content="M. Victòria  Clos" /></meta><meta name="dc.Creator" content="Isidro  Ferrer" /></meta><meta name="dc.Creator" content="Diego  Muñoz-Torrero" /></meta><meta name="dc.Description" content="We have synthesized a series of heptamethylene-linked levetiracetam–huprine and levetiracetam–(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-in..." /></meta><meta name="Description" content="We have synthesized a series of heptamethylene-linked levetiracetam–huprine and levetiracetam–(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-in..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 27, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00624" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00624" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00624" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00624" /></link>
        
    
    

<title>Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00624" /></meta><meta property="og:title" content="Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0009.jpeg" /></meta><meta property="og:description" content="We have synthesized a series of heptamethylene-linked levetiracetam–huprine and levetiracetam–(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer’s disease patients. These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Aβ42 and tau antiaggregating agents in a simple E. coli model of amyloid aggregation. Ex vivo determination of the brain acetylcholinesterase inhibitory activity of these compounds after intraperitoneal injection to C57BL6J mice has demonstrated their ability to enter the brain. The levetiracetam–huprine hybrid 10 significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-week treatment with a 5 mg/kg dose. Moreover, the hybrid 10 rescued transgenic mice from cognitive deficits, thereby emerging as an interesting disease-modifying anti-Alzheimer drug candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00624"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00624">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00624&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00624&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00624&amp;href=/doi/10.1021/acs.jmedchem.5b00624" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6018-6032</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00571" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00635" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene++Sola">Irene Sola</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ester++Aso">Ester Aso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Frattini">Daniela Frattini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene++L%C3%B3pez-Gonz%C3%A1lez">Irene López-González</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alba++Espargar%C3%B3">Alba Espargaró</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raimon++Sabat%C3%A9">Raimon Sabaté</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ornella++Di+Pietro">Ornella Di Pietro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Javier++Luque">F. Javier Luque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Vict%C3%B2ria++Clos">M. Victòria Clos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isidro++Ferrer">Isidro Ferrer</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diego++Mu%C3%B1oz-Torrero">Diego Muñoz-Torrero</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, E-08028, Barcelona, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Institut de Neuropatologia, Servei d’Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, L’Hospitalet de Llobregat, 08908 Barcelona, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto Carlos III, Spain</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Departament de Fisicoquímica, Facultat de Farmàcia, and Institut de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Departament de Fisicoquímica, Facultat de Farmàcia (Campus Torribera), and IBUB, Universitat de Barcelona, Prat de la Riba 171, E-08921, Santa Coloma de Gramenet, Spain</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Departament de Farmacologia, de Terapèutica, i de Toxicologia, Institut de Neurociències, Universitat Autònoma de Barcelona, E-08193, Bellaterra, Barcelona, Spain</span></div><div class="corresp-info"><strong>*</strong>I.F.: phone, +34-932607452; e-mail, <a href="/cdn-cgi/l/email-protection#487078707a212e29082f25292124662b2725"><span class="__cf_email__" data-cfemail="c7fff7fff5aea1a687a0aaa6aeabe9a4a8aa">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>D.M.-T.: phone, +34-934024533; e-mail, <a href="/cdn-cgi/l/email-protection#41252c342f2e3b352e333324332e0134236f242534"><span class="__cf_email__" data-cfemail="640009110a0b1e100b161601160b2411064a010011">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00624&amp;href=/doi/10.1021%2Facs.jmedchem.5b00624" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6018–6032</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 16, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 April 2015</li><li><span class="item_label"><b>Published</b> online</span>27 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00624</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6018%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIrene%2BSola%252C%2BEster%2BAso%252C%2BDaniela%2BFrattini%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D15%26contentID%3Dacs.jmedchem.5b00624%26title%3DNovel%2BLevetiracetam%2BDerivatives%2BThat%2BAre%2BEffective%2Bagainst%2Bthe%2BAlzheimer-like%2BPhenotype%2Bin%2BMice%253A%2BSynthesis%252C%2Bin%2BVitro%252C%2Bex%2BVivo%252C%2Band%2Bin%2BVivo%2BEfficacy%2BStudies%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6032%26publicationDate%3DAugust%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00624"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1744</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">41</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00624" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;Sola&quot;},{&quot;first_name&quot;:&quot;Ester&quot;,&quot;last_name&quot;:&quot;Aso&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Frattini&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;López-González&quot;},{&quot;first_name&quot;:&quot;Alba&quot;,&quot;last_name&quot;:&quot;Espargaró&quot;},{&quot;first_name&quot;:&quot;Raimon&quot;,&quot;last_name&quot;:&quot;Sabaté&quot;},{&quot;first_name&quot;:&quot;Ornella&quot;,&quot;last_name&quot;:&quot;Di Pietro&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Javier Luque&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Victòria Clos&quot;},{&quot;first_name&quot;:&quot;Isidro&quot;,&quot;last_name&quot;:&quot;Ferrer&quot;},{&quot;first_name&quot;:&quot;Diego&quot;,&quot;last_name&quot;:&quot;Muñoz-Torrero&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6018-6032&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00624&quot;},&quot;abstract&quot;:&quot;We have synthesized a series of heptamethylene-linked levetiracetam–huprine and levetiracetam–(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer’s disease patients. These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Aβ42 and tau antiaggregating agents in a simple E. coli model of amyloid aggregation. Ex vivo determination of the brain acetylcholinesterase inhibitory activity of these compounds after intraperitoneal injection to C57BL6J mice has demonstrated their ability to enter the brain. The levetiracetam–huprine hybrid 10 significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-week treatment with a 5 mg/kg dose. Moreover, the hybrid 10 rescued transgenic mice from cognitive deficits, thereby emerging as&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00624&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00624" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00624&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00624" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00624&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00624" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00624&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00624&amp;href=/doi/10.1021/acs.jmedchem.5b00624" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00624" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00624" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00624%26sid%3Dliteratum%253Aachs%26pmid%3D26181606%26genre%3Darticle%26aulast%3DSola%26date%3D2015%26atitle%3DNovel%2BLevetiracetam%2BDerivatives%2BThat%2BAre%2BEffective%2Bagainst%2Bthe%2BAlzheimer-like%2BPhenotype%2Bin%2BMice%253A%2BSynthesis%252C%2Bin%2BVitro%252C%2Bex%2BVivo%252C%2Band%2Bin%2BVivo%2BEfficacy%2BStudies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D15%26spage%3D6018%26epage%3D6032%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/jmcmar.2015.58.issue-15/20150813/jmcmar.2015.58.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have synthesized a series of heptamethylene-linked levetiracetam–huprine and levetiracetam–(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer’s disease patients. These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Aβ42 and tau antiaggregating agents in a simple <i>E. coli</i> model of amyloid aggregation. Ex vivo determination of the brain acetylcholinesterase inhibitory activity of these compounds after intraperitoneal injection to C57BL6J mice has demonstrated their ability to enter the brain. The levetiracetam–huprine hybrid <b>10</b> significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-week treatment with a 5 mg/kg dose. Moreover, the hybrid <b>10</b> rescued transgenic mice from cognitive deficits, thereby emerging as an interesting disease-modifying anti-Alzheimer drug candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder. It affects over 35 million people worldwide, and this figure will grow exponentially in the upcoming years along with demographic changes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently there exists no therapy that can halt or slow AD progression, so this disease inexorably leads to the death of the patient. Consequently, the increasing prevalence of AD is being accompanied by increasing mortality figures, in sharp contrast to other major causes of death such as cardiovascular disease or cancer, for which the number of associated deaths has been decreasing in the past decade.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Only five drugs have been approved so far for the treatment of AD, namely, the acetylcholinesterase (AChE) inhibitors tacrine, donepezil, rivastigmine, and galantamine and the glutamate NMDA receptor antagonist memantine.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> These drugs were developed to alleviate the cognitive and functional decline associated with neurotransmitter deficits that appear long after the initiation of the neurodegenerative process, and hence, they are regarded as mainly symptomatic treatments. An efficient management of AD relies heavily on the development of novel drugs that can address the earliest disease mechanisms as well as on the parallel discovery of suitable biomarkers and techniques that allow an early diagnosis, thereby enabling the use of putative disease-modifying drugs in the most appropriate time, i.e., when neurodegeneration is not too widespread. Two proteins, β-amyloid peptide (Aβ) and tau, are widely thought to be at the root of the pathogenesis of AD, even though it is not clear whether or not their appearance is a cause or a consequence of the disease. Particularly, huge economic and research investments have focused on the development of disease-modifying drug candidates that address the biology of the 39–43 amino acid peptide Aβ.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> However, these endeavors have so far failed to derive any new approved drug.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Indeed, it has been suggested that the formation and subsequent aggregation of Aβ might not be the sole cause of the disease but just one of the main components of a pathological network, where hyperphosphorylation and aggregation of protein tau, synaptic dysfunction, or neuroinflammation, among others, would be also key players.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">This conception of AD has prompted the development of an important number of compounds purposely designed to simultaneously hit several of the key biological targets or events of the AD pathological network.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19">(7-19)</a> In most cases, anti-Alzheimer multitarget compounds are designed to hit Aβ formation and/or aggregation and the enzyme AChE,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> which besides its cholinergic function has been reported to be able to interact with Aβ, thereby promoting its aggregation.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a></div><div class="NLM_p">It has been recently suggested that aberrant neuronal network activity might be another key component of the AD network,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> which has been associated with elevated levels of Aβ and causally linked to Aβ-induced synaptic and cognitive deficits.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, the incidence of epileptic seizures or epileptiform activity is increased in AD patients relative to the general population,<a onclick="showRef(event, 'ref24 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref26">(24, 26)</a> especially in those individuals with early onset AD, which is characterized by mutations in some deterministic genes encoding proteins involved in the production of Aβ, namely, amyloid precursor protein (APP) and the enzymes involved in the APP cleavage presenilin 1 and presenilin 2. Increased incidence of epileptic seizures also occurs in other conditions which are associated with elevated levels of Aβ such as patients with Down syndrome, which feature three copies of chromosome 21, where the APP gene is located, and the incidence is still higher in individuals with Down syndrome who develop AD.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Also, transgenic mouse models of AD that overexpress human mutated APP show epileptiform activity along with synaptic and cognitive deficits.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Very interestingly, chronic treatment with the antiepileptic drug levetiracetam (<b>1</b>, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) can effectively suppress aberrant network activity and improve memory performance in patients with amnestic mild cognitive impairment (aMCI)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> as well as in hAPPJ20 and APP/PS1 mouse models of AD,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> thereby highlighting the critical therapeutic potential of targeting excess neuronal network activity, especially in combination with other copathogenic factors that fuel the progression of AD such as Aβ and tau aggregation and accumulation.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of levetiracetam.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have recently developed several structural families of anti-Alzheimer hybrid compounds that contain the structure of 6-chlorotacrine (9-amino-6-chloro-1,2,3,4-tetrahydroacridine) or the high affinity AChE inhibitor huprine Y,<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33-36)</a> structurally related to tacrine, which exhibit a common multitarget biological profile encompassing inhibition of the aggregation of Aβ42 and tau and inhibition of both cholinesterases, i.e., AChE and butyrylcholinesterase (BChE), apart from modulation of other specific targets or pathological events.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a></div><div class="NLM_p last">Herein, we describe the synthesis and biological evaluation of a series of hybrid compounds that feature the 2-(2-oxopyrrolidin-1-yl)butyramide moiety of levetiracetam linked to a tacrine, 6-chlorotacrine, or huprine Y unit as novel multitarget anti-Alzheimer leads with potential to modify AD progression. The biological profiling of the novel compounds includes (i) the in vitro assessment of their human AChE and BChE inhibitory activity; (ii) the evaluation of their inhibitory activity against both Aβ42 and tau aggregation in intact <i>Escherichia coli</i> cells overexpressing these proteins, as a simple in vivo model of amyloid aggregation; (iii) the ex vivo evaluation of their brain AChE inhibitory activity after intraperitoneal injection in C57BL6J mice, as an indirect proof of their brain penetration; (iv) a preliminary assessment of their acute toxicity in C57BL6J mice; and (v) the in vivo efficacy studies after chronic administration to transgenic APP/PS1 mice, a well-established mouse model of AD, encompassing the evaluation of their effect on cognition, spontaneous epileptic seizures, cortical soluble Aβ40 and Aβ42 levels, cortical Aβ burden, and gliosis around Aβ plaques.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">In this work, we envisaged first the straightforward synthesis of hybrids (±)-<b>5</b> and (±)-<b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), which bear a tacrine or a 6-chlorotacrine unit linked to the racemic form of <b>1</b> (etiracetam), as well as the synthesis of the enantiopure hybrids (<i>S</i>)-<b>5</b>, featuring the (<i>S</i>)-eutomer form of etiracetam as an antiepileptic drug (levetiracetam), and its enantiomer (<i>R</i>)-<b>5</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), to assess potential enantioselective interactions with the targets to be evaluated in vitro, due to the levetiracetam moiety. The eutomer for AChE inhibition of huprine Y and other huprine-based hybrids previously developed in our group is the (7<i>S</i>,11<i>S</i>)-enantiomer, whereas the opposite trend or no enantioselectivity has been found for their interaction with other targets of interest such as BChE or Aβ and tau aggregation.<a onclick="showRef(event, 'ref34 ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref34 ref37 ref40">(34, 37, 40)</a> In this light, we also planned the synthesis of enantiopure levetiracetam–huprine hybrids <b>10</b> and <b>11</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), featuring the (<i>S</i>)-form of <b>1</b> and either a (7<i>S</i>,11<i>S</i>)- or (7<i>R</i>,11<i>R</i>)-huprine moiety. In all cases, a heptamethylene chain was chosen as the linker between the two pharmacophoric moieties because it should enable the hybrids to span the whole length of the active site gorge of AChE, one of their putative targets, thereby leading to high inhibitory potencies, as it has been reported for a number of tacrine-based dimeric and hybrid compounds.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Indeed, other heptamethylene-linked huprine-based hybrids recently developed in our group have been consistently found to be among the most potent AChE inhibitors of the corresponding structural families.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37, 40)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Levetiracetam–Tacrine Hybrids (±)-<b>5</b>, (<i>S</i>)-<b>5</b>, (<i>R</i>)-<b>5</b>, and (±)-<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (±)-<b>4</b>, (<i>S</i>)-<b>4</b> or (<i>R</i>)-<b>4</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then amine <b>2</b> or <b>3</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 93% [(±)-<b>5</b>], 60% [(<i>S</i>)-<b>5</b>], 27% [(<i>R</i>)-<b>5</b>], 78% [(±)-<b>6</b>].</p></p></figure><div class="NLM_p">The synthesis of hybrids (±)-<b>5</b> and (±)-<b>6</b> was carried out by treatment of the readily available racemic 2-(2-oxopyrrolidin-1-yl)butyric acid, (±)-<b>4</b>,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> with 1 equiv of ethyl chloroformate and 2 equiv of Et<sub>3</sub>N in CH<sub>2</sub>Cl<sub>2</sub>, followed by reaction of the resulting mixed anhydride with 1 equiv of the known 7-aminoheptyltacrines <b>2</b><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and <b>3</b><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> at room temperature for 3 days, followed by silica gel column chromatography purification of the crude products (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">Enantiopure carboxylic acids (<i>S</i>)-<b>4</b> or (<i>R</i>)-<b>4</b> were prepared through a methodology previously developed in our group, based on the resolution of the racemic acid (±)-<b>4</b> through formation and silica gel column chromatography separation of its diastereomeric esters with (<i>S</i>)-<i>N</i>-phenylpantolactam followed by separate hydrolysis with LiOH/H<sub>2</sub>O<sub>2</sub> in THF.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Coupling of aminoheptyltacrine <b>2</b> with carboxylic acids (<i>S</i>)-<b>4</b> and (<i>R</i>)-<b>4</b> under the same reaction conditions used for the racemic compound afforded in moderate yields the enantiopure hybrids (<i>S</i>)-<b>5</b> and (<i>R</i>)-<b>5</b>, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The synthesis of enantiopure hybrids <b>10</b> and <b>11</b> was undertaken starting from enantiopure huprines (7<i>S</i>,11<i>S</i>)-<b>7</b> and (7<i>R</i>,11<i>R</i>)-<b>7</b>, which are readily available even at multigram amounts by chromatographic resolution.<a onclick="showRef(event, 'ref33 ref46'); return false;" href="javascript:void(0);" class="ref ref33 ref46">(33, 46)</a> Alkylation of (7<i>S</i>,11<i>S</i>)-<b>7</b> and (7<i>R</i>,11<i>R</i>)-<b>7</b> with 7-bromoheptanenitrile in the presence of NaOH in DMSO afforded in moderate yields the novel enantiopure nitriles (7<i>S</i>,11<i>S</i>)-<b>8</b> and (7<i>R</i>,11<i>R</i>)-<b>8</b>, which were subsequently reduced to the novel amines (7<i>S</i>,11<i>S</i>)-<b>9</b> and (7<i>R</i>,11<i>R</i>)-<b>9</b> upon treatment with LiAlH<sub>4</sub> in Et<sub>2</sub>O (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Treatment of the mixed anhydride derived from carboxylic acid (<i>S</i>)-<b>4</b> and ethylchloroformate with amines (7<i>S</i>,11<i>S</i>)-<b>9</b> and (7<i>R</i>,11<i>R</i>)-<b>9</b> afforded the enantiopure levetiracetam–huprine hybrids (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> and (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b> in moderate yields, after silica gel column chromatography purification.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Levetiracetam–Huprine Hybrids (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> and (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaOH (3.3 equiv), 4 Å molecular sieves, DMSO, rt, 2 h; then 7-bromoheptanenitrile (1.2 equiv), DMSO, rt, overnight, 52% [(7<i>S</i>,11<i>S</i>)-<b>8</b>], 55% [(7<i>R</i>,11<i>R</i>)-<b>8</b>]; (ii) LiAlH<sub>4</sub> (6 equiv), Et<sub>2</sub>O, 0 °C to rt, 20 h at rt, 91% [(7<i>S</i>,11<i>S</i>)-<b>9</b>], 45% [(7<i>R</i>,11<i>R</i>)-<b>9</b>]; (iii) (<i>S</i>)-<b>4</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then amine (7<i>S</i>,11<i>S</i>)-<b>9</b> or (7<i>R</i>,11<i>R</i>)-<b>9</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 30% (<b>10</b>), 56% (<b>11</b>).</p></p></figure><div class="NLM_p last">The novel levetiracetam-based hybrids were converted into their hydrochloride salts for their chemical characterization and biological profiling.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro Inhibition of Human Cholinesterases</h3><div class="NLM_p">Together with AChE, BChE is partly responsible for the hydrolysis of the neurotransmitter acetylcholine. Unlike AChE, whose brain levels are significantly reduced when AD progresses, the levels of BChE remain the same or may be even increased.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Thus, dual inhibition of AChE and BChE is increasingly pursued in the search for novel AD treatments.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Accordingly, the inhibitory activity of the novel levetiracetam-based hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> and of the reference compounds (<i>S</i>)-<b>1</b>, tacrine, 6-chlorotacrine, and (7<i>S</i>,11<i>S</i>)- and (7<i>R</i>,11<i>R</i>)-huprine Y against human recombinant AChE (hAChE) and human serum BChE (hBChE) was evaluated by the method of Ellman et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The marketed anti-Alzheimer reversible AChE inhibitors donepezil and galantamine were also evaluated as reference compounds.</div><div class="NLM_p">All the levetiracetam-based hybrids turned out to be very potent inhibitors of hAChE, with IC<sub>50</sub> values in the low nanomolar range (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Indeed, in agreement with the expected binding of these hybrids along the active site gorge of AChE, the hybridization strategy led to increased hAChE inhibitory potencies of hybrids <b>5</b>, <b>6</b>, and <b>11</b> relative to their parent compounds tacrine, 6-chlorotacrine, (7<i>R</i>,11<i>R</i>)-huprine Y, and levetiracetam, which, to our surprise, exhibited an outstanding two-digit nanomolar hAChE inhibitory activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The sole exception was the levetiracetam–huprine hybrid <b>10</b>, which, despite its remarkable IC<sub>50</sub> value of 4.2 nM, was still 6-fold less potent than its highly potent parent compound (7<i>S</i>,11<i>S</i>)-huprine Y, as we have also found for other (7<i>S</i>,11<i>S</i>)-huprine Y-based hybrids.<a onclick="showRef(event, 'ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref40">(37, 40)</a> All of the hybrids were found to be much more potent than galantamine and two of them, <b>6</b> and <b>10</b>, also 2- to 3-fold more potent than donepezil. The order of hAChE inhibitory potencies found for the hybrids (<b>6</b> ∼ <b>10</b> > <b>5</b> > <b>11</b>) is consistent with the known positive effect of the chlorine atom at position 6 of the tacrine unit,<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> the levetiracetam–6-chlorotacrine hybrid <b>6</b> being 10-fold more potent than the levetiracetam–tacrine hybrid <b>5</b>, and with the higher potency of (7<i>S</i>,11<i>S</i>)-huprine derivatives relative to the (7<i>R</i>,11<i>R</i>)-counterparts,<a onclick="showRef(event, 'ref34 ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref34 ref37 ref40">(34, 37, 40)</a> hybrid <b>10</b> being 13-fold more potent than <b>11</b>. Regarding the influence of the stereochemistry of the levetiracetam moiety on hAChE inhibitory activity, the levetiracetam–tacrine hybrid (<i>R</i>)-<b>5</b> was found to be 3-fold more potent than its enantiomer.</div><div class="NLM_p">Like the reference compounds, including <b>1</b>, all of the novel levetiracetam-based hybrids were also found to be potent hBChE inhibitors, exhibiting two- to three-digit nanomolar IC<sub>50</sub> values (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and hence displaying an interesting dual AChE/BChE inhibitory activity. The known SAR trends for BChE inhibition regarding the presence of a chlorine atom at position 6 of the tacrine unit or at the equivalent position 3 of the huprine moiety and the enantiopreference of the huprine moiety are just the opposite than for AChE inhibition. Indeed, it is well-known that introduction of a chlorine atom at position 6 of the tacrine unit is somewhat detrimental for the interaction with BChE because of steric hindrance effects at the enzyme active site<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52, 53)</a> and that (7<i>R</i>,11<i>R</i>)-huprine derivatives are more potent hBChE inhibitors than their (7<i>S</i>,11<i>S</i>)-counterparts.<a onclick="showRef(event, 'ref34 ref37 ref40'); return false;" href="javascript:void(0);" class="ref ref34 ref37 ref40">(34, 37, 40)</a> Thus, the order of potencies for hBChE inhibition of the levetiracetam-based hybrids (<b>5</b> > <b>11</b> > <b>6</b> > <b>10</b>) is consistent with the expected SAR trends, with the levetiracetam–tacrine hybrid <b>5</b> being 4-fold more potent than the levetiracetam–6-chlorotacrine hybrid <b>6</b> and with hybrid <b>11</b> being 4-fold more potent than <b>10</b>. Additionally, it was found that for BChE inhibition the stereochemistry of the levetiracetam moiety did not seem to play a significant role, with hybrids (<i>S</i>)-<b>5</b> and (<i>R</i>)-<b>5</b> being roughly equipotent.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitory Activities of the Hydrochlorides of Levetiracetam-Based Hybrids and Reference Compounds toward AChE, BChE, and Aβ42, and Tau Aggregation<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">% inhibition<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hAChE</th><th class="colsep0 rowsep0" align="center">hBChE</th><th class="colsep0 rowsep0" align="center">Aβ42 aggregation</th><th class="colsep0 rowsep0" align="center">tau aggregation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>5</b></td><td class="colsep0 rowsep0" align="left">30.7 ± 6.9</td><td class="colsep0 rowsep0" align="left">21.8 ± 0.5</td><td class="colsep0 rowsep0" align="left">13.8 ± 2.3</td><td class="colsep0 rowsep0" align="left">12.8 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>5</b></td><td class="colsep0 rowsep0" align="left">89.9 ± 8.3</td><td class="colsep0 rowsep0" align="left">12.2 ± 1.0</td><td class="colsep0 rowsep0" align="left">12.6 ± 1.9</td><td class="colsep0 rowsep0" align="left">14.9 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>5</b></td><td class="colsep0 rowsep0" align="left">26.2 ± 1.7</td><td class="colsep0 rowsep0" align="left">17.5 ± 3.4</td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>6</b></td><td class="colsep0 rowsep0" align="left">3.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">135 ± 19</td><td class="colsep0 rowsep0" align="left">24.0 ± 0.9</td><td class="colsep0 rowsep0" align="left">34.0 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b></td><td class="colsep0 rowsep0" align="left">4.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">232 ± 9</td><td class="colsep0 rowsep0" align="left">36.4 ± 2.5</td><td class="colsep0 rowsep0" align="left">54.1 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b></td><td class="colsep0 rowsep0" align="left">56.0 ± 7.1</td><td class="colsep0 rowsep0" align="left">58 ± 10</td><td class="colsep0 rowsep0" align="left">26.0 ± 3.0</td><td class="colsep0 rowsep0" align="left">49.5 ± 2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-levetiracetam</td><td class="colsep0 rowsep0" align="left">75.7 ± 5.5</td><td class="colsep0 rowsep0" align="left">241 ± 50</td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tacrine</td><td class="colsep0 rowsep0" align="left">317 ± 15.3</td><td class="colsep0 rowsep0" align="left">24.5 ± 0.6</td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6-chlorotacrine</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.6</td><td class="colsep0 rowsep0" align="left">114 ± 4</td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left"><10<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(7<i>S</i>,11<i>S</i>)-<b>7</b></td><td class="colsep0 rowsep0" align="left">0.74 ± 0.06</td><td class="colsep0 rowsep0" align="left">222 ± 17</td><td class="colsep0 rowsep0" align="left">22.6 ± 2.9</td><td class="colsep0 rowsep0" align="left">33.3 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(7<i>R</i>,11<i>R</i>)-<b>7</b></td><td class="colsep0 rowsep0" align="left">321 ± 16</td><td class="colsep0 rowsep0" align="left">170 ± 17</td><td class="colsep0 rowsep0" align="left">24.2 ± 1.2</td><td class="colsep0 rowsep0" align="left">31.3 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">donepezil</td><td class="colsep0 rowsep0" align="left">10.4 ± 0.5</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">galantamine</td><td class="colsep0 rowsep0" align="left">735 ± 95</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> inhibitory concentration (nM) of human recombinant AChE or human serum BChE. Values are expressed as mean ± standard error of the mean (SEM) of at least three experiments (<i>n</i> = 3), each performed in duplicate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">% inhibition of Aβ42 and tau aggregation in intact <i>E. coli</i> cells with inhibitor at 20 μM. Values are expressed as mean ± SEM of four independent experiments (<i>n</i> = 4).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">2% inhibition.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">8.7% inhibition.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">9.1% inhibition.</p></div><div class="footnote" id="t1fn6"><sup>f</sup><p class="last">1.3% inhibition.</p></div><div class="footnote" id="t1fn7"><sup>g</sup><p class="last">No inhibiton was observed.</p></div><div class="footnote" id="t1fn8"><sup>h</sup><p class="last">2.3% inhibition.</p></div><div class="footnote" id="t1fn9"><sup>i</sup><p class="last">3.0% inhibition.</p></div><div class="footnote" id="t1fn10"><sup>j</sup><p class="last">Not determined.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Binding Mode within hAChE: Docking Studies</h3><div class="NLM_p">A dual site binding of hybrid <b>10</b> to hAChE has been suggested by docking calculations (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). As expected, the huprine moiety was positioned filling the catalytic site and the tether was aligned along the gorge, whereas the levetiracetam moiety was bound to the peripheral anionic site (PAS), at the entrance of the active site gorge, filling the space located around Trp286 and Tyr72 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). While for PAS binders containing aromatic rings (e.g., propidium) the stacking against Trp286 seems to be the major binding contribution, the analysis of the best poses of <b>10</b> suggests that the major contribution to the binding of its levetiracetam moiety comes from Tyr72, since the formation of a hydrogen bond between the hydroxyl group of Tyr72 and the amide NH/C═O groups of this moiety leads to two distinct arrangements in the PAS.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representation of the binding mode of hybrid <b>10</b> in hAChE. The huprine moiety fills the catalytic binding site, and the levetiracetam moiety is bound to the PAS, where the hydroxyl group of Tyr72 can form a hydrogen bond with either the (A) NH or (B) carbonyl group of the amide function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Inhibition of Aβ42 and Tau Aggregation in Intact <i>Escherichia coli</i> Cells</h3><div class="NLM_p">Besides the aggregation of Aβ42, it is also widely accepted that aggregation of another amyloidogenic protein, namely, tau protein, plays a pivotal role in AD network. Thus, a dual inhibition of Aβ42 and tau aggregation might be of utmost importance for effectively preventing or halting neurodegeneration.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> We have recently found that several classes of 6-chlorotacrine- and huprine-based hybrid compounds exhibit such a dual Aβ42 and tau antiaggregating profile in a simple in vivo model of protein aggregation, namely, in intact <i>E. coli</i> cells that overexpress these proteins.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> To assess whether the novel levetiracetam–tacrine, levetiracetam–6-chlorotacrine, and levetiracetam–huprine hybrids shared this dual antiaggregating profile, they were subjected to the <i>E. coli</i> assay, which is based on monitoring the changes in the fluorescence of thioflavin S after in vivo staining of the amyloid-containing insoluble inclusion bodies<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> that are formed upon expression and subsequent aggregation of the heterologous proteins in the bacteria.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">In contrast with the rather low antiaggregating activity found for racemic and enantiopure tacrine-based hybrids <b>5</b> and <b>6</b>, especially in the case of (<i>R</i>)-<b>5</b>, the levetiracetam–huprine hybrids <b>10</b> and <b>11</b> exhibited a moderately potent Aβ42 and tau antiaggregating activity, with percentages of inhibition around 30% and 50%, respectively, at 20 μM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These hybrids, and especially <b>10</b>, were clearly more potent than all the reference compounds, including both enantiomers of huprine Y, which displayed significant antiaggregating properties (around 20% and 30% for Aβ42 and tau aggregation, respectively).</div><div class="NLM_p last">Like Aβ, tau seems also to induce synaptic and neuronal network impairments, whereas reduction of tau pathology has been reported to prevent spontaneous epileptiform activity and to rescue hAPP mice from synaptic and cognitive deficits.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Thus, the dual effect of some of the novel levetiracetam-based hybrids on amyloid and tau pathology might well complement their expected in vivo effects on epileptiform activity and cognition due to the presence of the levetiracetam pharmacophore.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Brain Penetration and Preliminary Acute Toxicity Studies in C57BL6J Mice</h3><div class="NLM_p">An efficient brain penetration is a condition sine qua non for central nervous system drugs, including anti-Alzheimer drugs. Hybrid compounds resulting from pharmacophore combination approaches tend to be large molecules with molecular weights often exceeding 500, as it is the case for the levetiracetam–huprine hybrids <b>10</b> and <b>11</b>, which might challenge their ability to cross cell membranes.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> Therefore, an assessment of the ability of the novel hybrids to cross the blood–brain barrier (BBB) was deemed necessary before progressing into in vivo efficacy studies.</div><div class="NLM_p">To this end, we carried out the ex vivo determination of the brain AChE activity at two different times after intraperitoneal (ip) injection of 2.5 mg/kg of the levetiracetam-based hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> to C57BL6J mice. Ten minutes after administration of hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> mouse brain AChE activity had been inhibited by 19%, 31%, 16%, and 18% relative to untreated control animals, respectively, whereas the inhibitory activities decreased to 8%, 0%, 7%, and 1%, respectively, when the determination was carried out 20 min after administration. In the case of hybrid <b>10</b>, a dose of 5 mg/kg was also tested, which led to a remarkable 43% inhibition of C57BL6J mouse brain AChE 10 min after administration. The significant inhibition of mouse brain AChE after ip administration of the levetiracetam-based hybrids clearly demonstrates their ability to cross the BBB in vivo.</div><div class="NLM_p">To adjust the dose for the in vivo efficacy studies, a preliminary assessment of acute toxicity effects of the novel hybrids was carried out. We examined the general health of C57BL6/J mice at different times (5 min, 10 min, 20 min, 30 min, 45 min, 1 h, 3 h, and 24 h) after acute administration of increasing doses of the compounds (1.25, 2.5, 5, and 10 mg/kg). No clinical signs were observed at any dose except a reduced activity and ptosis from 10 to 45 min in those animals receiving the highest dose (10 mg/kg) of the compounds.</div><div class="NLM_p last">With the results obtained in C57BL6J mice, a dose of 5 mg/kg of the levetiracetam-based hybrids was selected for the in vivo efficacy studies.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Efficacy Studies in APP/PS1 Mice</h3><div class="NLM_p">After having demonstrated the ability of the levetiracetam-based hybrids to inhibit hAChE and hBChE in vitro and Aβ42 and tau aggregation in the <i>E. coli</i> model and to cross the BBB in vivo, it remained to be determined whether this multitarget profile might lead in vivo to a reduction of the Alzheimer-like phenotype, including cognitive deficits, amyloid pathology, and neuroinflammation. Particularly, we were very intrigued to see any potential reduction of epileptiform activity or seizures that might be ascribed to the presence of the levetiracetam pharmacophoric moiety of the hybrids and might be involved in their putative disease-modifying effects. Thus, we performed a chronic in vivo efficacy study using a well-established mouse model of AD, namely, transgenic APP/PS1 mice. Levetiracetam-based hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> at a dose of 5 mg/kg or vehicle were administered ip once daily for 4 weeks to 5-month-old transgenic mice (presymptomatic phase, <i>n</i> = 6–10 per group). Hybrids and vehicle were also administered using the same protocol to wild-type (C57BL6J) littermates (<i>n</i> = 6–11 per group), to enable the confirmation of the AD-like phenotype of APP/PS1 mice by comparison between both genotypes and to evaluate the chronic toxicity of the compounds in both healthy and AD-like mice. During the daily manipulation, the general health status of animals was monitored and their body weight, spontaneous seizures leading to convulsions, and abnormal behavior were recorded. After a 2-day washout period, animals were subjected to behavioral evaluation. At the end of the behavioral testing, the animals were sacrificed and their brains collected and processed for the quantification of cortical soluble Aβ40 and Aβ42 levels, cortical amyloid burden, and gliosis associated with Aβ deposition.</div><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effect of the Levetiracetam-Based Hybrids on Epileptic Seizures and General Health</h4><div class="NLM_p">Some lines of hAPP mice have convulsive seizures, although such events appear not to be very frequent in most hAPP mice.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Indeed, during the 4-week-treatment period, only 8 spontaneous seizures episodes were recorded in vehicle-treated APP/PS1 mice out of a total number of events of 330 (number of animals × days of observation), whereas none of the wild-type animals suffered any spontaneous seizure during the observation period. Notwithstanding the relatively low incidence of epileptic seizures in the vehicle-treated transgenic control group, a lower number of seizures was found in the APP/PS1 mice treated with all the levetiracetam-based hybrids, i.e., 4 episodes/300 events and 4 episodes/180 events in animals treated with the racemic compounds <b>5</b> and <b>6</b>, respectively, and only 1 episode/329 events and 2 episodes/180 events in the animals treated with the enantiopure compounds <b>10</b> and <b>11</b>, respectively, which feature the eutomeric form of levetiracetam as an antiepileptic [(<i>S</i>)-levetiracetam]. The χ<sup>2</sup> test revealed a significant reduction in the frequency of spontaneous convulsions in APP/PS1 mice treated with the levetiracetam–huprine hybrid <b>10</b> (χ<sup>2</sup><sub>(1)</sub> = 5.3880, <i>p</i> < 0.05), but not in the other compounds, when compared to vehicle-treated littermates.</div><div class="NLM_p last">The mechanism of antiepileptic action of levetiracetam, by modulation of synaptic vesicle protein SV2A<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> or by inhibition of presynaptic Ca<sub>V</sub> channels,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> has been reported that might result in altered cholinergic neurotransmission.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Also, a wide range of behavioral adverse effects has been reported to occur in up to 16% of patients treated with levetiracetam.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> These adverse effects might negatively impact the disease process. However, no significant body weight loss or other clinical signs were recorded in any of the wild-type or APP/PS1 mice treated with the novel levetiracetam-based hybrids, apart from the above-mentioned seizures, suggesting lack of side effects related to the chronic administration of the hybrid compounds in both healthy and AD-like animals.</div></div><div id="sec2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Behavioral Evaluation of Cognitive Performance</h4><div class="NLM_p">The effects of the levetiracetam-based hybrids on cognition were evaluated through the two-object recognition test. After 2 days of training in which mice were allowed first to explore the apparatus and then to explore two identical objects placed at the end of the arms of the maze during 9 min each session, one of the two familiar objects was replaced by a novel object and the time spent exploring the two objects was recorded. The object recognition index (RI) was calculated as the difference between the time spent exploring the novel (<i>T</i><sub>N</sub>) and the familiar object (<i>T</i><sub>F</sub>) divided by the total time spent exploring the two objects [RI = (<i>T</i><sub>N</sub> – <i>T</i><sub>F</sub>)/(<i>T</i><sub>N</sub> + <i>T</i><sub>F</sub>)]. Low RI values are indicative of memory impairment.</div><div class="NLM_p">APP/PS1 mice treated with vehicle and hybrids <b>6</b> and <b>11</b> exhibited low RI values and, hence, memory impairment in the two-object recognition test at 6 months of age (end of treatment and beginning of the symptomatic phase in APP/PS1 mice) when compared to corresponding WT littermates (<i>p</i> < 0.01, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Interestingly, APP/PS1 mice treated with hybrids <b>5</b> and <b>10</b> exhibited significantly increased recognition indices when compared to vehicle-treated animals (<i>p</i> < 0.05 in both cases). Thus, the levetiracetam–tacrine hybrid <b>5</b> and the levetiracetam–huprine hybrid <b>10</b> were able to prevent the memory impairment in APP/PS1 mice when administered at the presymptomatic stage. It is worth noting that the effective dose of hybrids <b>5</b> and <b>10</b> used in the present study (5 mg kg<sup>–1</sup> day<sup>–1</sup>) is much lower than the levetiracetam doses reported to be effective in previous studies (50–75 mg kg<sup>–1</sup> day<sup>–1</sup>) by using similar animal models of AD,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> thereby suggesting that the new compounds may exhibit a better therapeutic profile than levetiracetam itself.</div><div class="NLM_p">The cognition enhancing effects of hybrids <b>5</b> and <b>10</b> seem to be independent from their acute cholinesterase inhibitory activities. On the one hand, the results obtained in the behavioral test do not correlate with the in vitro anticholinesterasic potencies of the different hybrids. On the other hand, and more importantly, taking into account that the behavioral test was carried out 4 days after stopping compound treatments (2 days of washout period + 2 days of the training phase), it seems very likely that the cognition improvement found in APP/PS1 mice treated with hybrids <b>5</b> and <b>10</b> is not a mere result of an acute cholinergic action but rather it reflects long-lasting molecular modifications.</div><div class="NLM_p">In the light of the positive effect observed at the cognitive level in animals treated with hybrids <b>5</b> and <b>10</b> and the absence of any positive effect in animals treated with the other two compounds, further molecular studies were performed only on brain samples obtained from animals treated with <b>5</b> and <b>10</b>.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Memory performance in the two-object recognition test of wild-type (WT) and APP/PS1 mice after chronic treatment with the novel levetiracetam-based hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> (5 mg kg<sup>–1</sup> day<sup>–1</sup>, 4 weeks, ip). APP/PS1 mice chronically treated with vehicle (Veh), <b>6</b>, and <b>11</b> exhibit a significant reduction in the recognition index when compared to corresponding wild-type littermates. In contrast, chronic administration of <b>5</b> and <b>10</b> induces memory improvement in APP/PS1 mice, as demonstrated by the significant increase in the recognition index compared to transgenic mice treated with vehicle: (★★) <i>p</i> < 0.01 genotype effect; (☆) <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Effect of the Levetiracetam-Based Hybrids on Amyloid Burden and Soluble Aβ Levels</h4><div class="NLM_p">Aβ burden was quantified by immunohistochemical determination in the main regions of Aβ deposition in the neocortex of APP/PS1 mice treated with vehicle or hybrids <b>5</b> and <b>10</b>. Also, to assess whether the positive effects of these compounds on cognition arise from a reduction in the production of Aβ, the levels of soluble Aβ40 and Aβ42, two of the most toxic forms of Aβ peptide, were also quantified in the soluble fractions from cortex homogenates of APP/PS1 mice treated with these hybrids.</div><div class="NLM_p">Chronic treatment with the levetiracetam–huprine hybrid <b>10</b> reduced the Aβ burden in the cortex of APP/PS1 mice when compared to vehicle-treated animals (<i>p</i> < 0.05), whereas no significant modifications in the cortical Aβ burden were observed after chronic treatment with the levetiracetam–tacrine hybrid <b>5</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).</div><div class="NLM_p">Cortical soluble Aβ40 and Aβ42 levels were not significantly modified by chronic treatment with these compounds, in spite of a tendency to decrease both peptides in APP/PS1 mice treated with the levetiracetam–huprine hybrid <b>10</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Left: Aβ burden was significantly reduced in cortex of APP/PS1 mice treated with hybrid <b>10</b>. Right: Representative images of Aβ immunoreactivity in cortical sections of APP/PS1 mice subjected to chronic treatment with vehicle (Veh), <b>5</b>, and <b>10</b>. Scale bar represents 200 μm. (B) Soluble Aβ40 and Aβ42 levels were not significantly modified by chronic treatment with <b>5</b> or <b>10</b> in cortical homogenates from APP/PS1 mice, despite a tendency to decrease both peptides in mice treated with <b>10</b>. Data are expressed as the mean values ± SEM: (☆) <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The levetiracetam–huprine hybrid <b>10</b> was the most potent Aβ42 and tau antiaggregating compound of the series in the assay in <i>E. coli</i> cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The antiaggregating action of <b>10</b> seems to operate also in APP/PS1 mice, thereby accounting for the significant reduction of amyloid burden in the transgenic mice treated with this compound.</div></div><div id="sec2_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Effect of the Levetiracetam-Based Hybrids on Gliosis Associated with Aβ Deposition</h4><div class="NLM_p">The effects of the chronic treatment with hybrids <b>5</b> and <b>10</b> on the astrocytic and microglial responses to Aβ deposition in the neocortex of APP/PS1 mice were evaluated by glial and Aβ double immunofluorescence and densitometric quantification of GFAP and Iba1 protein expression levels around Aβ plaques. These assays revealed that chronic treatment with the levetiracetam–huprine hybrid <b>10</b> produced a significant reduction of GFAP positive astrocytes around Aβ plaques in APP/PS1 mice (<i>p</i> < 0.01, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). In a similar way, the number of Iba1 positive microglial cells associated with Aβ plaques was significantly reduced by hybrid <b>10</b> (<i>p</i> < 0.01) in comparison to vehicle-treated APP/PS1 animals (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,C), a tendency also observed in transgenic mice treated with hybrid <b>5</b>. These results are compatible with an anti-inflammatory effect of hybrid <b>10</b>, and likely <b>5</b>, considering the role of glial cells in the inflammatory processes occurring in AD.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative images of double GFAP (upper panels, red) or Iba1 (lower panels, red) and Aβ (green) immunoreactivity in cortical sections of APP/PS1 mice chronically treated with vehicle (Veh), <b>5</b>, and <b>10</b>. Scale bars represent 50 μm. Quantification of the glial staining around the Aβ plaques reveals a significant reduction of the astroglial (B) and microglial (C) response in APP/PS1 mice chronically treated with hybrid <b>10</b>. Data are expressed as the mean values ± SEM: (☆☆) <i>p</i> < 0.01 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">High levels of Aβ seem to be responsible for eliciting epileptiform activity and seizures in transgenic mouse models of AD that express human mutated APP, even at the early stages of the disease process.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This Aβ-induced aberrant neuronal network activity seems to be one of the mechanisms by which Aβ exerts its toxic effects to synapses, eventually leading to cognitive deficits, thereby constituting a prime target for AD drug discovery. The therapeutic potential of targeting aberrant neuronal network activity has been demonstrated with the antiepileptic drug levetiracetam, <b>1</b>, which can effectively suppress epileptiform activity and improve cognition in patients with aMCI<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and in different hAPP mouse models of AD.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> In this work, we have designed and synthesized a series of heptamethylene-linked hybrid compounds that combine the structure of <b>1</b> with the structure of a potent inhibitor of AChE such as tacrine, 6-chlorotacrine, or huprine Y, as a novel class of multitarget anti-Alzheimer compounds that might be endowed with the positive effects of <b>1</b> against Aβ-induced epileptiform activity and with a common pattern of inhibitory activities against AChE, BChE, and Aβ42 and tau aggregation found for other structurally related 6-chlorotacrine- and huprine-based hybrids.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> In agreement with the design rationale, the novel levetiracetam-based hybrids are very potent dual inhibitors of hAChE and hBChE in vitro and some of them, especially the enantiopure levetiracetam–huprine hybrid <b>10</b>, also moderately potent dual Aβ42 and tau antiaggregating agents in a simple in vivo model of amyloid aggregation in intact <i>E. coli</i> cells. The brain penetration of the levetiracetam-based hybrids has been demonstrated by acute ip administration of these compounds to C57BL6J mice and subsequent ex vivo determination of their inhibitory activity against AChE from brain homogenates of the treated mice. After a preliminary assessment of the acute toxicity of the novel hybrids in C57BL6J mice, a dose of 5 mg/kg was considered to be safe and was selected for a chronic in vivo efficacy study in transgenic APP/PS1 mice. Very interestingly, the number of epileptic seizures registered during the chronic treatment was lower in all of the groups of transgenic mice treated with the novel hybrids relative to the control transgenic group treated with vehicle, even though only for the group treated with the levetiracetam–huprine hybrid <b>10</b> the reduction of the incidence of epileptic seizures was statistically significant. Hybrids <b>5</b> and <b>10</b> led to a clear cognitive improvement in APP/PS1 mice after 4 days without receiving the compounds, with these results being indicative of a disease-modifying effect, independent from their anticholinesterasic acute action. Moreover, cortical amyloid burden and neuroinflammation around Aβ plaques were significantly reduced in transgenic animals treated with <b>10</b>, without altering the levels of soluble Aβ40 and Aβ42, but not in animals treated with <b>5</b>, which has discouraged us from testing in vivo any of its enantiomers. Likely, the antiaggregating effect found in <i>E. coli</i> for <b>10</b> also operates in transgenic mice, accounting for its positive effects on amyloid burden and cognition, but it seems also quite reasonable that an effect against the aberrant neuronal network activity of transgenic mice, due to the presence of the levetiracetam pharmacophore, might be also contributing to the disease-modifying effect of this compound that results in a significant reduction of epileptic seizures and in cognitive improvement. Indeed, the cognitive enhancing effects reported for <b>1</b> seem to arise only from the suppression of the epileptiform activity, inasmuch as it did not alter either soluble Aβ levels or Aβ deposition.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In the case of the levetiracetam–huprine hybrid <b>10</b>, its putative effect on epileptiform activity is complemented with a direct effect on amyloid and tau pathologies, neuroinflammation, and cholinesterases, thereby emerging as a very promising disease-modifying anti-Alzheimer drug candidate.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p last">Melting points were determined in open capillary tubes with a MFB 595010M Gallenkamp melting point apparatus. 400 MHz <sup>1</sup>H/100.6 MHz <sup>13</sup>C NMR spectra were recorded on a Varian Mercury 400 spectrometer. The chemical shifts are reported in ppm (δ scale) relative to residual solvent signals (CD<sub>3</sub>OD at 3.31 and 49.0 ppm in the <sup>1</sup>H and <sup>13</sup> C NMR spectra, respectively), and coupling constants are reported in hertz (Hz). The <i>syn</i> (<i>anti</i>) notation of the protons at position 13 of the huprine moiety of hybrids (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> and (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b> means that the corresponding proton at position 13 is on the same (different) side of the quinoline moiety with respect to the cyclohexene ring. IR spectra were run on a PerkinElmer Spectrum RX I spectrophotometer. Absorption values are expressed as wavenumbers (cm<sup>–1</sup>); only significant absorption bands are given. Optical rotations were measured on a PerkinElmer model 241 polarimeter. The specific rotation has not been corrected for the presence of solvent of crystallization. Column chromatography was performed on silica gel 60 AC.C (40–60 mesh, SDS, ref 2000027). Thin-layer chromatography was performed with aluminum-backed sheets with silica gel 60 F<sub>254</sub> (Merck, ref 1.05554), and spots were visualized with UV light and 1% aqueous KMnO<sub>4</sub>. NMR spectra of all of the new compounds were performed at the Centres Cientı́fics i Tecnològics of the University of Barcelona (CCiTUB), while elemental analyses and high resolution mass spectra were carried out at the Mycroanalysis Service of the IIQAB (CSIC, Barcelona, Spain) with a Carlo Erba 1106 analyzer and at the CCiTUB with a LC/MSD TOF Agilent Technologies spectrometer, respectively. The analytical samples of all of the levetiracetam-based hybrids which were subjected to pharmacological evaluation possess a purity of ≥95% as indicated by their elemental analyses [(±)-<b>5</b>, and (±)-<b>6</b>] or by HPLC measurements [(<i>S</i>)-<b>5</b>, (<i>R</i>)-<b>5</b>, <b>10</b>, and <b>11</b>]. The enantiopurity of the levetiracetam–tacrine hybrids (<i>S</i>)-<b>5</b> and (<i>R</i>)-<b>5</b> was confirmed by chiral HPLC, carried out with a PerkinElmer model 200 chromatograph equipped with a variable λ UV detector, using a CHIRALPAK IC column, a mixture of heptane/<i>i</i>-PrOH/diethylamine 55:45:0.1 as the eluent, flow 1 mL/min, λ = 235 nm; (<i>R</i>)-<b>5</b>, retention time = 35.99 min; (<i>S</i>)-<b>5</b>, retention time = 55.90 min. The enantio- and diastereo-purity of the levetiracetam–huprine hybrids (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> and (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b> was confirmed by chiral HPLC, using the above-described equipment and conditions but with a mixture of heptane/<i>i</i>-PrOH/diethylamine 63:37:0.1 as the eluent; (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b>, retention time = 34.65 min; (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b>, retention time = 36.36 min.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (±)-<i>N</i>-{7-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(±)-<b>5</b>]</h3><div class="NLM_p">A solution of (±)-2-(2-oxopyrrolidin-1-yl)butanoic acid [(±)-<b>4</b>] (445 mg, 2.60 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (26 mL) was cooled to 0 °C with an ice bath and treated dropwise with anhydrous Et<sub>3</sub>N (0.72 mL, 525 mg, 5.20 mmol) and ClCO<sub>2</sub>Et (0.25 mL, 282 mg, 2.60 mmol). The resulting mixture was stirred at 0 °C for 30 min and treated with a solution of amine <b>2</b> (810 mg, 2.60 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (20 mL). The reaction mixture was stirred at rt for 3 days and treated with 10% aq Na<sub>2</sub>CO<sub>3</sub> (150 mL). The phases were separated, and the aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 150 mL). The combined organic extracts were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and evaporated under reduced pressure to give a crude product (1.25 g), which was subjected to column chromatography [40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures]. On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.8:0.2:0.2 to 98:2:0.2, levetiracetam–tacrine hybrid (±)-<b>5</b> (1.12 g, 93% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.52 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last">A solution of (±)-<b>5</b> (1.12 g, 2.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (60 mL) was filtered through a 0.2 μm NYL filter, treated with methanolic HCl (0.55 N, 19.7 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 5 mL) to give, after drying at 40 °C/30 Torr for 48 h, (±)-<b>5</b>·HCl (641 mg) as a very hygroscopic yellowish solid: mp 55–58 °C; IR (KBr) ν 3500–2500 (max at 3243, 3060, 2928, 2854, N–H, N<sup>+</sup>–H, and C–H st), 1654, 1633, 1580, 1572, 1522 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.89 (dd, <i>J</i> = <i>J</i>′ = 7.2 Hz, 3H, 4-H<sub>3</sub>), 1.25–1.53 (complex signal, 8H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>, 4″-H<sub>2</sub>, 5″-H<sub>2</sub>), 1.70 (ddq, <i>J</i> = 14.4 Hz, <i>J</i>′ = 9.6 Hz, <i>J</i>″ = 7.2 Hz, 1H, 3-H<sub>a</sub>), 1.79–2.08 (complex signal, 9H, 3-H<sub>b</sub>, 4′-H<sub>2</sub>, 6″-H<sub>2</sub>, 2‴-H<sub>2</sub>, 3‴-H<sub>2</sub>), 2.40 (m, 2H, 3′-H<sub>2</sub>), 2.71 (br t, <i>J</i> = 5.6 Hz, 2H, 1‴-H<sub>2</sub>), 3.02 (br t, <i>J</i> = 6.0 Hz, 2H, 4‴-H<sub>2</sub>), 3.16 (td, <i>J</i> = 7.2 Hz, <i>J</i>′ = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 3.46 (m, 1H) and 3.56 (m, 1H) (5′-H<sub>2</sub>), 3.95 (t, <i>J</i> = 7.6 Hz, 2H, 7″-H<sub>2</sub>), 4.40 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 2-H), 4.85 (s, NH, <sup>+</sup>NH), 7.59 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.6 Hz, 1H, 7‴-H), 7.76 (br d, <i>J</i> = 8.4 Hz, 1H, 5‴-H), 7.85 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.2 Hz, 1H, 6‴-H), 7.97 (br signal, 1H, NHCO), 8.40 (br d, <i>J</i> = 8.4 Hz, 1H, 8‴-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 11.0 (CH<sub>3</sub>, C4), 19.2 (CH<sub>2</sub>, C3), 21.8 (CH<sub>2</sub>, C3‴), 23.0 (CH<sub>2</sub>, C2‴), 23.2 (CH<sub>2</sub>, C4′), 24.9 (CH<sub>2</sub>, C1‴), 27.6 (CH<sub>2</sub>, C5″), 27.7 (CH<sub>2</sub>, C3″), 29.3 (CH<sub>2</sub>, C4‴), 29.8 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>, C2″ major rotamer), 30.7 (CH<sub>2</sub>, C2″ minor rotamer), 31.4 (CH<sub>2</sub>, C6″), 32.0 (CH<sub>2</sub>, C3′), 40.2 (CH<sub>2</sub>, C1″ minor rotamer), 40.3 (CH<sub>2</sub>, C1″ major rotamer), 45.4 (CH<sub>2</sub>, C5′), 49.1 (CH<sub>2</sub>, C7″), 57.97 (CH, C2 minor rotamer), 58.01 (CH, C2 major rotamer), 112.8 (C) and 117.0 (C) (C8a‴, C9a‴), 120.1 (CH, C5‴), 126.3 (CH, C7‴), 126.5 (CH, C8‴), 134.1 (CH, C6‴), 139.8 (C, C10a‴), 151.7 (C, C4a‴), 158.0 (C, C9‴), 172.4 (C, C1 minor rotamer), 172.5 (C, C1 major rotamer), 178.4 (C, C2′). HRMS (ESI) calcd for (C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 465.3224, found 465.3212. Anal. (C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub>·HCl·1.25H<sub>2</sub>O) C, H, N, Cl. HPLC purity 95%.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>S</i>)-<i>N</i>-{7-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(<i>S</i>)-<b>5</b>]</h3><div class="NLM_p">It was prepared as described for (±)-<b>5</b>. From acid (<i>S</i>)-<b>4</b> (159 mg, 0.93 mmol) and amine <b>2</b> (291 mg, 0.93 mmol), a crude product (732 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.8:0.2:0.2 to 99.6:0.4:0.2, impure levetiracetam–tacrine hybrid (<i>S</i>)-<b>5</b> (568 mg) was isolated; <i>R</i><sub><i>f</i></sub> = 0.52 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last">A solution of impure (<i>S</i>)-<b>5</b> (568 mg) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) was filtered through a 0.2 μm NYL filter, treated with methanolic HCl (0.55 N, 11 mL), and evaporated under reduced pressure. The resulting solid was taken in MeOH (0.75 mL) and precipitated from EtOAc (4 mL). The solid was washed with pentane (3 × 5 mL) to give, after drying at 40 °C/30 Torr for 48 h, pure (<i>S</i>)-<b>5</b>·HCl (281 mg, 60% yield) as a very hygroscopic yellowish solid: [α]<sup>20</sup><sub>D</sub> −36 (<i>c</i> 0.46, MeOH); mp 49–51 °C; IR (ATR) ν 3500–2500 (max at 3232, 3055, 2924, 2850, N–H, N<sup>+</sup>–H, and C–H st), 1657, 1650, 1632, 1580, 1573, 1523 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (<i>S</i>)-<b>5</b>·HCl were identical to those of the racemic compound (±)-<b>5</b>. HRMS (ESI) calcd for (C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 465.3224, found 465.3223. HPLC purity 96%.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (<i>R</i>)-<i>N</i>-{7-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(<i>R</i>)-<b>5</b>]</h3><div class="NLM_p last">It was prepared as described for (±)-<b>5</b>. From acid (<i>R</i>)-<b>4</b> (128 mg, 0.75 mmol) and amine <b>2</b> (232 mg, 0.75 mmol), a crude product (295 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99:1:0.2, levetiracetam–tacrine hybrid (<i>R</i>)-<b>5</b> (93 mg, 27% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.52 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (<i>R</i>)-<b>5</b>·HCl: [α]<sup>20</sup><sub>D</sub> +32 (<i>c</i> 1.25, MeOH); mp 61–63 °C; IR (ATR) ν 3500–2500 (max at 3256, 3115, 3048, 2927, 2846, N–H, N<sup>+</sup>–H, and C–H st), 1659, 1651, 1633, 1568, 1524 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (<i>R</i>)-<b>5</b>·HCl were identical to those of the racemic compound (±)-<b>5</b>. HRMS (ESI) calcd for (C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 465.3224, found 465.3224. HPLC purity >99%.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (±)-<i>N</i>-{7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(±)-<b>6</b>]</h3><div class="NLM_p last">It was prepared as described for (±)-<b>5</b>. From acid (±)-<b>4</b> (298 mg, 1.74 mmol) and amine <b>3</b> (602 mg, 1.74 mmol), a crude product (892 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.8:0.2:0.2 to 99:1:0.2, levetiracetam–chlorotacrine hybrid (±)-<b>6</b> (677 mg, 78% yield) was isolated; <i>R</i><sub><i>f</i></sub> = 0.65 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (±)-<b>6</b>·HCl: mp 65–68 °C; IR (KBr) ν 3500–2500 (max at 3251, 3050, 2928, 2854, 2802, 2749, N–H, N<sup>+</sup>–H, and C–H st), 1659, 1652, 1632, 1601, 1573, 1538, 1519 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.89 (dd, <i>J</i> = <i>J</i>′ = 7.2 Hz, 3H, 4-H<sub>3</sub>), 1.25–1.54 (complex signal, 8H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>, 4″-H<sub>2</sub>, 5″-H<sub>2</sub>), 1.70 (ddq, <i>J</i> = 14.4 Hz, <i>J</i>′ = 9.6 Hz, <i>J</i>″ = 7.2 Hz, 1H, 3-H<sub>a</sub>), 1.79–2.10 (complex signal, 9H, 3-H<sub>b</sub>, 4′-H<sub>2</sub>, 6″-H<sub>2</sub>, 2‴-H<sub>2</sub>, 3‴-H<sub>2</sub>), 2.40 (m, 2H, 3′-H<sub>2</sub>), 2.68 (m, 2H, 1‴-H<sub>2</sub>), 3.00 (t, <i>J</i> = 5.6 Hz, 2H, 4‴-H<sub>2</sub>), 3.15 (br t, <i>J</i> = 7.2 Hz, 2H, 1″-H<sub>2</sub>), 3.46 (m, 1H) and 3.57 (m, 1H) (5′-H<sub>2</sub>), 3.94 (t, <i>J</i> = 7.6 Hz, 2H, 7″-H<sub>2</sub>), 4.40 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 2-H), 4.85 (s, NH, <sup>+</sup>NH), 7.57 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7‴-H), 7.78 (d, <i>J</i> = 2.0 Hz, 1H, 5‴-H), 7.58 (br signal, 1H, NHCO), 8.39 (d, <i>J</i> = 9.2 Hz, 1H, 8‴-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 11.0 (CH<sub>3</sub>, C4), 19.2 (CH<sub>2</sub>, C3), 21.8 (CH<sub>2</sub>, C3‴), 22.9 (CH<sub>2</sub>, C2‴), 23.2 (CH<sub>2</sub>, C4′), 24.8 (CH<sub>2</sub>, C1‴), 27.6 (CH<sub>2</sub>, C5″), 27.7 (CH<sub>2</sub>, C3″), 29.4 (CH<sub>2</sub>, C4‴), 29.8 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>, C2″ major rotamer), 30.7 (CH<sub>2</sub>, C2″ minor rotamer), 31.3 (CH<sub>2</sub>, C6″), 32.0 (CH<sub>2</sub>, C3′), 40.2 (CH<sub>2</sub>, C1″ major rotamer), 40.3 (CH<sub>2</sub>, C1″ minor rotamer), 45.4 (CH<sub>2</sub>, C5′), 49.2 (CH<sub>2</sub>, C7″), 58.0 (CH, C2), 113.4 (C, C9a‴), 115.5 (C, C8a‴), 119.2 (CH, C5‴), 126.7 (CH, C7‴), 128.8 (CH, C8‴), 140.0 (C, C6‴), 140.6 (C, C10a‴), 152.2 (C, C4a‴), 157.8 (C, C9‴), 172.4 (C, C1 major rotamer), 172.5 (C, C1 minor rotamer), 178.4 (C, C2′). HRMS (ESI) calcd for (C<sub>28</sub>H<sub>39</sub><sup>35</sup>ClN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 499.2834, found 499.2827. Anal. (C<sub>28</sub>H<sub>39</sub>ClN<sub>4</sub>O<sub>2</sub>·HCl·H<sub>2</sub>O) C, H, N, Cl. HPLC purity >99%.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (7<i>S</i>,11<i>S</i>)-7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]heptanenitrile [(7<i>S</i>,11<i>S</i>)-<b>8</b>]</h3><div class="NLM_p">A suspension of (7<i>S</i>,11<i>S</i>)-huprine Y, (7<i>S</i>,11<i>S</i>)-<b>7</b> (1.00 g, 3.52 mmol), and finely powdered NaOH (0.46 g, 11.6 mmol) and 4 Å molecular sieves in anhydrous DMSO (15 mL) was stirred, heating every 10 min approximately with a heat gun for 1 h and at rt one additional hour, and then treated with a solution of 7-bromoheptanenitrile (90% purity reagent, 0.61 mL, 0.77 g, 4.05 mmol) in anhydrous DMSO (1 mL) dropwise for 30 min. The reaction mixture was stirred at rt overnight, diluted with aq 2 N NaOH (50 mL), and extracted with EtOAc (3 × 75 mL). The combined organic extracts were washed with H<sub>2</sub>O and aq 5 N NaOH (6 × 100 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to give a yellow oily residue (953 mg), which was purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 97.5:2.5:0.2, nitrile (7<i>S</i>,11<i>S</i>)-<b>8</b> (514 mg, 52% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.80 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last">A solution of (7<i>S</i>,11<i>S</i>)-<b>8</b> (40 mg, 0.10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was filtered through a 0.2 μm NYL filter, treated with methanolic HCl (0.53 N, 0.58 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 5 mL) to give, after drying at 65 °C/30 Torr for 48 h, (7<i>S</i>,11<i>S</i>)-<b>8</b>·HCl (43 mg) as a yellowish solid: [α]<sup>20</sup><sub>D</sub> −203 (<i>c</i> 1, MeOH); mp 98–102 °C; IR (KBr) ν 3500–2500 (max at 3229, 3044, 2928, 2905, 2865, 2759, N–H, N<sup>+</sup>–H, and C–H st), 2234 (CN st), 1630, 1582, 1567, 1513 (Ar–C–C and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (7<i>S</i>,11<i>S</i>)-<b>8</b>·HCl were identical to those reported for the racemic compound.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HRMS (ESI) calcd for (C<sub>24</sub>H<sub>28</sub><sup>35</sup>ClN<sub>3</sub> + H<sup>+</sup>): 394.2045, found 394.2049.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (7<i>R</i>,11<i>R</i>)-7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]heptanenitrile [(7<i>R</i>,11<i>R</i>)-<b>8</b>]</h3><div class="NLM_p last">It was prepared as described for (7<i>S</i>,11<i>S</i>)-<b>8</b>. From (7<i>R</i>,11<i>R</i>)-<b>7</b> (1.00 g, 3.52 mmol) and 7-bromoheptanenitrile (90% purity reagent, 0.61 mL, 0.77 g, 4.05 mmol), a yellow oily residue (780 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 100:0:0.2 to 95:5:0.2, nitrile (7<i>R</i>,11<i>R</i>)-<b>8</b> (755 mg, 55% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.80 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (7<i>R</i>,11<i>R</i>)-<b>8</b>·HCl: [α]<sup>20</sup><sub>D</sub> +234 (<i>c</i> 0.52, MeOH); mp 107–110 °C; IR (KBr) ν 3500–2500 (max at 3229, 3044, 2925, 2854, 2775, N–H, N<sup>+</sup>–H, and C–H st), 2242 (CN st), 1631, 1581, 1560, 1513 (Ar–C–C and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (7<i>R</i>,11<i>R</i>)-<b>8</b>·HCl were identical to those reported for the racemic compound.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HRMS (ESI) calcd for (C<sub>24</sub>H<sub>28</sub><sup>35</sup>ClN<sub>3</sub> + H<sup>+</sup>): 394.2045, found 394.2046.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (7<i>S</i>,11<i>S</i>)-<i>N</i>-(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)heptane-1,7-diamine [(7<i>S</i>,11<i>S</i>)-<b>9</b>]</h3><div class="NLM_p">A solution of nitrile (7<i>S</i>,11<i>S</i>)-<b>8</b> (474 mg, 1.20 mmol) in anhydrous Et<sub>2</sub>O (22 mL) was cooled to 0 °C and treated dropwise with a 4 M solution of LiAlH<sub>4</sub> in Et<sub>2</sub>O (0.90 mL, 3.60 mmol). The reaction mixture was stirred at rt for 20 h and then treated dropwise with H<sub>2</sub>O and 5 N NaOH and extracted with EtOAc (3 × 100 mL). The combined organic extracts were washed with H<sub>2</sub>O (3 × 100 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and evaporated under reduced pressure to furnish amine (7<i>S</i>,11<i>S</i>)-<b>9</b> (432 mg, 91% yield) as a yellowish oil; <i>R</i><sub><i>f</i></sub> = 0.16 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05).</div><div class="NLM_p last">A solution of (7<i>S</i>,11<i>S</i>)-<b>9</b> (40 mg, 0.10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was filtered through a 0.2 μm PTFE filter, treated with methanolic HCl (0.53 N, 1.71 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 2 mL) to give, after drying at 65 °C/30 Torr for 48 h, (7<i>S</i>,11<i>S</i>)-<b>9</b>·2HCl (45 mg) as a yellow solid: [α]<sup>20</sup><sub>D</sub> −197 (<i>c</i> 1.14, MeOH); mp 176–180 °C; IR (KBr) ν 3500–2500 (max at 3250, 2891, 2870, N–H, N<sup>+</sup>–H, and C–H st), 1629, 1580, 1548, 1538, 1514 (Ar–C–C and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (7<i>S</i>,11<i>S</i>)-<b>9</b>·2HCl were identical to those reported for the racemic compound.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HRMS (ESI) calcd for (C<sub>24</sub>H<sub>32</sub><sup>35</sup>ClN<sub>3</sub> + H<sup>+</sup>): 398.2358, found 398.2356.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (7<i>R</i>,11<i>R</i>)-<i>N</i>-(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)heptane-1,7-diamine [(7<i>R</i>,11<i>R</i>)-<b>9</b>]</h3><div class="NLM_p last">It was prepared as described for (7<i>S</i>,11<i>S</i>)-<b>9</b>. From nitrile (7<i>R</i>,11<i>R</i>)-<b>8</b> (599 mg, 1.52 mmol), a yellow oily residue (445 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.8:0.2:1 to 99:1:1, amine (7<i>R</i>,11<i>R</i>)-<b>9</b> (270 mg, 45% yield) was isolated as a yellowish oil; <i>R</i><sub><i>f</i></sub> = 0.16 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (7<i>R</i>,11<i>R</i>)-<b>9</b>·2HCl: [α]<sup>20</sup><sub>D</sub> +176 (<i>c</i> 1.08, MeOH); mp 179–183 °C; IR (KBr) ν 3500–2500 (max at 3240, 2923, 2849, 2802, N–H, N<sup>+</sup>–H, and C–H st), 1629, 1581, 1551, 1513 (Ar–C–C and Ar–C–N st) cm<sup>–1</sup>. The <sup>1</sup>H and <sup>13</sup>C NMR spectra of (7<i>R</i>,11<i>R</i>)-<b>9</b>·2HCl were identical to those reported for the racemic compound.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> HRMS (ESI) calcd for (C<sub>24</sub>H<sub>32</sub><sup>35</sup>ClN<sub>3</sub> + H<sup>+</sup>): 398.2358, found 398.2356.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<i>N</i>-{7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b>]</h3><div class="NLM_p last">It was prepared as described for (±)-<b>5</b>. From acid (<i>S</i>)-<b>4</b> (169 mg, 0.99 mmol) and amine (7<i>S</i>,11<i>S</i>)-<b>9</b> (392 mg, 0.99 mmol), a crude product (681 mg) was obtained. After two consecutive column chromatography purifications (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures and hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution), levetiracetam–huprine hybrid (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> (30 mg on elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.95:0.05:0.2 + 131 mg on elution with hexane/EtOAc/Et<sub>3</sub>N 30:70:0.2 to 10:90:0.2, 30% total yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.71 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b>·HCl: [α]<sup>20</sup><sub>D</sub> −195 (<i>c</i> 0.80, MeOH); mp 96–99 °C; IR (KBr) ν 3500–2500 (max at 3249, 3055, 2925, 2854, 2786, N–H, N<sup>+</sup>–H, and C–H st), 1656, 1649, 1633, 1581, 1565, 1518 (C═O, Ar–C–C and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.89 (dd, <i>J</i> = <i>J</i>′ = 7.2 Hz, 3H, 4-H<sub>3</sub>), 1.24–1.54 (complex signal, 8H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>, 4″-H<sub>2</sub>, 5″-H<sub>2</sub>), 1.58 (s, 3H, 9‴-CH<sub>3</sub>), 1.70 (ddq, <i>J</i> = 14.4 Hz, <i>J</i>′ = 9.6 Hz, <i>J</i>″ = 7.2 Hz, 1H, 3-H<sub>a</sub>), 1.80–2.11 (complex signal, 7H, 3-H<sub>b</sub>, 4′-H<sub>2</sub>, 6″-H<sub>2</sub>, 13‴-H<sub><i>syn</i></sub>, 13‴-H<sub><i>anti</i></sub>), overimposed in part 1.93 (br d, <i>J</i> = 17.6 Hz, 1H, 10‴-H<sub><i>endo</i></sub>), 2.40 (m, 2H, 3′-H<sub>2</sub>), 2.55 (br dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 4.8 Hz, 1H, 10‴-H<sub><i>exo</i></sub>), 2.77 (m, 1H, 7‴-H), 2.88 (br d, <i>J</i> = 18.0 Hz, 1H, 6‴-H<sub><i>endo</i></sub>), 3.16 (td, <i>J</i> = 6.8 Hz, <i>J</i>′ = 6.0 Hz, 2H, 1″-H<sub>2</sub>), overimposed in part 3.21 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 6‴-H<sub><i>exo</i></sub>), overimposed 3.42–3.49 (m, 1H, 11‴-H), 3.46 (m, 1H) and 3.57 (m, 1H) (5′-H<sub>2</sub>), 3.98 (t, <i>J</i> = 7.6 Hz, 2H, 7″-H<sub>2</sub>), 4.41 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 2-H), 4.85 (s, NH, <sup>+</sup>NH), 5.59 (br d, <i>J</i> = 4.8 Hz, 1H, 8‴-H), 7.55 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 1.6 Hz, 1H, 2‴-H), 7.78 (d, <i>J</i> = 1.6 Hz, 1H, 4‴-H), 7.99 (m, 1H, NHCO), 8.40 (d, <i>J</i> = 9.6 Hz, 1H, 1‴-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 11.0 (CH<sub>3</sub>, C4), 19.2 (CH<sub>2</sub>, C3), 23.2 (CH<sub>2</sub>, C4′), 23.5 (CH<sub>3</sub>, 9‴-CH<sub>3</sub>), 27.3 (CH, C11‴), 27.7 (2 CH<sub>2</sub>, C3″, C5″), 27.8 (CH, C7‴), 29.3 (CH<sub>2</sub>, C13‴), 29.8 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>, C2″ major rotamer), 30.7 (CH<sub>2</sub>, C2″ minor rotamer), 31.2 (CH<sub>2</sub>, C6″), 32.0 (CH<sub>2</sub>, C3′), 36.0 (CH<sub>2</sub>) and 36.1 (CH<sub>2</sub>) (C6‴, C10‴), 40.2 (CH<sub>2</sub>, C1″ minor rotamer), 40.3 (CH<sub>2</sub>, C1″ major rotamer), 45.4 (CH<sub>2</sub>, C5′), 49.6 (CH<sub>2</sub>, C7″), 57.96 (CH, C2 minor rotamer), 58.00 (CH, C2 major rotamer), 115.6 (C, C12a‴), 117.6 (C, C11a‴), 119.1 (CH, C4‴), 125.1 (CH, C8‴), 126.7 (CH, C2‴), 129.5 (CH, C1‴), 134.5 (C, C9‴), 140.2 (C, C3‴), 141.0 (C, C4a‴), 151.2 (C, C5a‴), 156.9 (C, C12‴), 172.36 (C, C1 minor rotamer), 172.44 (C, C1 major rotamer), 178.4 (C, C2′). HRMS (ESI) calcd for (C<sub>32</sub>H<sub>43</sub><sup>35</sup>ClN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 551.3147, found 551.3135; HPLC purity 96%.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<i>N</i>-{7-[(3-Chloro-6,7,10,11-tetrahydro-9-methyl-7,11-methanocycloocta[<i>b</i>]quinolin-12-yl)amino]heptyl}-2-(2-oxopyrrolidin-1-yl)butanamide [(2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b>]</h3><div class="NLM_p last">It was prepared as described for (±)-<b>5</b>. From acid (<i>S</i>)-<b>4</b> (99 mg, 0.58 mmol) and amine (7<i>R</i>,11<i>R</i>)-<b>9</b> (230 mg, 0.58 mmol), a crude product (343 mg) was obtained and purified by column chromatography (40–60 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.95:0.05:0.2, levetiracetam–huprine hybrid (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b> (176 mg, 56% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> = 0.70 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 9:1:0.05). (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b>·HCl: [α]<sup>20</sup><sub>D</sub> +152 (<i>c</i> 0.48, MeOH); mp 102–105 °C; IR (KBr) ν 3500–2500 (max at 3256, 3055, 2925, 2854, 2796, N–H, N<sup>+</sup>–H and C–H st), 1657, 1649, 1630, 1581, 1565, 1514 (C═O, Ar–C–C, and Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 0.89 (dd, <i>J</i> = <i>J</i>′ = 7.2 Hz, 3H, 4-H<sub>3</sub>), 1.25–1.54 (complex signal, 8H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>, 4″-H<sub>2</sub>, 5″-H<sub>2</sub>), 1.58 (s, 3H, 9‴-CH<sub>3</sub>), 1.70 (ddq, <i>J</i> = 14.4 Hz, <i>J</i>′ = 9.6 Hz, <i>J</i>″ = 7.2 Hz, 1H, 3-H<sub>a</sub>), 1.80–2.12 (complex signal, 7H, 3-H<sub>b</sub>, 4′-H<sub>2</sub>, 6″-H<sub>2</sub>, 13‴-H<sub><i>syn</i></sub>, 13‴-H<sub><i>anti</i></sub>), overimposed in part 1.93 (br d, <i>J</i> = 17.6 Hz, 1H, 10‴-H<sub><i>endo</i></sub>), 2.40 (m, 2H, 3′-H<sub>2</sub>), 2.55 (br dd, <i>J</i> = 17.6 Hz, <i>J</i>′ = 4.0 Hz, 1H, 10‴-H<sub><i>exo</i></sub>), 2.77 (m, 1H, 7‴-H), 2.88 (br d, <i>J</i> = 18.0 Hz, 1H, 6‴-H<sub><i>endo</i></sub>), 3.16 (td, <i>J</i> = <i>J</i>′ = 6.4 Hz, 2H, 1″-H<sub>2</sub>), overimposed in part 3.21 (dd, <i>J</i> = 18.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 6‴-H<sub><i>exo</i></sub>), overimposed in part 3.45 (m, 1H, 11‴-H), 3.46 (m, 1H) and 3.57 (m, 1H) (5′-H<sub>2</sub>), 3.98 (t, <i>J</i> = 7.2 Hz, 2H, 7″-H<sub>2</sub>), 4.41 (dd, <i>J</i> = 9.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 2-H), 4.86 (s, NH, <sup>+</sup>NH), 5.59 (br d, <i>J</i> = 4.4 Hz, 1H, 8‴-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 2‴-H), 7.78 (d, <i>J</i> = 2.0 Hz, 1H, 4‴-H), 7.99 (m, 1H, NHCO), 8.40 (d, <i>J</i> = 9.2 Hz, 1H, 1‴-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 11.0 (CH<sub>3</sub>, C4), 19.2 (CH<sub>2</sub>, C3), 23.2 (CH<sub>2</sub>, C4′), 23.5 (CH<sub>3</sub>, 9‴-CH<sub>3</sub>), 27.3 (CH, C11‴), 27.7 (2 CH<sub>2</sub>, C3″, C5″), 27.8 (CH, C7‴), 29.3 (CH<sub>2</sub>, C13‴), 29.8 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>, C2″ major rotamer), 30.7 (CH<sub>2</sub>, C2″ minor rotamer), 31.2 (CH<sub>2</sub>, C6″), 32.0 (CH<sub>2</sub>, C3′), 36.0 (CH<sub>2</sub>) and 36.1 (CH<sub>2</sub>) (C6‴, C10‴), 40.2 (CH<sub>2</sub>, C1″ minor rotamer), 40.3 (CH<sub>2</sub>, C1″ major rotamer), 45.4 (CH<sub>2</sub>, C5′), 49.6 (CH<sub>2</sub>, C7″), 57.96 (CH, C2 minor rotamer), 58.00 (CH, C2 major rotamer), 115.6 (C, C12a‴), 117.6 (C, C11a‴), 119.1 (CH, C4‴), 125.1 (CH, C8‴), 126.7 (CH, C2‴), 129.5 (CH, C1‴), 134.5 (C, C9‴), 140.2 (C, C3‴), 141.0 (C, C4a‴), 151.2 (C, C5a‴), 156.9 (C, C12‴), 172.4 (C, C1 minor rotamer), 172.5 (C, C1 major rotamer), 178.4 (C, C2′). HRMS (ESI) calcd for (C<sub>32</sub>H<sub>43</sub><sup>35</sup>ClN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>): 551.3147, found 551.3138; HPLC purity 95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vitro Biological Studies. AChE and BChE Inhibition Assay</h3><div class="NLM_p">Human recombinant AChE (Sigma-Aldrich) and human serum BChE (Sigma-Aldrich) inhibitory activities were evaluated spectrophotometrically by the method of Ellman et al.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The reactions took place in a final volume of 300 μL of 0.1 M phosphate-buffered solution, pH 8.0, containing hAChE or hBChE (0.02 U/mL) and 333 μM 5,5′-dithiobis(2-nitrobenzoic) acid (DTNB; Sigma-Aldrich) solution used to produce the yellow anion of 5-thio-2-nitrobenzoic acid. Inhibition curves were performed in duplicate using at least 10 increasing concentrations of inhibitors and preincubating for 20 min at 37 °C before adding the substrate.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> One duplicate sample without inhibitor was always present to yield 100% of AChE or BChE activities. Then substrates, acetylthiocholine iodide (450 μM; Sigma-Aldrich) or butyrylthiocholine iodide (300 μM; Sigma-Aldrich), were added and the reaction was developed for 5 min at 37 °C. Color production was measured at 414 nm using a LabSystems Multiskan spectrophotometer.</div><div class="NLM_p last">Data from concentration–inhibition experiments of the inhibitors were calculated by nonlinear regression analysis, using the GraphPad Prism program package (GraphPad software; San Diego, CA, USA), which gave estimates of the IC<sub>50</sub> (concentration of drug producing 50% of enzyme activity inhibition). Results are expressed as mean ± SEM of at least four experiments performed in duplicate.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Aβ42 and Tau Aggregation Inhibition Assay in <i>Escherichia coli</i> Cells Overexpressing Aβ42 and Tau</h3><div class="NLM_p">Cloning and overexpression of Aβ42 peptide: <i>Escherichia coli</i> competent cells BL21 (DE3) were transformed with the pET28a vector (Novagen, Inc., Madison, WI, USA) carrying the DNA sequence of Aβ42. Because of the addition of the initiation codon ATG in front of both genes, the overexpressed peptide contains an additional methionine residue at its N terminus. For overnight culture preparation, an amount of 10 mL of M9 minimal medium containing 50 μg·mL<sup>–1</sup> of kanamycin was inoculated with a colony of BL21 (DE3) bearing the plasmid to be expressed at 37 °C. For expression of the Aβ42 peptide, the required volume of overnight culture to obtain 1:500 dilution was added into fresh M9 minimal medium containing 50 μg·mL<sup>–1</sup> of kanamycin and 250 μM Th-S. The bacterial culture was grown at 37 °C and 250 rpm. When the cell density reached OD<sub>600</sub> = 0.6, an amount of 980 μL of culture was transferred into Eppendorf tubes of 1.5 mL with 10 μL of each compound to be tested in DMSO and 10 μL of isopropyl 1-thio-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside (IPTG) at 100 mM. The final concentration of drug was fixed at 20 μM. The samples were grown overnight at 37 °C and 1400 rpm using a Thermomixer (Eppendorf, Hamburg, Germany). As negative control (maximal amyloid presence) the same amount of DMSO without drug was added in the sample. In parallel, noninduced samples (in absence of IPTG) were also prepared and used as positive controls (non-amyloid presence). In addition, these samples were used to assess the potential intrinsic toxicity of the compounds and to confirm the correct bacterial growth.</div><div class="NLM_p"><i>Cloning and Overexpression of Tau Protein.</i><i>E. coli</i> BL21 (DE3) competent cells were transformed with pTARA containing the RNA-polymerase gen of T7 phage (T7RP) under the control of the promoter PBAD. <i>E. coli</i> BL21 (DE3) with pTARA competent cells were transformed with pRKT42 vector encoding four repeats of tau protein in two inserts. For overnight culture preparation, 10 mL of M9 medium containing 0.5% of glucose, 50 μg·mL<sup>–1</sup> of ampicillin, and 12.5 μg·mL<sup>–1</sup> of chloramphenicol were inoculated with a colony of BL21 (DE3) bearing the plasmids to be expressed at 37 °C. For expression of tau protein, the required volume of overnight culture to obtain 1:500 dilution was added to fresh M9 minimal medium containing 0.5% of glucose, 50 μg·mL<sup>–1</sup> of ampicillin, 12.5 μg·mL<sup>–1</sup> of chloramphenicol, and 250 μM Th-S. The bacterial culture was grown at 37 °C and 250 rpm. When the cell density reached OD<sub>600</sub> = 0.6, an amount of 980 μL of culture was transferred into Eppendorf tubes of 1.5 mL with 10 μL of each compound to be tested in DMSO and 10 μL of arabinose at 25%. The final concentration of drug was fixed at 20 μM. The samples were grown overnight at 37 °C and 1400 rpm using a Thermomixer (Eppendorf, Hamburg, Germany). As negative control (maximal presence of tau), the same amount of DMSO without drug was added in the sample. In parallel, noninduced samples (in absence of arabinose) were also prepared and used as positive controls (absence of tau). In addition, these samples were used to assess the potential intrinsic toxicity of the compounds and to confirm the correct bacterial growth.</div><div class="NLM_p last"><i>Thioflavin S (Th-S) Steady-State Fluorescence.</i> Th-S (T1892) and other chemical reagents were purchased from Sigma (St. Louis, MO). Th-S stock solution (2500 mM) was prepared in double-distilled water purified through a Milli-Q system (Millipore, USA). For the fluorescence assay, the Th-S spectra were measured on an Aminco Bowman series 2 luminescence spectrophotometer (Aminco-Bowman AB2, SLM Aminco, Rochester, NY, USA) from 460 to 600 nm at 25 °C using an excitation wavelength of 440 nm and slit widths of 4 nm. The emission at 485 nm (Th-S peak fluorescence in the presence of amyloids) was recorded. In order to normalize the Th-S fluorescence as a function of the bacterial concentration, OD<sub>600</sub> was obtained using a Shimadzu UV-2401 PC UV–Vis spectrophotometer (Shimadzu, Japan). Note that the fluorescence normalization was carried out considering as 100% the Th-S fluorescence of the bacterial cells expressing the peptide or protein in the absence of drug and 0% the Th-S fluorescence of the bacterial cells nonexpressing the peptide or protein.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Ex Vivo BBB Permeation Studies and Acute Administration in C57BL/6J Mice</h3><div class="NLM_p">The capability of the novel levetiracetam-based hybrid compounds to cross the BBB was evaluated ex vivo. The compounds at a dose of 2.5 and 5 mg/kg were administered intraperitoneally to C57BL/6J mice and 10 or 20 min after administration their brains were collected (<i>n</i> = 3, each group). Brains were homogenized in 0.5 volumes of phosphate buffer 0.1 M (pH 8.0) with 0.7% Triton at 4 °C. Just before analysis of the enzymatic activity, an amount of 100 μL of homogenate was diluted 2.5 times in 0.1 M phosphate-buffered solution (pH 8.0). The inhibitory effect of the novel compounds on AChE activity was evaluated spectrophotometrically at 25 °C by the method of Ellman et al.,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> modified according to Lassiter et al.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The reaction took place in a final volume of 300 μL of 0.1 M phosphate-buffered solution (pH 8.0) containing 100 μL of diluted homogenate and 333 μM DTNB solution. To avoid interferences between AChE and BChE activities, 100 μM ISO-OMPA (specific BChE inhibitor) was present in the incubation medium. Prior to the addition of the substrate acetylthiocholine, a preincubation period of 5 min was used to eliminate the endogenous acetylcholine present in the homogenates. The reaction was started by the addition of acetylthiocholine iodide (450 μM), and the absorbance at 414 nm was evaluated 2 min after the substrate addition.</div><div class="NLM_p">Percent of inhibition was calculated by comparing AChE activity in brain of the drug-treated mice with activity from untreated controls. This protocol was approved by the Animals Ethics Committee of the Universitat Autònoma de Barcelona and complies with the current laws of Spain, which are in accordance with the European Communities Council Directive 2010/63/EU. All efforts were made to minimize animal suffering and to reduce the number of animals used.</div><div class="NLM_p last">Increasing amounts of the novel levetiracetam-based hybrid compounds (1.25, 2.5, 5, and 10 mg/kg ip) were acutely administered to C57BL/6J mice, and the state of general health was assessed at 5 min, 10 min, 20 min, 30 min, 45 min, 1 h, 3 h, and 24 h after administration (<i>n</i> = 3, each group).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vivo Efficacy Studies in APP/PS1 Mice. Animals</h3><div class="NLM_p last">The experiments were carried out on male AβPP/PS1 mice and wild-type littermates that were 5 months old at the beginning of the study. The generation of mice expressing the human mutated forms APPswe and PS1dE9 (AβPP/PS1) has been already described.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Animals were maintained under standard animal housing conditions in a normal 12 h dark–light cycle with free access to food and water. Animal procedures were conducted according to ethical guidelines (European Community Council Directive 2010/63/EU) and approved by the local ethical committee (Universitat de Barcelona).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Chronic Treatment</h3><div class="NLM_p last">The novel levetiracetam-based hybrid compounds (5 mg/kg) were dissolved in 1% DMSO and 90% saline and were injected intraperitoneally (ip) in a volume of 10 mL/kg body weight. Animals were treated once daily for 4 weeks with the compounds or the corresponding vehicle (wild-type, <i>n</i> = 6–11; APP/PS1, <i>n</i> = 6–10, each group). During the daily manipulation, the health status of animals was monitored and body weight, spontaneous seizures leading to convulsions, and abnormal behavior of mice were recorded. After 2 days of washout period, animals were subjected to behavioral evaluation.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Behavioral Evaluation of Cognitive Performance</h3><div class="NLM_p last">The two-object recognition test was performed in a V-maze because it improves the exploration time of the animals with respect to a classical open field. On day 1, mice were habituated for 9 min, allowing them to freely explore the apparatus. On the second day, mice were placed for 9 min in the maze, where two identical objects were situated at the end of the arms, and the time that the mice spent exploring each object was recorded. Then, 24 h after the training session, animals were placed again in the V-maze where one of the two familiar objects was replaced by a novel object. The time that the animals spent exploring the two objects was recorded and an object recognition index (RI) was calculated as the difference between the time spent exploring the novel (<i>T</i><sub>N</sub>) and the familiar object (<i>T</i><sub>F</sub>), divided by the total time spent exploring the two objects [RI = (<i>T</i><sub>N</sub> – <i>T</i><sub>F</sub>)/(<i>T</i><sub>N</sub> + <i>T</i><sub>F</sub>)]. Animals exhibiting memory impairments revealed a lower object recognition index.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Tissue Collection</h3><div class="NLM_p last">At the end of the behavioral testing, the animals were sacrificed and their brains were removed. One brain hemisphere was dissected on ice, immediately frozen, and stored at −80 °C until processing for protein quantification. The other brain hemisphere was fixed in 4% paraformaldehyde and processed for immunohistochemistry.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Aβ Immunohistochemistry</h3><div class="NLM_p last">Tissue samples were embedded in paraffin and coronal sections (4 μm) were cut with a microtome. Dewaxed sections were incubated with 98% formic acid (3 min) and then treated with citrate buffer (20 min) to enhance antigenicity. Then, the endogenous peroxidases were blocked by incubation in 10% MeOH–1% H<sub>2</sub>O<sub>2</sub> solution (15 min). Sections were blocked with 3% normal horse serum solution and then incubated at 4 °C overnight with the primary antibody against Aβ (1:50, Dako, clone 6F/3D). Sections were subsequently rinsed and incubated with biotinylated secondary antibody (Dako), followed by EnVision+ system peroxidase (Dako) and finally with the chromogen diaminobenzidine and H<sub>2</sub>O<sub>2</sub>. Some sections were incubated without the primary antibody. No immunostaining was detected in these sections. Sections were lightly counterstained with hematoxylin. After staining, the sections were dehydrated and coverslipped for microscopic observation. The Aβ burden in neocortex was calculated as the percentage of the Aβ deposition area with respect to the total area in nine representative pictures in each animal, corresponding to the main regions where Aβ deposition is observed in AβPP/PS1 mice. Sections from all the AβPP/PS1 animals were evaluated by using the Analysis tool of the software Adobe Photoshop CS4.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Aβ Soluble Quantification: Enzyme-Linked Immunosorbent Assay (ELISA)</h3><div class="NLM_p last">Fresh-frozen mouse brain cortex was homogenized in 4 volumes (wt/vol) of TBS extraction buffer (140 mM NaCl, 3 mM KCl, 25 mM Tris (pH 7.4), 5 mM EDTA, and protease inhibitor cocktail (Roche Molecular Systems, Pleasanton, CA, USA). Homogenate was spun 100 000<i>g</i> × 1 h, and the supernatant was saved as the soluble fraction for Aβ quantification. Aβ<sub>40</sub> and Aβ<sub>42</sub> human ELISA kits (Invitrogen Corporation, Camarillo, CA, USA) were used to quantify the levels of Aβ<sub>40</sub> and Aβ<sub>42</sub> peptides in the brain soluble fractions. Quantitative determination was carried out according to the manufacturer’s instructions. Aβ<sub>40</sub> and Aβ<sub>42</sub> levels were normalized to the total amount of protein from each individual sample (BCA method, Thermo Fisher Scientific, Wilmington, DE, USA).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Glial and Aβ Double-Immunofluorescence</h3><div class="NLM_p last">Dewaxed sections were stained with a saturated solution of Sudan black B (Merck) for 30 min to block the autofluorescence of lipofuscin granules present in cell bodies, then rinsed in 70% EtOH and washed in distilled water. The sections were treated with 98% formic acid (3 min) and with citrate buffer to enhance antigenicity and then incubated at 4 °C overnight with combinations of primary antibodies against Aβ (1:50, Dako) and GFAP (1:250, Dako, Denmark) or Iba1 (1:250, Wako, USA). After washing, the sections were incubated with Alexa488 or Alexa546 (1:400, Molecular Probes) fluorescence secondary antibodies against the corresponding host species. After washing, the sections were mounted in Immuno-Fluore mounting medium (ICN Biomedicals, USA), sealed, and dried overnight. Sections were examined with an Olympus BX51 microscope.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Densitometric Quantification of Glia Around Aβ Plaques</h3><div class="NLM_p last">Astrocytic and microglial responses to Aβ deposition were evaluated by densitometric quantification of GFAP and Iba1 protein expression levels around Aβ plaques, respectively. The GFAP and Iba1 immunostaining was in reference to the Aβ plaque area in five representative pictures taken from the neocortex of each animal (<i>n</i> = 5 per group) using the software Adobe Photoshop CS4.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Statistical Analyses</h3><div class="NLM_p last">Data were analyzed by two-way ANOVA with genotype and treatment as between factors, followed by Tukey’s post hoc test. Aβ and glia quantifications were analyzed by one-way ANOVA followed by Tukey’s post hoc test. The frequency of spontaneous seizures was analyzed by Pearson’s χ<sup>2</sup> test. In all the experiments, the significance level was set at <i>p</i> < 0.05.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Molecular Modeling</h3><div class="NLM_p">The X-ray crystallographic structure of the recombinant human acetylcholinesterase (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LII">3LII</a>)<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> was used for docking calculations. <i>N</i>-Acetyl-<span class="smallcaps smallerCapital">d</span>-glucosamine and sulfate anions were removed, hydrogen atoms were added, and the missing loop defined by residues 259–263 was rebuilt from the X-ray structure of hAChE complexed with huprine W (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDT">4BDT</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The enzyme was modeled in its physiological active form with neutral His447 and deprotonated Glu334, which together with Ser203 form the catalytic triad. PROPKA3<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> was used to assign the protonation state of ionizable residues at neutral pH, suggesting that residues Glu285, Glu450, and Glu452 were protonated. Finally, three disulfide bridges (residues 69–96, 257–272, and 409–529) were defined. Since Trp286 can adopt three main conformations in the peripheral binding site,<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> three models were built up by reorienting the side chain of Trp286 as found in the X-ray structures of the AChE complexes with propidium, bis(7)-tacrine, and <i>syn</i>-TZ2PA6 (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N5R">1N5R</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKM">2CKM</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a>, respectively).</div><div class="NLM_p last">Docking was performed using the rDock program,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> which was successful in predicting the binding mode of a variety of AChE inhibitors to the enzyme gorge.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> A cavity of radius 17 Å centered on a superligand containing huprine X, donepezil, and propidium (as found in the X-ray structures <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66">1E66</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE">1EVE</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N5R">1N5R</a>)<a onclick="showRef(event, 'ref36 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref36 ref73 ref74">(36, 73, 74)</a> was used to define the docking volume. Since huprine X and propidium are bound to the catalytic and peripheral binding sites, and donepezil is aligned along the gorge, this definition guarantees the exploration of the binding mode along the whole volume accessible for binding. Docking calculations were performed separately for the three models of the human enzyme (see above). Conformational flexibility around rotatable bonds of the ligand was allowed, whereas adjustments of other residues in the binding site were accounted for indirectly by rescaling (by a factor of 0.9) the van der Waals volume of atoms. Each compound was subjected to 100 docking runs, and the poses were sorted according to its docking score. The top 50 best scored poses were clustered and further analyzed by visual inspection.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00624" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isidro Ferrer</span> - <span class="hlFld-Affiliation affiliation">Institut
de Neuropatologia,
Servei d’Anatomia Patològica, IDIBELL-Hospital Universitari
de Bellvitge, Universitat de Barcelona, L’Hospitalet
de Llobregat, 08908 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">CIBERNED, Centro
de Investigación Biomédica en Red de Enfermedades Neurodegenerativas,
Instituto Carlos III, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#360e060e045f505776515b575f5a1855595b"><span class="__cf_email__" data-cfemail="fdc5cdc5cf949b9cbd9a909c9491d39e9290">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diego Muñoz-Torrero</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Química Farmacèutica (Unitat Associada al CSIC),
Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, E-08028, Barcelona, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d29203823223739223f3f283f220d382f63282938"><span class="__cf_email__" data-cfemail="650108100b0a1f110a171700170a2510074b000110">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene Sola</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Química Farmacèutica (Unitat Associada al CSIC),
Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, E-08028, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ester Aso</span> - <span class="hlFld-Affiliation affiliation">Institut
de Neuropatologia,
Servei d’Anatomia Patològica, IDIBELL-Hospital Universitari
de Bellvitge, Universitat de Barcelona, L’Hospitalet
de Llobregat, 08908 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">CIBERNED, Centro
de Investigación Biomédica en Red de Enfermedades Neurodegenerativas,
Instituto Carlos III, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Frattini</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Química Farmacèutica (Unitat Associada al CSIC),
Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, E-08028, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene López-González</span> - <span class="hlFld-Affiliation affiliation">Institut
de Neuropatologia,
Servei d’Anatomia Patològica, IDIBELL-Hospital Universitari
de Bellvitge, Universitat de Barcelona, L’Hospitalet
de Llobregat, 08908 Barcelona, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">CIBERNED, Centro
de Investigación Biomédica en Red de Enfermedades Neurodegenerativas,
Instituto Carlos III, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alba Espargaró</span> - <span class="hlFld-Affiliation affiliation">Departament
de Fisicoquímica, Facultat de Farmàcia, and Institut
de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raimon Sabaté</span> - <span class="hlFld-Affiliation affiliation">Departament
de Fisicoquímica, Facultat de Farmàcia, and Institut
de Nanociència i Nanotecnologia (IN2UB), Universitat de Barcelona, 08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ornella Di Pietro</span> - <span class="hlFld-Affiliation affiliation">Laboratori
de Química Farmacèutica (Unitat Associada al CSIC),
Facultat de Farmàcia, and Institut de Biomedicina (IBUB), Universitat de Barcelona, Av. Joan XXIII 27-31, E-08028, Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Javier Luque</span> - <span class="hlFld-Affiliation affiliation">Departament
de Fisicoquímica, Facultat de Farmàcia (Campus Torribera),
and IBUB, Universitat de Barcelona, Prat de la Riba 171, E-08921, Santa Coloma de Gramenet, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Victòria Clos</span> - <span class="hlFld-Affiliation affiliation">Departament
de Farmacologia, de Terapèutica, i de Toxicologia, Institut
de Neurociències, Universitat Autònoma
de Barcelona, E-08193, Bellaterra, Barcelona, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>I.S. and E.A. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2004e4822-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Ministerio de Ciencia e Innovación (MICINN) (Grants CTQ2011-22433, SAF2009-10553, start-up grant of the Ramón y Cajal program for R.S.), Ministerio de Economı́a y Competitividad (MINECO) (Grant SAF2014-57094-R), Instituto de Salud Carlos III (ISCIII) (Grant FIS PI14/00757), and Generalitat de Catalunya (GC) (Grants 2014SGR52, 2014SGR938, 2014SGR1189). Fellowships from GC to I.S. and from Lifelong Learning Programme/Erasmus to D.F., a contract from the Ramón y Cajal program of MICINN to R.S. (Grant RYC-2011-07987), and a contract from the Juan de la Cierva program of MINECO to A.E. (Grant JCI-2012-12193) are gratefully acknowledged. We thank Arnau Novell for his assistance in the chiral HPLC analyses of the enantiopure hybrids, and Dr. Carles Codina and Dr. Jaume Bastida for their generous gift of a sample of galantamine.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">aMCI</td><td class="NLM_def"><p class="first last">amnestic mild cognitive impairment</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">DTNB</td><td class="NLM_def"><p class="first last">5,5′-dithiobis(2-nitrobenzoic acid)</p></td></tr><tr><td class="NLM_term">hAChE</td><td class="NLM_def"><p class="first last">human acetylcholinesterase</p></td></tr><tr><td class="NLM_term">hBChE</td><td class="NLM_def"><p class="first last">human butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term">RI</td><td class="NLM_def"><p class="first last">recognition index</p></td></tr><tr><td class="NLM_term">Veh</td><td class="NLM_def"><p class="first last">vehicle</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65002" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65002" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 74 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Prince, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, C. P.</span><span> </span><span class="NLM_article-title">The global prevalence of dementia: A systematic review and metaanalysis</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.jalz.2012.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23305823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=63-75&author=M.+Princeauthor=R.+Bryceauthor=E.+Albaneseauthor=A.+Wimoauthor=W.+Ribeiroauthor=C.+P.+Ferri&title=The+global+prevalence+of+dementia%3A+A+systematic+review+and+metaanalysis&doi=10.1016%2Fj.jalz.2012.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global prevalence of dementia: a systematic review and metaanalysis</span></div><div class="casAuthors">Prince Martin; Bryce Renata; Albanese Emiliano; Wimo Anders; Ribeiro Wagner; Ferri Cleusa P</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75.e2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The evidence base on the prevalence of dementia is expanding rapidly, particularly in countries with low and middle incomes.  A reappraisal of global prevalence and numbers is due, given the significant implications for social and public policy and planning.  METHODS:  In this study we provide a systematic review of the global literature on the prevalence of dementia (1980-2009) and metaanalysis to estimate the prevalence and numbers of those affected, aged ≥60 years in 21 Global Burden of Disease regions.  RESULTS:  Age-standardized prevalence for those aged ≥60 years varied in a narrow band, 5%-7% in most world regions, with a higher prevalence in Latin America (8.5%), and a distinctively lower prevalence in the four sub-Saharan African regions (2%-4%).  It was estimated that 35.6 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050.  In 2010, 58% of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63% in 2030 and 71% in 2050.  CONCLUSION:  The detailed estimates in this study constitute the best current basis for policymaking, planning, and allocation of health and welfare resources in dementia care.  The age-specific prevalence of dementia varies little between world regions, and may converge further.  Future projections of numbers of people with dementia may be modified substantially by preventive interventions (lowering incidence), improvements in treatment and care (prolonging survival), and disease-modifying interventions (preventing or slowing progression).  All countries need to commission nationally representative surveys that are repeated regularly to monitor trends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDDwrf5YqtWIIRAdBLKY41fW6udTcc2eZnCSTq5XZq4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVemsQ%253D%253D&md5=cbf1b2107d191f459ba6fe3e6194b3ec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DR.%26aulast%3DAlbanese%26aufirst%3DE.%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DW.%26aulast%3DFerri%26aufirst%3DC.%2BP.%26atitle%3DThe%2520global%2520prevalence%2520of%2520dementia%253A%2520A%2520systematic%2520review%2520and%2520metaanalysis%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.jalz.2012.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Alzheimer’s Association (<a href="http://www.alz.org" class="extLink">www.alz.org</a>). 2015 Alzheimer’s disease facts and figures. <a href="https://www.alz.org/facts/downloads/facts_figures_2015.pdf" class="extLink">https://www.alz.org/facts/downloads/facts_figures_2015.pdf</a>. Accessed on March 26,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+%28www.alz.org%29.+2015+Alzheimer%E2%80%99s+disease+facts+and+figures.+https%3A%2F%2Fwww.alz.org%2Ffacts%2Fdownloads%2Ffacts_figures_2015.pdf.+Accessed+on+March+26%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacobini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantua, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014</span> <span class="citation_source-journal">J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1111/joim.12191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fjoim.12191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24605808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=251-283&author=L.+S.+Schneiderauthor=F.+Mangialascheauthor=N.+Andreasenauthor=H.+Feldmanauthor=E.+Giacobiniauthor=R.+Jonesauthor=V.+Mantuaauthor=P.+Mecocciauthor=L.+Paniauthor=B.+Winbladauthor=M.+Kivipelto&title=Clinical+trials+and+late-stage+drug+development+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+from+1984+to+2014&doi=10.1111%2Fjoim.12191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014</span></div><div class="casAuthors">Schneider L S; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The modern era of drug development for Alzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984 research criteria for Alzheimer's disease.  Since then, despite the evaluation of numerous potential treatments in clinical trials, only four cholinesterase inhibitors and memantine have shown sufficient safety and efficacy to allow marketing approval at an international level.  Although this is probably because the other drugs tested were ineffective, inadequate clinical development methods have also been blamed for the failures.  Here, we review the development of treatments for Alzheimer's disease during the past 30 years, considering the drugs, potential targets, late-stage clinical trials, development methods, emerging use of biomarkers and evolution of regulatory considerations in order to summarize advances and anticipate future developments.  We have considered late-stage Alzheimer's disease drug development from 1984 to 2013, including individual clinical trials, systematic and qualitative reviews, meta-analyses, methods, commentaries, position papers and guidelines.  We then review the evolution of drugs in late clinical development, methods, biomarkers and regulatory issues.  Although a range of small molecules and biological products against many targets have been investigated in clinical trials, the predominant drug targets have been the cholinergic system and the amyloid cascade.  Trial methods have evolved incrementally: inclusion criteria have largely remained focused on mild-to-moderate Alzheimer's disease criteria, recently extending to early or prodromal Alzheimer disease or 'mild cognitive impairment due to Alzheimer's disease', for drugs considered to be disease modifying.  The duration of trials has remained at 6-12 months for drugs intended to improve symptoms; 18- to 24-month trials have been established for drugs expected to attenuate clinical course.  Cognitive performance, activities of daily living, global change and severity ratings have persisted as the primary clinically relevant outcomes.  Regulatory guidance and oversight have evolved to allow for enrichment of early-stage Alzheimer's disease trial samples using biomarkers and phase-specific outcomes.  In conclusion, validated drug targets for Alzheimer's disease remain to be developed.  Only drugs that affect an aspect of cholinergic function have shown consistent, but modest, clinical effects in late-phase trials.  There is opportunity for substantial improvements in drug discovery and clinical development methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiLqeiU50WDCA3UY9EwTNrfW6udTcc2eYQiayxWSzOtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D&md5=7e34762560c7cb2ce25084827c348cdc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12191%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMantua%26aufirst%3DV.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPani%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DClinical%2520trials%2520and%2520late-stage%2520drug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520from%25201984%2520to%25202014%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D251%26epage%3D283%26doi%3D10.1111%2Fjoim.12191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0liOfuvAoh0Pig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mucke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Neurotoxicity of amyloid-β protein: Synaptic and network dysfunction</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006338</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1101%2Fcshperspect.a006338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006338&author=L.+Muckeauthor=D.+J.+Selkoe&title=Neurotoxicity+of+amyloid-%CE%B2+protein%3A+Synaptic+and+network+dysfunction&doi=10.1101%2Fcshperspect.a006338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006338%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DNeurotoxicity%2520of%2520amyloid-%25CE%25B2%2520protein%253A%2520Synaptic%2520and%2520network%2520dysfunction%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006338%26doi%3D10.1101%2Fcshperspect.a006338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the amyloid cascade hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.1016/j.biocel.2008.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+amyloid+cascade+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2008.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0lhFErgwY1n6DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520amyloid%2520cascade%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268%26doi%3D10.1016%2Fj.biocel.2008.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">For reviews see refs <a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">7−12</a>.</p></div><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lhFErgwY1n6DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieckowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.2174/0929867321666141106122628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F0929867321666141106122628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25386820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=373-404&author=N.+Guziorauthor=A.+Wieckowskaauthor=D.+Panekauthor=B.+Malawska&title=Recent+development+of+multifunctional+agents+as+potential+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867321666141106122628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimerμs Disease</span></div><div class="casAuthors">Guzior, Natalia; Wieckowska, Anna; Panek, Dawid; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-404</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder.  The available therapy is limited to the symptomatic treatment and its efficacy remains unsatisfactory.  In view of the prevalence and expected increase in the incidence of AD, the development of an effective therapy is crucial for public health.  Due to the multifactorial etiol. of this disease, the multi-target-directed ligand (MTDL) approach is a promising method in search for new drugs for AD.  This review updates information on the development of multifunctional potential anti-AD agents published within the last three years.  The majority of the recently reported structures are acetylcholinesterase inhibitors, often endowed with some addnl. properties.  These properties enrich the pharmacol. profile of the compds. giving hope for not only symptomatic but also causal treatment of the disease.  Among these advantageous properties, the most often reported are an amyloid-β antiaggregation activity, inhibition of β-secretase and monoamine oxidase, an antioxidant and metal chelating activity, NOreleasing ability and interaction with cannabinoid, NMDA or histamine H3 receptors.  The majority of novel mols. possess heterodimeric structures, able to interact with multiple targets by combining different pharmacophores, original or derived from natural products or existing therapeutics (tacrine, donepezil, galantamine, memantine).  Among the described compds., several seem to be promising drug candidates, while others may serve as a valuable inspiration in the search for new effective therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Eztutww8UbVg90H21EOLACvtfcHk0lhsswRyjo5y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSrurs%253D&md5=acca283f8e4bf5fae5011523d0639314</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141106122628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141106122628%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DRecent%2520development%2520of%2520multifunctional%2520agents%2520as%2520potential%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D373%26epage%3D404%26doi%3D10.2174%2F0929867321666141106122628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Rationally designed multi-targeted agents against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span><span class="refDoi"> DOI: 10.2174/09298673113209990112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F09298673113209990112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23410161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1662-1672&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Rationally+designed+multi-targeted+agents+against+neurodegenerative+diseases&doi=10.2174%2F09298673113209990112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally designed multi-targeted agents against neurodegenerative diseases</span></div><div class="casAuthors">Geldenhuys, W. J.; Van der Schyf, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1662-1672</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are complex disorders with several pathoetiol. pathways leading to cell death.  Rationally designed multi-targeted agents, or "multi-targeted designed drugs" (MTDD) show significant promise in preclin. studies as neuroprotective and disease-modifying agents.  In this review, we highlight the use of chem. scaffolds that lend themselves exquisitely to the development of MTDDs in neurodegeneration.  Notably, synthetic polycyclic cage compds. have served as scaffolds for novel voltage-gated calcium channel blockers, NMDA receptor antagonists, and sigma-receptor ligands - attractive targets in neurodegeneration.  In an entirely different approach, compds. contg. the thiazolidinedione moiety (referred to as glitazones) alter mitochondrial function through the mitochondrial protein mitoNEET, an attractive new drug target for the treatment of neurodegenerative diseases.  The design strategy for yet another agent, ladostigil, employed the amalgamation of active chem. moieties of the AChE inhibitor rivastigmine, and the monoamine oxidase-B (MAO-B) inhibitor rasagiline, leading to a single compd. that targets both enzymes simultaneously.  Natural products have also served as design templates for several MTDD design studies.  In particular, the stilbene scaffold has become popular in particular due to the neuroprotective effects of the non-flavonoid natural product resveratrol.  Recently, stilbene scaffold-based compds. were developed to reduce - through chelation with metal ions that interact with beta-amyloid - both metal-induced beta-amyloid protein aggregation, and ROS generated from this aggregate.  Other subtle modifications of the stilbene motif led to the creation of reversible, non-competitive MAO inhibitors.  Finally, compds. derived from the xanthine scaffold afford neuroprotection in Parkinson's disease through mechanisms that include dual adenosine A2A receptor antagonism and MAO-B inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZJN4lAGwOrVg90H21EOLACvtfcHk0lhsswRyjo5y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbw%253D&md5=626f69acb3b3ff995e31b042e48dfba3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990112%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DRationally%2520designed%2520multi-targeted%2520agents%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1662%26epage%3D1672%26doi%3D10.2174%2F09298673113209990112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Multi-target compounds acting in the central nervous system designed from natural products</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.2174/0929867311320130007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F0929867311320130007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23410166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1673-1685&author=X.+Chenauthor=M.+Decker&title=Multi-target+compounds+acting+in+the+central+nervous+system+designed+from+natural+products&doi=10.2174%2F0929867311320130007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target compounds acting in the central nervous system designed from natural products</span></div><div class="casAuthors">Chen, X.; Decker, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1673-1685</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Modern medicinal chem. has come to its bottleneck and is full of challenges, specially when facing with long-term central nervous system (CNS) disorders induced by several factors, such as Alzheimer's disease (AD) or Parkinson's disease (PD).  In order to probe these challenges, multi-target directed ligands (MTDLs) design has been applied recently by medicinal scientists trying to get single compds. that can simultaneously modulate multiple targets.  In addn., natural products have drawn the attention of drug developers again in recent years, as they have been used by human race for thousands of years and are full of diversity with their concomitant high potential to exhibit biol. activities.  We hereby review some of the research within the last few years focusing on multiple-target compds. acting in the CNS using natural products as lead resources.  The target compds. obtained and described here represent bioactive hybrids either covalently connected or obtained by fusion of different bioactive moieties with at least one part derived from or representing directly natural products, along with some natural compds. themselves showing multiple pharmacol. activities.  We describe suitable ways to connect the drug components chem., how to use the approach to enhance biol. activity and selectivity, as well as potential drawbacks of the hybrid approach.  This review will also show the rationale that these MTDLs are more than just the sum of their components but in many cases should be considered as new pharmacol. entities in their own respect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJPeb-9Q6fbVg90H21EOLACvtfcHk0lhsswRyjo5y2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbo%253D&md5=f4176c96cf0837f4e391770c6d033f90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DMulti-target%2520compounds%2520acting%2520in%2520the%2520central%2520nervous%2520system%2520designed%2520from%2520natural%2520products%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1673%26epage%3D1685%26doi%3D10.2174%2F0929867311320130007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">The multifactorial nature of Alzheimer’s disease for developing potential therapeutics</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span><span class="refDoi"> DOI: 10.2174/15680266113139990135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1745-1770&author=M.+C.+Carreirasauthor=E.+Mendesauthor=M.+J.+Perryauthor=A.+P.+Franciscoauthor=J.+Marco-Contelles&title=The+multifactorial+nature+of+Alzheimer%E2%80%99s+disease+for+developing+potential+therapeutics&doi=10.2174%2F15680266113139990135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics</span></div><div class="casAuthors">Carreiras, M. Carmo; Mendes, Eduarda; Perry, M. Jesus; Francisco, Ana Paula; Marco-Contelles, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1745-1770</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with several target proteins contributing to its etiol.  Pathol., genetic, biochem., and modeling studies all point to a crit. role of Aβ aggregation in AD.  Though there are still many enigmatic aspects of the Aβ cascade, none of the gaps invalidate the hypothesis.  The amyloid hypothesis dets. that the prodn., aggregation and accumulation of Aβ in the brain gives rise to a cascade of neurotoxic events that proceed to neuronal degeneration.  Different targets of the disease include APP pathogenic cleavage, cytoskeletal destabilization, neurotransmitter and ion dyshomeostasis, metal ion accumulation, protein misfolding, oxidative stress, neuronal death and gene mutations.  Thus, disease-modifying treatments for AD must interfere with the pathogenic steps responsible for the clin. symptoms: the deposition of extracellular Aβ plaques, the intracellular neurofibrillary tangles, inflammation, oxidative stress, iron deregulation, among others.  The observations supporting the development of multifunctional compds. in assocn. with the perception that several dual binding site AChEIs were able to reach different targets guided the development of a new drug design strategy, the multi-target-directed-ligand (MTDL) approach.  This may be regarded as the buildup of hybrid mols. composed of distinct pharmacophores of different drugs.  Thus, each pharmacophore of the new hybrid drug would preserve the capacity of interacting with their specific sites on the targets and, therefore, generate multiple specific pharmacol. responses which would enable the treatment of multi-factorial diseases.  This review summarizes a few current therapeutic trends on MTDL strategy intended to halt or revert the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv2AQj0ZD1CbVg90H21EOLACvtfcHk0lilS6LnT99ZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs73F&md5=875ba6e404accc11098651f6ca5b0435</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990135%26sid%3Dliteratum%253Aachs%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMendes%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DM.%2BJ.%26aulast%3DFrancisco%26aufirst%3DA.%2BP.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DThe%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520for%2520developing%2520potential%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1745%26epage%3D1770%26doi%3D10.2174%2F15680266113139990135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">Emerging targets in neurodegeneration: New opportunities for Alzheimer’s disease treatment?</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span><span class="refDoi"> DOI: 10.2174/15680266113139990143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFequ73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1879-1904&author=A.+Rampaauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Bisi&title=Emerging+targets+in+neurodegeneration%3A+New+opportunities+for+Alzheimer%E2%80%99s+disease+treatment%3F&doi=10.2174%2F15680266113139990143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?</span></div><div class="casAuthors">Rampa, Angela; Gobbi, Silvia; Belluti, Federica; Bisi, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1879-1904</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain assocd. with memory impairment, progressive cognitive decline and changes in personality and behavior, with rising incidence among elderly people.  Reflecting the world population ageing, the scenario is expected to worsen in the next decades if novel drugs or mechanisms that help to counteract neurodegeneration will not be identified.  The complex neuropathol. of AD is characterized by cholinergic loss, extracellular deposition of amyloid- plaques, formation of intracellular neurofibrillary tangles, chronic brain inflammation and oxidative damage.  To date, there are no effective treatments that can slow or halt the disease, and currently approved drugs only seem to act as palliative by temporary ameliorating cognitive impairment.  On the other hand, the role played by other biol. systems in the pathogenetic process is now clearly growing and, as knowledge on how AD develops and triggers brain damage proceeds, drug discovery attempts to identify new potential therapeutic targets.  This review will focus on these emerging strategies, some of which could open new therapeutic perspectives in Alzheimer's disease, adding new elements for the medicinal chemist to handle and combine for the design of novel multi-target-directed ligands able to simultaneously modulate "old classic" and newly identified targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRRMXNZHI-7Vg90H21EOLACvtfcHk0lilS6LnT99ZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFequ73L&md5=8720c73d56defcd67375ade38ae5dc35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990143%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DEmerging%2520targets%2520in%2520neurodegeneration%253A%2520New%2520opportunities%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1879%26epage%3D1904%26doi%3D10.2174%2F15680266113139990143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">For recent examples see refs <a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19">13−19</a>.</p></div><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: Triazinones as BACE-1 and GSK-3β inhibidors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+Triazinones+as+BACE-1+and+GSK-3%CE%B2+inhibidors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Triazinones%2520as%2520BACE-1%2520and%2520GSK-3%25CE%25B2%2520inhibidors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT<sub>4</sub>R) agonist activities as potential agents against Alzheimer’s disease: The design of donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Fr%C3%A9onauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+multitarget-directed+ligands+%28MTDLs%29+with+acetylcholinesterase+%28AChE%29+inhibitory+and+serotonergic+subtype+4+receptor+%285-HT4R%29+agonist+activities+as+potential+agents+against+Alzheimer%E2%80%99s+disease%3A+The+design+of+donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0lgZKCZgM3VCOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Fr%25C3%25A9on%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520%2528MTDLs%2529%2520with%2520acetylcholinesterase%2520%2528AChE%2529%2520inhibitory%2520and%2520serotonergic%2520subtype%25204%2520receptor%2520%25285-HT4R%2529%2520agonist%2520activities%2520as%2520potential%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520design%2520of%2520donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurpiewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewinski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pislar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25621991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=738-749&author=N.+Guziorauthor=M.+Bajdaauthor=M.+Skrokauthor=K.+Kurpiewskaauthor=K.+Lewinskiauthor=B.+Brusauthor=A.+Pislarauthor=J.+Kosauthor=S.+Gobecauthor=B.+Malawska&title=Development+of+multifunctional%2C+heterodimeric+isoindoline-1%2C3-dione+derivatives+as+cholinesterase+and+%CE%B2-amyloid+aggregation+inhibitors+with+neuroprotective+properties&doi=10.1016%2Fj.ejmech.2015.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties</span></div><div class="casAuthors">Guzior, Natalia; Bajda, Marek; Skrok, Miroslaw; Kurpiewska, Katarzyna; Lewinski, Krzysztof; Brus, Boris; Pislar, Anja; Kos, Janko; Gobec, Stanislav; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">738-749</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The presented study describes the synthesis, pharmacol. evaluation (AChE and BuChE inhibition, beta amyloid anti-aggregation effect and neuroprotective effect), mol. modeling and crystallog. studies of a novel series of isoindoline-1,3-dione derivs.  The target compds. were designed as dual binding site acetylcholinesterase inhibitors with an arylalkylamine moiety binding at the catalytic site of the enzyme and connected via an alkyl chain to a heterocyclic fragment, capable of binding at the peripheral anionic site of AChE.  Among these mols., compd. I was found to be the most potent and selective AChE inhibitor (IC50EeAChE = 0.034 μM).  Moreover, compd. II in addn. to AChE inhibition (IC50 EeAChE = 0.219 μM) possesses addnl. properties, such as the ability to inhibit Aβ aggregation (65.96% at 10 μM) and a neuroprotective effect against Aβ toxicity at 1 and 3 μM.  Compd. II emerges as a promising multi-target ligand for the further development of the therapy for age-related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7pUEAUjEtsbVg90H21EOLACvtfcHk0lgZKCZgM3VCOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCitw%253D%253D&md5=a545fb00b9719881affc9db4cfd560dc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DSkrok%26aufirst%3DM.%26aulast%3DKurpiewska%26aufirst%3DK.%26aulast%3DLewinski%26aufirst%3DK.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DDevelopment%2520of%2520multifunctional%252C%2520heterodimeric%2520isoindoline-1%252C3-dione%2520derivatives%2520as%2520cholinesterase%2520and%2520%25CE%25B2-amyloid%2520aggregation%2520inhibitors%2520with%2520neuroprotective%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D738%26epage%3D749%26doi%3D10.1016%2Fj.ejmech.2015.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer’s disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.01.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=42-50&author=S.-S.+Xieauthor=J.-S.+Lanauthor=X.-B.+Wangauthor=N.+Jiangauthor=G.+Dongauthor=Z.-R.+Liauthor=K.+D.+G.+Wangauthor=P.-P.+Guoauthor=L.-Y.+Kong&title=Multifunctional+tacrine%E2%80%93trolox+hybrids+for+the+treatment+of+Alzheimer%E2%80%99s+disease+with+cholinergic%2C+antioxidant%2C+neuroprotective+and+hepatoprotective+properties&doi=10.1016%2Fj.ejmech.2015.01.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DGuo%26aufirst%3DP.-P.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine%25E2%2580%2593trolox%2520hybrids%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520cholinergic%252C%2520antioxidant%252C%2520neuroprotective%2520and%2520hepatoprotective%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D93%26spage%3D42%26epage%3D50%26doi%3D10.1016%2Fj.ejmech.2015.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.02.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.02.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25778991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVertrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=348-366&author=Z.+Sangauthor=X.+Qiangauthor=Y.+Liauthor=W.+Yuanauthor=Q.+Liuauthor=Y.+Shiauthor=A.+Weiauthor=Y.+Luoauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+scutellarein-O-alkylamines+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.02.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Sang, Zhipei; Qiang, Xiaoming; Li, Yan; Yuan, Wen; Liu, Qiang; Shi, Yikun; Wei, Ang; Luo, Youfu; Tan, Zhenghuai; Deng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-366</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of scutellarein-O-alkylamine derivs. were designed, synthesized and tested as multifunctional agents for the treatment of Alzheimer's disease (AD).  The results showed that most of these compds. exhibited good multifunctional activities.  Among them, compd. 16d demonstrated significant metal chelating properties, moderate acetylcholinesterase (AChE) inhibitory and anti-oxidative activity, and excellent inhibitory effects on self-induced Aβ1-42 aggregation, Cu2+-induced Aβ1-42 aggregation, human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils.  Both kinetic anal. of AChE inhibition and mol. modeling study suggested that 16d binds simultaneously to the catalytic active site and peripheral anionic site of AChE.  Moreover, compd. 16d showed a good protective effect against H2O2-induced PC12 cell injury, with low toxicity in SH-SY5Y cells.  Furthermore, the step-down passive avoidance test showed this compd. significantly reversed scopolamine-induced memory deficit in mice.  Thus, 16d was shown to be an interesting multifunctional lead compd. worthy of further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKl89ID7O2fbVg90H21EOLACvtfcHk0lhJJfZXuegCQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVertrs%253D&md5=31fb4dd317c08e80bec9a3004fc60b10</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.063%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DZ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520scutellarein-O-alkylamines%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D348%26epage%3D366%26doi%3D10.1016%2Fj.ejmech.2015.02.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Benchekroun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pudlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refouvelet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andrés, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Arozamena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaili, L.</span><span> </span><span class="NLM_article-title">Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: A synthetic renewal in tacrine–ferulic acid hybrids</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1002/cmdc.201402409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fcmdc.201402409" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=523-539&author=M.+Benchekrounauthor=M.+Bartoliniauthor=J.+Egeaauthor=A.+Romeroauthor=E.+Sorianoauthor=M.+Pudloauthor=V.+Luzetauthor=V.+Andrisanoauthor=M.-L.+Jimenoauthor=M.+G.+L%C3%B3pezauthor=S.+Wehleauthor=T.+Gharbiauthor=B.+Refouveletauthor=L.+de+Andr%C3%A9sauthor=C.+Herrera-Arozamenaauthor=B.+Montiauthor=M.+L.+Bolognesiauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+Deckerauthor=J.+Marco-Contellesauthor=L.+Ismaili&title=Novel+tacrine-grafted+Ugi+adducts+as+multipotent+anti-Alzheimer+drugs%3A+A+synthetic+renewal+in+tacrine%E2%80%93ferulic+acid+hybrids&doi=10.1002%2Fcmdc.201402409"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402409%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DPudlo%26aufirst%3DM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DJimeno%26aufirst%3DM.-L.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DGharbi%26aufirst%3DT.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3Dde%2BAndr%25C3%25A9s%26aufirst%3DL.%26aulast%3DHerrera-Arozamena%26aufirst%3DC.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DNovel%2520tacrine-grafted%2520Ugi%2520adducts%2520as%2520multipotent%2520anti-Alzheimer%2520drugs%253A%2520A%2520synthetic%2520renewal%2520in%2520tacrine%25E2%2580%2593ferulic%2520acid%2520hybrids%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D523%26epage%3D539%26doi%3D10.1002%2Fcmdc.201402409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of chromone-2-carboxamidoalkylbenzylamines as multifunctional agents for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bmc.2015.01.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=911-923&author=Q.+Liuauthor=X.+Qiangauthor=Y.+Liauthor=Z.+Sangauthor=Y.+Liauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+chromone-2-carboxamidoalkylbenzylamines+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2015.01.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520chromone-2-carboxamidoalkylbenzylamines%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D911%26epage%3D923%26doi%3D10.1016%2Fj.bmc.2015.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maramai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verga, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lorenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">Disease-modifying anti-Alzheimer’s drugs: Inhibitors of human cholinesterases interfering with β-amyloid aggregation</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1111/cns.12290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fcns.12290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24935788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWktLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=624-632&author=S.+Brogiauthor=S.+Butiniauthor=S.+Maramaiauthor=R.+Colomboauthor=L.+Vergaauthor=C.+Lanniauthor=E.+De+Lorenziauthor=S.+Lamponiauthor=M.+Andreassiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=E.+Novellinoauthor=G.+Campianiauthor=M.+Brindisiauthor=S.+Gemma&title=Disease-modifying+anti-Alzheimer%E2%80%99s+drugs%3A+Inhibitors+of+human+cholinesterases+interfering+with+%CE%B2-amyloid+aggregation&doi=10.1111%2Fcns.12290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-Modifying Anti-Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β-Amyloid Aggregation</span></div><div class="casAuthors">Brogi, Simone; Butini, Stefania; Maramai, Samuele; Colombo, Raffaella; Verga, Laura; Lanni, Cristina; De Lorenzi, Ersilia; Lamponi, Stefania; Andreassi, Marco; Bartolini, Manuela; Andrisano, Vincenza; Novellino, Ettore; Campiani, Giuseppe; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Aims : We recently described multifunctional tools (2a-c) as potent inhibitors of human Cholinesterases (ChEs) also able to modulate events correlated with Aβ aggregation.  We herein propose a thorough biol. and computational anal. aiming at understanding their mechanism of action at the mol. level.  Methods : We detd. the inhibitory potency of 2a-c on Aβ1-42 self-aggregation, the interference of 2a with the toxic Aβ oligomeric species and with the postaggregation states by capillary electrophoresis anal. and transmission electron microscopy.  The modulation of Aβ toxicity was assessed for 2a and 2b on human neuroblastoma cells.  The key interactions of 2a with Aβ and with the Aβ-preformed fibrils were computationally analyzed. 2a-c toxicity profile was also assessed (human hepatocytes and mouse fibroblasts).  Results : Our prototypical pluripotent analog 2a interferes with Aβ oligomerization process thus reducing Aβ oligomers-mediated toxicity in human neuroblastoma cells. 2a also disrupts preformed fibrils.  Computational studies highlighted the bases governing the diversified activities of 2a.  Conclusion : Converging anal., biol., and in silico data explained the mechanism of action of 2a on Aβ1-42 oligomers formation and against Aβ-preformed fibrils.  This evidence, combined with toxicity data, will orient the future design of safer analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXZfHUZuTBbVg90H21EOLACvtfcHk0lhJJfZXuegCQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWktLzM&md5=29880e30e1d7f9a9c8727798dac60550</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fcns.12290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12290%26sid%3Dliteratum%253Aachs%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DVerga%26aufirst%3DL.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DDe%2BLorenzi%26aufirst%3DE.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DAndreassi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DDisease-modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%253A%2520Inhibitors%2520of%2520human%2520cholinesterases%2520interfering%2520with%2520%25CE%25B2-amyloid%2520aggregation%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2014%26volume%3D20%26spage%3D624%26epage%3D632%26doi%3D10.1111%2Fcns.12290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span><span class="refDoi"> DOI: 10.2174/15680266113139990139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1820-1842&author=E.+Viaynaauthor=R.+Sabateauthor=D.+Mu%C3%B1oz-Torrero&title=Dual+inhibitors+of+%CE%B2-amyloid+aggregation+and+acetylcholinesterase+as+multi-target+anti-Alzheimer+drug+candidates&doi=10.2174%2F15680266113139990139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Sabate, Raimon; Muaoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1820-1842</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Notwithstanding the functional role that the aggregates of some amyloidogenic proteins can play in different organisms, protein aggregation plays a pivotal role in the pathogenesis of a large no. of human diseases.  One of such diseases is Alzheimer's disease (AD), where the overprodn. and aggregation of the β-amyloid peptide (A β) are regarded as early crit. factors.  Another protein that seems to occupy a prominent position within the complex pathol. network of AD is the enzyme acetylcholinesterase (AChE), with classical and non-classical activities involved at the late (cholinergic deficit) and early (A β aggregation) phases of the disease.  Dual inhibitors of A aggregation and AChE are thus emerging as promising multi-target agents with potential to efficiently modify the natural course of AD.  In the initial phases of the drug discovery process of such compds., in vitro evaluation of the inhibition of Aβ β aggregation is rather troublesome, as it is very sensitive to exptl. assay conditions, and requires expensive synthetic Aβ peptides, which makes cost-prohibitive the screening of large compd. libraries.  Herein, we review recently developed multitarget anti-Alzheimer compds. that exhibit both Aβ aggregation and AChE inhibitory activities, and, in some cases also addnl. valuable activities such as BACE-1 inhibition or antioxidant properties.  We also discuss the development of simplified in vivo methods for the rapid, simple, reliable, unexpensive, and high-throughput amenable screening of Aβ aggregation inhibitors that rely on the overexpression of Aβ42 alone or fused with reporter proteins in Escherichia coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyUwDaYut4bVg90H21EOLACvtfcHk0li19PiwMf2-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M&md5=5df3642ce69af587b82d1dac92014f0d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990139%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DDual%2520inhibitors%2520of%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520acetylcholinesterase%2520as%2520multi-target%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1820%26epage%3D1842%26doi%3D10.2174%2F15680266113139990139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme&doi=10.1016%2FS0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0li19PiwMf2-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2FS0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10447</span><span class="NLM_x">–</span> <span class="NLM_lpage">10457</span><span class="refDoi"> DOI: 10.1021/bi0101392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0101392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10447-10457&author=G.+V.+De+Ferrariauthor=M.+A.+Canalesauthor=I.+Shinauthor=L.+M.+Weinerauthor=I.+Silmanauthor=N.+C.+Inestrosa&title=A+structural+motif+of+acetylcholinesterase+that+promotes+amyloid+beta-peptide+fibril+formation&doi=10.1021%2Fbi0101392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi0101392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0101392%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26aulast%3DCanales%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DA%2520structural%2520motif%2520of%2520acetylcholinesterase%2520that%2520promotes%2520amyloid%2520beta-peptide%2520fibril%2520formation%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10447%26epage%3D10457%26doi%3D10.1021%2Fbi0101392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Epilepsy and cognitive impairments in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1001/archneurol.2009.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1001%2Farchneurol.2009.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19204149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BD1M3nsVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=435-440&author=J.+J.+Palopauthor=L.+Mucke&title=Epilepsy+and+cognitive+impairments+in+Alzheimer+disease&doi=10.1001%2Farchneurol.2009.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Epilepsy and cognitive impairments in Alzheimer disease</span></div><div class="casAuthors">Palop Jorge J; Mucke Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures.  Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors.  However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models.  The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs.  Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD.  We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQY55la9yVoz8zK395ZObgVfW6udTcc2eZjgnocgKgx1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3nsVCjsA%253D%253D&md5=f537495f95da17a06c1f38a674e24b62</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2009.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2009.15%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DEpilepsy%2520and%2520cognitive%2520impairments%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D435%26epage%3D440%26doi%3D10.1001%2Farchneurol.2009.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1038/nn.2583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1038%2Fnn.2583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20581818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFSgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=812-818&author=J.+J.+Palopauthor=L.+Mucke&title=Amyloid-%CE%B2-induced+neuronal+dysfunction+in+Alzheimer%E2%80%99s+disease%3A+from+synapses+toward+neural+networks&doi=10.1038%2Fnn.2583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks</span></div><div class="casAuthors">Palop, Jorge J.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-818</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most frequent neurodegenerative disorder and the most common cause of dementia in the elderly.  Diverse lines of evidence suggest that amyloid-β (Aβ) peptides have a causal role in its pathogenesis, but the underlying mechanisms remain uncertain.  Here we discuss recent evidence that Aβ may be part of a mechanism controlling synaptic activity, acting as a pos. regulator presynaptically and a neg. regulator postsynaptically.  The pathol. accumulation of oligomeric Aβ assemblies depresses excitatory transmission at the synaptic level, but also triggers aberrant patterns of neuronal circuit activity and epileptiform discharges at the network level.  Aβ-induced dysfunction of inhibitory interneurons likely increases synchrony among excitatory principal cells and contributes to the destabilization of neuronal networks.  Strategies that block these Aβ effects may prevent cognitive decline in Alzheimer's disease.  Potential obstacles and next steps toward this goal are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LiGQBN055bVg90H21EOLACvtfcHk0ljCvFcqsgTNvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFSgtr0%253D&md5=12f7dfe712d2b2c1d7087f9a45224a96</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnn.2583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2583%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAmyloid-%25CE%25B2-induced%2520neuronal%2520dysfunction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520synapses%2520toward%2520neural%2520networks%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D812%26epage%3D818%26doi%3D10.1038%2Fnn.2583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Vossel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beagle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naasan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornes, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorno-Tempini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Seizures and epileptiform activity in the early stages of Alzheimer disease</span> <span class="citation_source-journal">JAMA Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span><span class="refDoi"> DOI: 10.1001/jamaneurol.2013.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1001%2Fjamaneurol.2013.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23835471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC3sjovFOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=1158-1166&author=K.+A.+Vosselauthor=A.+J.+Beagleauthor=G.+D.+Rabinoviciauthor=H.+Shuauthor=S.+E.+Leeauthor=G.+Naasanauthor=M.+Hegdeauthor=S.+B.+Cornesauthor=M.+L.+Henryauthor=A.+B.+Nelsonauthor=W.+W.+Seeleyauthor=M.+D.+Geschwindauthor=M.+L.+Gorno-Tempiniauthor=T.+Shihauthor=H.+E.+Kirschauthor=P.+A.+Garciaauthor=B.+L.+Millerauthor=L.+Mucke&title=Seizures+and+epileptiform+activity+in+the+early+stages+of+Alzheimer+disease&doi=10.1001%2Fjamaneurol.2013.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Seizures and epileptiform activity in the early stages of Alzheimer disease</span></div><div class="casAuthors">Vossel Keith A; Beagle Alexander J; Rabinovici Gil D; Shu Huidy; Lee Suzee E; Naasan Georges; Hegde Manu; Cornes Susannah B; Henry Maya L; Nelson Alexandra B; Seeley William W; Geschwind Michael D; Gorno-Tempini Maria L; Shih Tina; Kirsch Heidi E; Garcia Paul A; Miller Bruce L; Mucke Lennart</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1158-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IMPORTANCE:  Epileptic activity associated with Alzheimer disease (AD) deserves increased attention because it has a harmful impact on these patients, can easily go unrecognized and untreated, and may reflect pathogenic processes that also contribute to other aspects of the illness.  We report key features of AD-related seizures and epileptiform activity that are instructive for clinical practice and highlight similarities between AD and transgenic animal models of the disease.  OBJECTIVE:  To describe common clinical characteristics and treatment outcomes of patients with amnestic mild cognitive impairment (aMCI) or early AD who also have epilepsy or subclinical epileptiform activity.  DESIGN:  Retrospective observational study from 2007 to 2012.  SETTING Memory and Aging Center, University of California, San Francisco.  PATIENTS:  We studied 54 patients with a diagnosis of aMCI plus epilepsy (n = 12), AD plus epilepsy (n = 35), and AD plus subclinical epileptiform activity (n = 7).  MAIN OUTCOMES AND MEASURES:  Clinical and demographic data, electroencephalogram (EEG) readings, and treatment responses to antiepileptic medications.  RESULTS:  Patients with aMCI who had epilepsy presented with symptoms of cognitive decline 6.8 years earlier than patients with aMCI who did not have epilepsy (64.3 vs 71.1 years; P = .02).  Patients with AD who had epilepsy presented with cognitive decline 5.5 years earlier than patients with AD who did not have epilepsy (64.8 vs 70.3 years; P = .001).  Patients with AD who had subclinical epileptiform activity also had an early onset of cognitive decline (58.9 years).  The timing of seizure onset in patients with aMCI and AD was nonuniform (P < .001), clustering near the onset of cognitive decline.  Epilepsies were most often complex partial seizures (47%) and more than half were nonconvulsive (55%).  Serial or extended EEG monitoring appeared to be more effective than routine EEG at detecting interictal and subclinical epileptiform activity.  Epileptic foci were predominantly unilateral and temporal.  Of the most commonly prescribed antiepileptics, treatment outcomes appeared to be better for lamotrigine and levetiracetam than for phenytoin.  CONCLUSIONS AND RELEVANCE:  Common clinical features of patients with aMCI- or AD-associated epilepsy at our center included early age at onset of cognitive decline, early incidence of seizures in the disease course, unilateral temporal epileptic foci detected by serial/extended EEG, transient cognitive dysfunction, and good seizure control and tolerability with lamotrigine and levetiracetam.  Careful identification and treatment of epilepsy in such patients may improve their clinical course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROB3JO8qkWLUBuFdjgVNKSfW6udTcc2eaVbZZi2k5BjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjovFOmtA%253D%253D&md5=76d111f46f35cded57a44e631d10dac2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.136%26sid%3Dliteratum%253Aachs%26aulast%3DVossel%26aufirst%3DK.%2BA.%26aulast%3DBeagle%26aufirst%3DA.%2BJ.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DShu%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BE.%26aulast%3DNaasan%26aufirst%3DG.%26aulast%3DHegde%26aufirst%3DM.%26aulast%3DCornes%26aufirst%3DS.%2BB.%26aulast%3DHenry%26aufirst%3DM.%2BL.%26aulast%3DNelson%26aufirst%3DA.%2BB.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DGorno-Tempini%26aufirst%3DM.%2BL.%26aulast%3DShih%26aufirst%3DT.%26aulast%3DKirsch%26aufirst%3DH.%2BE.%26aulast%3DGarcia%26aufirst%3DP.%2BA.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DSeizures%2520and%2520epileptiform%2520activity%2520in%2520the%2520early%2520stages%2520of%2520Alzheimer%2520disease%26jtitle%3DJAMA%2520Neurol.%26date%3D2013%26volume%3D70%26spage%3D1158%26epage%3D1166%26doi%3D10.1001%2Fjamaneurol.2013.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McCarron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, C.</span><span> </span><span class="NLM_article-title">Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia</span> <span class="citation_source-journal">J. Intellect. Disabil. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1111/j.1365-2788.2005.00704.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fj.1365-2788.2005.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=15966964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BD2MzhvFWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=560-566&author=M.+McCarronauthor=M.+Gillauthor=P.+McCallionauthor=C.+Begley&title=Health+co-morbidities+in+ageing+persons+with+Down+syndrome+and+Alzheimer%E2%80%99s+dementia&doi=10.1111%2Fj.1365-2788.2005.00704.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia</span></div><div class="casAuthors">McCarron M; Gill M; McCallion P; Begley C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of intellectual disability research : JIDR</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">Pt 7</span>),
    <span class="NLM_cas:pages">560-6</span>
        ISSN:<span class="NLM_cas:issn">0964-2633</span>.
    </div><div class="casAbstract">BACKGROUND:  Consideration of the relationship between physical and mental health co-morbidities in ageing persons with Down syndrome (DS) and Alzheimer's dementia (AD) is of clinical importance both from a care and resource perspective.  AIM To investigate and measure health co-morbidities in ageing persons with Down syndrome with and without AD.  METHODS:  Recorded physical and mental health needs were ascertained for 124 persons with DS>35 years through a systematic and detailed search of individual medical and nursing case records.  Differences in persons with and without AD were investigated, by stage of dementia and by level of intellectual disability (ID).  A summed score for health co-morbidities was created and compared using t-tests.  RESULTS:  Persons with AD had significantly higher co-morbidity scores than persons without AD (t=-8.992, d.f.=121, P<0.0001).  There was also a significant difference in summed co-morbidity scores for persons at end-stage vs. persons at mid-stage AD (t=-6.429, d.f.=56, P<0.0001).  No differences were found by level of ID.  CONCLUSIONS:  Increasing health co-morbidities in persons with DS and AD have important implications for care and resources.  Appropriate environmental supports combined with competent skilled staff are crucial and will have an important impact on the quality of life for this increasingly at risk population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2XV3lckz1m9enUz0lpNqnfW6udTcc2eaVbZZi2k5BjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzhvFWgsQ%253D%253D&md5=92d3eeac14fd302535ab57d6f0638e07</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2788.2005.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2788.2005.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarron%26aufirst%3DM.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DMcCallion%26aufirst%3DP.%26aulast%3DBegley%26aufirst%3DC.%26atitle%3DHealth%2520co-morbidities%2520in%2520ageing%2520persons%2520with%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520dementia%26jtitle%3DJ.%2520Intellect.%2520Disabil.%2520Res.%26date%3D2005%26volume%3D49%26spage%3D560%26epage%3D566%26doi%3D10.1111%2Fj.1365-2788.2005.00704.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thwin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bien-Ly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.neuron.2007.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=17785178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2qtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=697-711&author=J.+J.+Palopauthor=J.+Chinauthor=E.+D.+Robersonauthor=J.+Wangauthor=M.+T.+Thwinauthor=N.+Bien-Lyauthor=J.+Yooauthor=K.+O.+Hoauthor=G.+Q.+Yuauthor=A.+Kreitzerauthor=S.+Finkbeinerauthor=J.+L.+Noebelsauthor=L.+Mucke&title=Aberrant+excitatory+neuronal+activity+and+compensatory+remodeling+of+inhibitory+hippocampal+circuits+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2007.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease</span></div><div class="casAuthors">Palop, Jorge J.; Chin, Jeannie; Roberson, Erik D.; Wang, Jun; Thwin, Myo T.; Bien-Ly, Nga; Yoo, Jong; Ho, Kaitlyn O.; Yu, Gui-Qiu; Kreitzer, Anatol; Finkbeiner, Steven; Noebels, Jeffrey L.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">697-711</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neural network dysfunction may play an important role in Alzheimer's disease (AD).  Neuronal circuits vulnerable to AD are also affected in human amyloid precursor protein (hAPP) transgenic mice.  HAPP mice with high levels of amyloid-β peptides in the brain develop AD-like abnormalities, including cognitive deficits and depletions of calcium-related proteins in the dentate gyrus, a region critically involved in learning and memory.  Here, we report that hAPP mice have spontaneous nonconvulsive seizure activity in cortical and hippocampal networks, which is assocd. with GABAergic sprouting, enhanced synaptic inhibition, and synaptic plasticity deficits in the dentate gyrus.  Many Aβ-induced neuronal alterations could be simulated in nontransgenic mice by excitotoxin challenge and prevented in hAPP mice by blocking overexcitation.  Aberrant increases in network excitability and compensatory inhibitory mechanisms in the hippocampus may contribute to Aβ-induced neurol. deficits in hAPP mice and, possibly, also in humans with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyANoCdgosrbVg90H21EOLACvtfcHk0ljGVIsKxUhteg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2qtrfO&md5=11507c966f258bef0b1f8d2a3641bd8d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DThwin%26aufirst%3DM.%2BT.%26aulast%3DBien-Ly%26aufirst%3DN.%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DK.%2BO.%26aulast%3DYu%26aufirst%3DG.%2BQ.%26aulast%3DKreitzer%26aufirst%3DA.%26aulast%3DFinkbeiner%26aufirst%3DS.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAberrant%2520excitatory%2520neuronal%2520activity%2520and%2520compensatory%2520remodeling%2520of%2520inhibitory%2520hippocampal%2520circuits%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2007%26volume%3D55%26spage%3D697%26epage%3D711%26doi%3D10.1016%2Fj.neuron.2007.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bakker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yassa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassett, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M.</span><span> </span><span class="NLM_article-title">Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.neuron.2012.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.neuron.2012.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22578498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFantr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=467-474&author=A.+Bakkerauthor=G.+L.+Kraussauthor=M.+S.+Albertauthor=C.+L.+Speckauthor=L.+R.+Jonesauthor=C.+E.+Starkauthor=M.+A.+Yassaauthor=S.+S.+Bassettauthor=A.+L.+Sheltonauthor=M.+Gallagher&title=Reduction+of+hippocampal+hyperactivity+improves+cognition+in+amnestic+mild+cognitive+impairment&doi=10.1016%2Fj.neuron.2012.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment</span></div><div class="casAuthors">Bakker, Arnold; Krauss, Gregory L.; Albert, Marilyn S.; Speck, Caroline L.; Jones, Lauren R.; Stark, Craig E.; Yassa, Michael A.; Bassett, Susan S.; Shelton, Amy L.; Gallagher, Michela</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Elevated hippocampal activation is obsd. in conditions that confer risk for Alzheimer's disease, including amnestic mild cognitive impairment (aMCI).  Studies in relevant animal models have indicated that overactivity in selective hippocampal circuits contributes to cognitive impairment.  Here, we tested the effect of reducing hippocampal activation in aMCI.  Under placebo treatment, hippocampal activation in the dentate gyrus/CA3 was elevated in aMCI patients compared to a healthy control group.  By using a low dose of the antiepileptic levetiracetam hippocampal activation in aMCI was reduced to a level that did not differ from the control group.  Compared to aMCI memory performance under placebo, performance in the scanning task was significantly improved under drug treatment.  Contrary to the view that greater hippocampal activation might serve a beneficial function, these results support the view that increased hippocampal activation in aMCI is a dysfunctional condition and that targeting excess hippocampal activity has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7GcrYTocgkLVg90H21EOLACvtfcHk0ljewBPLvttwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFantr4%253D&md5=290b84cad5dc37686c8199d3ed389ca1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DBakker%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DG.%2BL.%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DSpeck%26aufirst%3DC.%2BL.%26aulast%3DJones%26aufirst%3DL.%2BR.%26aulast%3DStark%26aufirst%3DC.%2BE.%26aulast%3DYassa%26aufirst%3DM.%2BA.%26aulast%3DBassett%26aufirst%3DS.%2BS.%26aulast%3DShelton%26aufirst%3DA.%2BL.%26aulast%3DGallagher%26aufirst%3DM.%26atitle%3DReduction%2520of%2520hippocampal%2520hyperactivity%2520improves%2520cognition%2520in%2520amnestic%2520mild%2520cognitive%2520impairment%26jtitle%3DNeuron%26date%3D2012%26volume%3D74%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.neuron.2012.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sanchez, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vossel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devidze, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2895</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2903</span><span class="refDoi"> DOI: 10.1073/pnas.1121081109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1073%2Fpnas.1121081109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22869752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WmsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E2895-E2903&author=P.+E.+Sanchezauthor=L.+Zhuauthor=L.+Verretauthor=K.+A.+Vosselauthor=A.+G.+Orrauthor=J.+R.+Cirritoauthor=N.+Devidzeauthor=K.+Hoauthor=G.-Q.+Yuauthor=J.+J.+Palopauthor=L.+Mucke&title=Levetiracetam+suppresses+neuronal+network+dysfunction+and+reverses+synaptic+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1073%2Fpnas.1121081109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Sanchez, Pascal E.; Zhu, Lei; Verret, Laure; Vossel, Keith A.; Orr, Anna G.; Cirrito, John R.; Devidze, Nino; Ho, Kaitlyn; Yu, Gui-Qiu; Palop, Jorge J.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">E2895-E2903, SE2895/1-SE2895/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In light of the rising prevalence of Alzheimer's disease (AD), new strategies to prevent, halt, and reverse this condition are needed urgently.  Perturbations of brain network activity are obsd. in AD patients and in conditions that increase the risk of developing AD, suggesting that aberrant network activity might contribute to AD-related cognitive decline.  Human amyloid precursor protein (hAPP) transgenic mice simulate key aspects of AD, including pathol. elevated levels of amyloid-β peptides in brain, aberrant neural network activity, remodeling of hippocampal circuits, synaptic deficits, and behavioral abnormalities.  Whether these alterations are linked in a causal chain remains unknown.  To explore whether hAPP/amyloid-β-induced aberrant network activity contributes to synaptic and cognitive deficits, we treated hAPP mice with different antiepileptic drugs.  Among the drugs tested, only levetiracetam (LEV) effectively reduced abnormal spike activity detected by electroencephalog.  Chronic treatment with LEV also reversed hippocampal remodeling, behavioral abnormalities, synaptic dysfunction, and deficits in learning and memory in hAPP mice.  Our findings support the hypothesis that aberrant network activity contributes causally to synaptic and cognitive deficits in hAPP mice.  LEV might also help ameliorate related abnormalities in people who have or are at risk for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUfooUianbtLVg90H21EOLACvtfcHk0ljewBPLvttwUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WmsbjK&md5=3d9c87f1c9c1738c4734432af89fc9ea</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121081109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121081109%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DP.%2BE.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DVerret%26aufirst%3DL.%26aulast%3DVossel%26aufirst%3DK.%2BA.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DDevidze%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DG.-Q.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DLevetiracetam%2520suppresses%2520neuronal%2520network%2520dysfunction%2520and%2520reverses%2520synaptic%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE2895%26epage%3DE2903%26doi%3D10.1073%2Fpnas.1121081109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Shi, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-D.</span><span> </span><span class="NLM_article-title">Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span><span class="refDoi"> DOI: 10.1111/cns.12144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fcns.12144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23889921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Gku7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=871-881&author=J.-Q.+Shiauthor=B.-R.+Wangauthor=Y.-Y.+Tianauthor=J.+Xuauthor=L.+Gaoauthor=S.-L.+Zhaoauthor=T.+Jiangauthor=H.-G.+Xieauthor=Y.-D.+Zhang&title=Antiepileptics+topiramate+and+levetiracetam+alleviate+behavioral+deficits+and+reduce+neuropathology+in+APPswe%2FPS1dE9+transgenic+mice&doi=10.1111%2Fcns.12144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice</span></div><div class="casAuthors">Shi, Jian-Quan; Wang, Bian-Rong; Tian, You-Yong; Xu, Jun; Gao, Li; Zhao, Shu-Li; Jiang, Teng; Xie, Hong-Guang; Zhang, Ying-Dong</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">871-881</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: The close relationship between epileptic seizure and Alzheimer's disease (AD) has been demonstrated in the past decade.  Valproic acid, a traditional first-line antiepileptic drug, exerted protective effects in transgenic models of AD.  It remains uncertain whether new antiepileptic drugs could reverse neuropathol. and behavioral deficits in AD transgenic mice.  Aims: APPswe/PS1dE9 transgenic mice were used in this study, which over express the Swedish mutation of amyloid precursor protein together with presenilin 1 deleted in exon 9. 7-mo-old APPswe/PS1dE9 transgenic mice were treated daily with 20 mg/kg topiramate (TPM) and 50 mg/kg levetiracetam (LEV) for 30 days by i.p. injection to explore the effects of TPM and LEV on the neuropathol. and behavioral deficits.  Results: The results indicated that TPM and LEV alleviated behavioral deficits and reduced amyloid plaques in APPswe/PS1dE9 transgenic mice.  TPM and LEV increased Aβ clearance and up-regulated Aβ transport and autophagic degrdn.  TPM and LEV inhibited Aβ generation and suppressed γ-secretase activity.  TPM and LEV inhibited GSK-3β activation and increased the activation of AMPK/Akt activation.  Further, TPM and LEV inhibited histone deacetylase activity in vivo.  Conclusions: Therefore, TPM and LEV might have the potential to treat AD effectively in patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlOJf22rLb7Vg90H21EOLACvtfcHk0lim5Chv-SmXRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Gku7bE&md5=af18b87a1722b432431ebb6b1a6784e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fcns.12144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12144%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.-Q.%26aulast%3DWang%26aufirst%3DB.-R.%26aulast%3DTian%26aufirst%3DY.-Y.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DS.-L.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DH.-G.%26aulast%3DZhang%26aufirst%3DY.-D.%26atitle%3DAntiepileptics%2520topiramate%2520and%2520levetiracetam%2520alleviate%2520behavioral%2520deficits%2520and%2520reduce%2520neuropathology%2520in%2520APPswe%252FPS1dE9%2520transgenic%2520mice%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2013%26volume%3D19%26spage%3D871%26epage%3D881%26doi%3D10.1111%2Fcns.12144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mucke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Neurotoxicity of amyloid-β protein: Synaptic and network dysfunction</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006338</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1101%2Fcshperspect.a006338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006338&author=L.+Muckeauthor=D.+J.+Selkoe&title=Neurotoxicity+of+amyloid-%CE%B2+protein%3A+Synaptic+and+network+dysfunction&doi=10.1101%2Fcshperspect.a006338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006338%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DNeurotoxicity%2520of%2520amyloid-%25CE%25B2%2520protein%253A%2520Synaptic%2520and%2520network%2520dysfunction%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006338%26doi%3D10.1101%2Fcshperspect.a006338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Font-Bardia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solans, X.</span><span> </span><span class="NLM_article-title">Enantioselective synthesis of tacrine–huperzine A hybrids. Preparative chiral MPLC separation of their racemic mixtures and absolute configuration assignments by X-ray diffraction analysis</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1016/S0957-4166(98)00029-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0957-4166%2898%2900029-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=835-849&author=P.+Campsauthor=J.+Contrerasauthor=M.+Font-Bardiaauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=X.+Solans&title=Enantioselective+synthesis+of+tacrine%E2%80%93huperzine+A+hybrids.+Preparative+chiral+MPLC+separation+of+their+racemic+mixtures+and+absolute+configuration+assignments+by+X-ray+diffraction+analysis&doi=10.1016%2FS0957-4166%2898%2900029-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900029-9%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DJ.%26aulast%3DFont-Bardia%26aufirst%3DM.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSolans%26aufirst%3DX.%26atitle%3DEnantioselective%2520synthesis%2520of%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids.%2520Preparative%2520chiral%2520MPLC%2520separation%2520of%2520their%2520racemic%2520mixtures%2520and%2520absolute%2520configuration%2520assignments%2520by%2520X-ray%2520diffraction%2520analysis%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D835%26epage%3D849%26doi%3D10.1016%2FS0957-4166%2898%2900029-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baños, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">New tacrine–huperzine A hybrids (huprines): Highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4666</span><span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine%E2%80%93huperzine+A+hybrids+%28huprines%29%3A+Highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0lim5Chv-SmXRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520Highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span> </span><span class="NLM_article-title">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=409-417&author=P.+Campsauthor=B.+Cusackauthor=W.+D.+Mallenderauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=T.+L.+Rosenberry&title=Huprine+X+is+a+novel+high-affinity+inhibitor+of+acetylcholinesterase+that+is+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26atitle%3DHuprine%2520X%2520is%2520a%2520novel%2520high-affinity%2520inhibitor%2520of%2520acetylcholinesterase%2520that%2520is%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">3D Structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamics correlates</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2970</span><span class="NLM_x">–</span> <span class="NLM_lpage">2981</span><span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+Structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+Kinetic+and+molecular+dynamics+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0lgbgafKjXq0Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520Structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520Kinetic%2520and%2520molecular%2520dynamics%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lgbgafKjXq0Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Tetrahydrobenzo[<i>h</i>][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+hybrids+as+a+new+family+of+anti-Alzheimer+agents+targeting+%CE%B2-amyloid%2C+tau%2C+and+cholinesterase+pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0lhyd0NsXQrAKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520hybrids%2520as%2520a%2520new%2520family%2520of%2520anti-Alzheimer%2520agents%2520targeting%2520%25CE%25B2-amyloid%252C%2520tau%252C%2520and%2520cholinesterase%2520pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallverdú-Queralt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragusa, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamuela-Raventós, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5298</span><span class="NLM_x">–</span> <span class="NLM_lpage">5307</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol%E2%80%93huprine+hybrids%3A+Dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol%25E2%2580%2593huprine%2520hybrids%253A%2520Dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minguillón, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0ljVR233kdS4nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Pang, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiram, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelacic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimijoin, S.</span><span> </span><span class="NLM_article-title">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">23646</span><span class="NLM_x">–</span> <span class="NLM_lpage">23649</span><span class="refDoi"> DOI: 10.1074/jbc.271.39.23646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1074%2Fjbc.271.39.23646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=8798583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23646-23649&author=Y.-P.+Pangauthor=P.+Quiramauthor=T.+Jelacicauthor=F.+Hongauthor=S.+Brimijoin&title=Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase&doi=10.1074%2Fjbc.271.39.23646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease</span></div><div class="casAuthors">Pang, Yuan-Ping; Quiram, Polly; Jelacic, Tanya; Hong, Feng; Brimijoin, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23646-23649</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report highly potent, selective, and low cost bifunctional acetylcholinesterase (AChE) inhibitors developed by our two-step prototype optimization strategy utilizing computer modeling of ligand docking with target proteins: (1) identify low affinity sites normally missed by x-ray crystallog.; and (2) design bifunctional analogs capable of simultaneous binding at the computer-detd. low affinity site and the x-ray-identified high affinity site.  Applying this strategy to 9-amino-1,2,3,4-tetrahydroacridine (THA), a drug for Alzheimer's disease, we obtained alkylene linked bis-THA analogs.  These analogs were up to 10,000-fold more selective and 1,000-fold more potent than THA in inhibiting rat AChE and yet required one simple reaction to synthesize.  Addnl., alkylene linked benzyl-THA analogs were developed to examine the specificity of the docking-derived low affinity THA peripheral site in AChE.  The present work and our previous computational studies strongly suggest that a low affinity THA peripheral site exists in AChE.  This peripheral site provides a structural basis for design of improved cholinesterase ligands for treating Alzheimer's disease and for other health-related purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjTElkdbiv7Vg90H21EOLACvtfcHk0ljVR233kdS4nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D&md5=d8ff73789f75d61060df44c3d5edc769</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23646%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DY.-P.%26aulast%3DQuiram%26aufirst%3DP.%26aulast%3DJelacic%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DHighly%2520potent%252C%2520selective%252C%2520and%2520low%2520cost%2520bis-tetrahydroaminacrine%2520inhibitors%2520of%2520acetylcholinesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23646%26epage%3D23649%26doi%3D10.1074%2Fjbc.271.39.23646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Li, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K. K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. F.</span><span> </span><span class="NLM_article-title">East meets West in the search for Alzheimer’s therapeutics - Novel dimeric inhibitors from tacrine and huperzine A</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.2174/156720507781788918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F156720507781788918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=17908041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=386-396&author=W.+M.+Liauthor=K.+K.+W.+Kanauthor=P.+R.+Carlierauthor=Y.+P.+Pangauthor=Y.+F.+Han&title=East+meets+West+in+the+search+for+Alzheimer%E2%80%99s+therapeutics+-+Novel+dimeric+inhibitors+from+tacrine+and+huperzine+A&doi=10.2174%2F156720507781788918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">East meets west in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A</span></div><div class="casAuthors">Li, W. M.; Kan, K. K. W.; Carlier, P. R.; Pang, Y. P.; Han, Y. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is linked to cholinergic deficiency and the overactivation of glutamate receptors.  The acetylcholinesterase (AChE) inhibition treatment approach has produced the most encouraging results in clin. practice, and memantine, a moderate antagonist of N-methyl-D-aspartate (NMDA) receptors, has been approved for treating AD.  However, AChE inhibitors have limited success as they only improve memory in mild dementia but cannot stop the process of neurodegeneration; while memantine possesses neuroprotective effects only with a little ability in memory enhancement.  There has been a major rush among neuroscience research institutions and pharmaceutical firms worldwide to search for safer and more effective therapeutic agents for AD.  The novel dimers, derived from tacrine and the fragment of huperzine A (HA'), have been demonstrated to be potent and selective reversible inhibitors of AChE.  Bis(7)-tacrine, bis(12)-hypyridone (E12E) and HA'(10)-tacrine, are representatives of three series of novel dimers.  According to the pre-clin. studies, these compds. have been shown to have low toxicity and high efficacy for improving cognitive deficits in several animal models.  More interestingly, bis(7)-tacrine, similar to memantine, prevents glutamate-induced neurotoxicity by moderately blocking glutamate receptor NMDA subtype.  Furthermore, bis(7)-tacrine, as well as E12E, possesses multiple neuroprotective effects in vitro and in vivo.  Taking together, these dimeric AChE inhibitors, esp. bis(7)-tacrine, E12E and HA'(10)-tacrine, may provide beneficial effects in AD and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonIecPwLr6X7Vg90H21EOLACvtfcHk0ljVR233kdS4nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL7F&md5=41a0ab662f6a7b9c28fcaee9d981db77</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F156720507781788918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788918%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%2BM.%26aulast%3DKan%26aufirst%3DK.%2BK.%2BW.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DPang%26aufirst%3DY.%2BP.%26aulast%3DHan%26aufirst%3DY.%2BF.%26atitle%3DEast%2520meets%2520West%2520in%2520the%2520search%2520for%2520Alzheimer%25E2%2580%2599s%2520therapeutics%2520-%2520Novel%2520dimeric%2520inhibitors%2520from%2520tacrine%2520and%2520huperzine%2520A%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D386%26epage%3D396%26doi%3D10.2174%2F156720507781788918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Boschi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes-Franchini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, L.</span><span> </span><span class="NLM_article-title">A synthesis of levetiracetam based on (<i>S</i>)-<i>N</i>-phenylpantolactam as a chiral auxiliary</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3745</span><span class="refDoi"> DOI: 10.1016/j.tetasy.2005.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.tetasy.2005.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GitbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=3739-3745&author=F.+Boschiauthor=P.+Campsauthor=M.+Comes-Franchiniauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Ricciauthor=L.+S%C3%A1nchez&title=A+synthesis+of+levetiracetam+based+on+%28S%29-N-phenylpantolactam+as+a+chiral+auxiliary&doi=10.1016%2Fj.tetasy.2005.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A synthesis of levetiracetam based on (S)-N-phenylpantolactam as a chiral auxiliary</span></div><div class="casAuthors">Boschi, Francesca; Camps, Pelayo; Comes-Franchini, Mauro; Munoz-Torrero, Diego; Ricci, Alfredo; Sanchez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3739-3745</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of levetiracetam and its enantiomer was carried out by deracemization of (±)-2-bromobutyric acid using either (S)- or (R)-N-phenylpantolactam as chiral auxiliaries followed by SN2 substitution of the bromine atom by a 2-oxopyrrolidin-1-yl group and amidation of the carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ0bMzKAvxBbVg90H21EOLACvtfcHk0lh4RRS4UbYUww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GitbfM&md5=cce521c0a9c96d5ff4839a8a2e5405bf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2005.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2005.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DBoschi%26aufirst%3DF.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DComes-Franchini%26aufirst%3DM.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DL.%26atitle%3DA%2520synthesis%2520of%2520levetiracetam%2520based%2520on%2520%2528S%2529-N-phenylpantolactam%2520as%2520a%2520chiral%2520auxiliary%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2005%26volume%3D16%26spage%3D3739%26epage%3D3745%26doi%3D10.1016%2Fj.tetasy.2005.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, E. S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.-P.</span><span> </span><span class="NLM_article-title">Heterodimeric tacrine-based acetylcholinesterase inhibitors: Investigating ligand–peripheral site interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1021/jm990224w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990224w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4225-4231&author=P.+R.+Carlierauthor=E.+S.-H.+Chowauthor=Y.+Hanauthor=J.+Liuauthor=J.+El+Yazalauthor=Y.-P.+Pang&title=Heterodimeric+tacrine-based+acetylcholinesterase+inhibitors%3A+Investigating+ligand%E2%80%93peripheral+site+interactions&doi=10.1021%2Fjm990224w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm990224w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990224w%26sid%3Dliteratum%253Aachs%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DChow%26aufirst%3DE.%2BS.-H.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEl%2BYazal%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.-P.%26atitle%3DHeterodimeric%2520tacrine-based%2520acetylcholinesterase%2520inhibitors%253A%2520Investigating%2520ligand%25E2%2580%2593peripheral%2520site%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4225%26epage%3D4231%26doi%3D10.1021%2Fjm990224w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Muñoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: New disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span><span class="refDoi"> DOI: 10.1021/jm0503289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+New+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm0503289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease</span></div><div class="casAuthors">Munoz-Ruiz, Pilar; Rubio, Laura; Garcia-Palomero, Esther; Dorronsoro, Isabel; Monte-Millan, Maria del; Valenzuela, Rita; Usan, Paola; de Austria, Celia; Bartolini, Manuela; Andrisano, Vincenza; Bidon-Chanal, Axel; Orozco, Modesto; Luque, F. Javier; Medina, Miguel; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7223-7233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New dual binding site acetylcholinesterase (AChE) inhibitors have been designed and synthesized as new potent drugs that may simultaneously alleviate cognitive deficits and behave as disease-modifying agents by inhibiting the β-amyloid (Aβ) peptide aggregation through binding to both catalytic and peripheral sites of the enzyme.  Particularly, compds. 5 and 6 emerged as the most potent heterodimers reported so far, displaying IC50 values for AChE inhibition of 20 and 60 pM, resp.  More importantly, these dual AChE inhibitors inhibit the AChE-induced Aβ peptide aggregation with IC50 values 1 order of magnitude lower than that of propidium, thus being the most potent derivs. with this activity reported up to date.  We therefore conclude that these compds. are very promising disease-modifying agents for the treatment of Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryN7Kwa5OXZ7Vg90H21EOLACvtfcHk0lh4RRS4UbYUww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO&md5=bb5781896d759075a46bbe2222bbca03</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520New%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233%26doi%3D10.1021%2Fjm0503289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diomede, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colantuono, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Multigram synthesis and <i>in vivo</i> efficacy studies of a novel multitarget anti-Alzheimer compound</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4492</span><span class="NLM_x">–</span> <span class="NLM_lpage">4515</span><span class="refDoi"> DOI: 10.3390/molecules20034492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.3390%2Fmolecules20034492" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=4492-4515&author=I.+Solaauthor=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=M.+Cassinaauthor=P.+Campsauthor=M.+Romeoauthor=L.+Diomedeauthor=M.+Salmonaauthor=P.+Francoauthor=M.+Schaefferauthor=D.+Colantuonoauthor=D.+Robinauthor=D.+Brunnerauthor=N.+Taubauthor=B.+Hutter-Paierauthor=D.+Mu%C3%B1oz-Torrero&title=Multigram+synthesis+and+in+vivo+efficacy+studies+of+a+novel+multitarget+anti-Alzheimer+compound&doi=10.3390%2Fmolecules20034492"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20034492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20034492%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DCassina%26aufirst%3DM.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DDiomede%26aufirst%3DL.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DP.%26aulast%3DSchaeffer%26aufirst%3DM.%26aulast%3DColantuono%26aufirst%3DD.%26aulast%3DRobin%26aufirst%3DD.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DTaub%26aufirst%3DN.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMultigram%2520synthesis%2520and%2520in%2520vivo%2520efficacy%2520studies%2520of%2520a%2520novel%2520multitarget%2520anti-Alzheimer%2520compound%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D4492%26epage%3D4515%26doi%3D10.3390%2Fmolecules20034492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Lane, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1017/S1461145705005833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1017%2FS1461145705005833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=16083515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-124&author=R.+M.+Laneauthor=S.+G.+Potkinauthor=A.+Enz&title=Targeting+acetylcholinesterase+and+butyrylcholinesterase+in+dementia&doi=10.1017%2FS1461145705005833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span></div><div class="casAuthors">Lane, Roger M.; Potkin, Steven G.; Enz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-124</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying the cognitive and neuropsychiatric dysfunctions in patients with AD.  Inhibition of brain acetylcholinesterase (AChE) has been the major therapeutic target of ChE-I treatment strategies for Alzheimer's disease (AD).  AChE-pos. neurons project diffusely to the cortex, modulating cortical processing and responses to new and relevant stimuli.  Butyrylcholinesterase (BuChE)-pos. neurons project specifically to the frontal cortex, and may have roles in attention, executive function, emotional memory and behavior.  Furthermore, BuChE activity progressively increases as the severity of dementia advances, while AChE activity declines.  Therefore, inhibition of BuChE may provide addnl. benefits.  The two cholinesterase (ChE) enzymes that metabolize acetylcholine (ACh) differ significantly in substrate specificity, enzyme kinetics, expression and activity in different brain regions, and complexity of gene regulation.  In addn., recent evidence suggests that AChE and BuChE may have roles beyond classical' co-regulatory esterase functions in terminating ACh-mediated neurotransmission.  Non-classical' roles in modulating the activity of other proteins, regional cerebral blood flow, tau phosphorylation, and the amyloid cascade may affect rates of AD progression.  If these addnl. mechanisms are demonstrated to underlie clin. meaningful effects, modification of the over-simplistic cholinergic hypothesis in AD that is limited to symptomatic treatment, ignoring the potential of cholinergic therapies to modify the disease process, may be appropriate.  The specificity of ChE inhibitory activity, up-regulation of AChE activity and changes in the compn. of AChE mol. forms over time, selectivity for AD-relevant ChE mol. forms, brain vs. peripheral selectivity, and pharmacokinetic profile may be important determinants of the acute and long-term efficacy, safety and tolerability profiles of the different ChE-Is.  This review focuses on new evidence for the roles of BuChE and AChE in symptom generation and rate of underlying disease progression in dementia, and argues that it may be appropriate to re-evaluate the place of ChE-Is in the treatment of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYzIuEFXpTS7Vg90H21EOLACvtfcHk0lgaRG6ZirAckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D&md5=b5871dacc777b6c8769be565106cb988</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1017%2FS1461145705005833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705005833%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BM.%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DEnz%26aufirst%3DA.%26atitle%3DTargeting%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520in%2520dementia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D124%26doi%3D10.1017%2FS1461145705005833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Macdonald, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvesh, S.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibition in Alzheimer’s disease: Is specificity the answer?</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.3233/JAD-140219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.3233%2FJAD-140219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24898642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=379-384&author=I.+R.+Macdonaldauthor=K.+Rockwoodauthor=E.+Martinauthor=S.+Darvesh&title=Cholinesterase+inhibition+in+Alzheimer%E2%80%99s+disease%3A+Is+specificity+the+answer%3F&doi=10.3233%2FJAD-140219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?</span></div><div class="casAuthors">Macdonald, Ian R.; Rockwood, Kenneth; Martin, Earl; Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinesterase inhibitors are the std. of care for Alzheimer's disease (AD).  Acetylcholinesterase (AChE) catalyzes the hydrolysis of the cholinergic neurotransmitter acetylcholine.  However, the related enzyme butyrylcholinesterase (BuChE) also breaks down acetylcholine and is likewise targeted by the same clin. cholinesterase inhibitors.  The lack of clin. efficacy for the highly specific and potent AChE inhibitor, (-) huperzine A, is intriguing, given the known cholinergic deficit in AD.  Based on the proven efficacy of inhibitors affecting both cholinesterases and the apparent failure of specific AChE inhibition, focused BuChE inhibition seems important for more effective treatment of AD.  Therefore, BuChE-selective inhibitors provide promise for improved benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0L1sVpCa_7Vg90H21EOLACvtfcHk0lgaRG6ZirAckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M&md5=010bac9c291fd9c4d44e97fb5fa065f0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3233%2FJAD-140219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-140219%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DI.%2BR.%26aulast%3DRockwood%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DCholinesterase%2520inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Is%2520specificity%2520the%2520answer%253F%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D379%26epage%3D384%26doi%3D10.3233%2FJAD-140219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lgaRG6ZirAckg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span> </span><span class="NLM_article-title">SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: Synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span><span class="refDoi"> DOI: 10.1021/jm990971t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2007-2018&author=M.+Recanatiniauthor=A.+Cavalliauthor=F.+Bellutiauthor=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=V.+Cavrini&title=SAR+of+9-amino-1%2C2%2C3%2C4-tetrahydroacridine-based+acetylcholinesterase+inhibitors%3A+Synthesis%2C+enzyme+inhibitory+activity%2C+QSAR%2C+and+structure-based+CoMFA+of+tacrine+analogues&doi=10.1021%2Fjm990971t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues</span></div><div class="casAuthors">Recanatini, Maurizio; Cavalli, Andrea; Belluti, Federica; Piazzi, Lorna; Rampa, Angela; Bisi, Alessandra; Gobbi, Silvia; Valenti, Piero; Andrisano, Vincenza; Bartolini, Manuela; Cavrini, Vanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2007-2018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we attempted to derive a comprehensive SAR picture for the class of acetylcholinesterase (AChE) inhibitors related to tacrine, a drug currently in use for the treatment of the Alzheimer's disease.  Toward this aim, we synthesized and tested a series of 9-amino-1,2,3,4-tetrahydroacridine derivs. substituted at positions 6 and 7 of the acridine nucleus and bearing selected groups on the 9-amino function.  By means of the Hansch approach, QSAR equations were obtained, quant. accounting for both the detrimental steric effect of substituents in position 7 and the favorable electron-attracting effect exerted by substituents in positions 6 and 7 of the 9-amino-1,2,3,4-tetrahydroacridine derivs.  The three-dimensional (3D) properties of the inhibitors were taken into consideration by performing a comparative mol. field anal. (CoMFA) on the series of AChE inhibitors made by twelve 9-amino-1,2,3,4-tetrahydroacridines and thirteen 11H-indeno[1,2-b]quinolin-10-ylamines previously developed in our lab.  The alignment of the mols. to be submitted to the CoMFA procedure was carried out by taking advantage of docking models calcd. for the interactions of both the unsubstituted 9-amino-1,2,3,4-tetrahydroacridine and 11H-indeno[1,2-b]quinolin-10-ylamine with the target enzyme.  A highly significant CoMFA model was obtained using the steric field alone, and the features of such a 3D QSAR model were compared with the classical QSAR equations previously calcd.  The two models appeared to be consistent with one another, with the following main aspects in common: (a) individuation of the strongly neg. contribution of substituents in position 7 of tacrine, and (b) tentative assignment of hydrophobic character to the favorable effect exerted by the substituents in position 6.  Finally, to test the predictive ability of the QSAR models, 6-bromo-9-amino-1,2,3,4-tetrahydroacridine, a new tacrine deriv. designed on the basis of both classical and 3D QSAR equations was synthesized and kinetically evaluated.  This compd. was predicted to have a pIC50 value of 7.31 by the classical QSAR model and 7.40 by the CoMFA model; its exptl. IC50 value was equal to 0.066 (±0.009) μM, which corresponds to a pIC50 of 7.18, and shows reasonable agreement with the predicted AChE inhibition data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DgmKhtx11LVg90H21EOLACvtfcHk0liY-9Y3YgP6EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D&md5=f9e8a7eb7bb347bfd80953e2870a789c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm990971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990971t%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26atitle%3DSAR%2520of%25209-amino-1%252C2%252C3%252C4-tetrahydroacridine-based%2520acetylcholinesterase%2520inhibitors%253A%2520Synthesis%252C%2520enzyme%2520inhibitory%2520activity%252C%2520QSAR%252C%2520and%2520structure-based%2520CoMFA%2520of%2520tacrine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2007%26epage%3D2018%26doi%3D10.1021%2Fjm990971t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Wlodek, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antosiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straatsma, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:1<109::AID-BIP9>3.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Savini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaeta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalanotti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiasserini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKissic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0liY-9Y3YgP6EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Elsinghorst, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tränkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">First gallamine–tacrine hybrid: Design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5685</span><span class="NLM_x">–</span> <span class="NLM_lpage">5695</span><span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine%E2%80%93tacrine+hybrid%3A+Design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0li60xcJD1w-Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine%25E2%2580%2593tacrine%2520hybrid%253A%2520Design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">New perspectives on the role of tau in Alzheimer’s disease. Implicactions for therapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1016/j.bcp.2014.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bcp.2014.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=540-547&author=M.+Medinaauthor=J.+Avila&title=New+perspectives+on+the+role+of+tau+in+Alzheimer%E2%80%99s+disease.+Implicactions+for+therapy&doi=10.1016%2Fj.bcp.2014.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520role%2520of%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Implicactions%2520for%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D88%26spage%3D540%26epage%3D547%26doi%3D10.1016%2Fj.bcp.2014.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Lansdall, C. J.</span><span> </span><span class="NLM_article-title">An effective treatment for Alzheimer’s disease must consider both amyloid and tau</span> <span class="citation_source-journal">Biosci. Horiz.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">hzu002</span><span class="refDoi"> DOI: 10.1093/biohorizons/hzu002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1093%2Fbiohorizons%2Fhzu002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=hzu002&author=C.+J.+Lansdall&title=An+effective+treatment+for+Alzheimer%E2%80%99s+disease+must+consider+both+amyloid+and+tau&doi=10.1093%2Fbiohorizons%2Fhzu002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fbiohorizons%2Fhzu002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbiohorizons%252Fhzu002%26sid%3Dliteratum%253Aachs%26aulast%3DLansdall%26aufirst%3DC.%2BJ.%26atitle%3DAn%2520effective%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520must%2520consider%2520both%2520amyloid%2520and%2520tau%26jtitle%3DBiosci.%2520Horiz.%26date%3D2014%26volume%3D7%26spage%3Dhzu002%26doi%3D10.1093%2Fbiohorizons%2Fhzu002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Villar-Piqué, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, S.</span><span> </span><span class="NLM_article-title">Modeling amyloids in bacteria</span> <span class="citation_source-journal">Microb. Cell Fact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="refDoi"> DOI: 10.1186/1475-2859-11-166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1186%2F1475-2859-11-166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23272903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=166&author=A.+Villar-Piqu%C3%A9author=S.+Ventura&title=Modeling+amyloids+in+bacteria&doi=10.1186%2F1475-2859-11-166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling amyloids in bacteria</span></div><div class="casAuthors">Villar-Pique, Anna; Ventura, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Microbial Cell Factories</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">166</span>CODEN:
                <span class="NLM_cas:coden">MCFICT</span>;
        ISSN:<span class="NLM_cas:issn">1475-2859</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of proteins are being shown to assemble into amyloid structures, self-seeding fibrillar aggregates that may lead to pathol. states or play essential biol. functions in organisms.  Bacterial cell factories have raised as privileged model systems to understand the mechanisms behind amyloid assembly and the cellular fitness cost assocd. to the formation of these aggregates.  In the near future, these bacterial systems will allow implementing high-throughput screening approaches to identify effective modulators of amyloid aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSzDOb6azsY7Vg90H21EOLACvtfcHk0li60xcJD1w-Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyit7k%253D&md5=ab71613fc0fe2b57df0a7c6f107483e2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1186%2F1475-2859-11-166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2859-11-166%26sid%3Dliteratum%253Aachs%26aulast%3DVillar-Piqu%25C3%25A9%26aufirst%3DA.%26aulast%3DVentura%26aufirst%3DS.%26atitle%3DModeling%2520amyloids%2520in%2520bacteria%26jtitle%3DMicrob.%2520Cell%2520Fact.%26date%3D2012%26volume%3D11%26spage%3D166%26doi%3D10.1186%2F1475-2859-11-166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Pouplana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span> </span><span class="NLM_article-title">Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span><span class="refDoi"> DOI: 10.2174/09298673113206660256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F09298673113206660256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24059241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1152-1159&author=S.+Pouplanaauthor=A.+Espargar%C3%B3author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=S.+Venturaauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Thioflavin-S+staining+of+bacterial+inclusion+bodies+for+the+fast%2C+simple%2C+and+inexpensive+screening+of+amyloid+aggregation+inhibitors&doi=10.2174%2F09298673113206660256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors</span></div><div class="casAuthors">Pouplana, S.; Espargaro, A.; Galdeano, C.; Viayna, E.; Sola, I.; Ventura, S.; Munoz-Torrero, D.; Sabate, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid aggregation is linked to a large no. of human disorders, from neurodegenerative diseases as Alzheimer's disease (AD) or spongiform encephalopathies to non-neuropathic localized diseases as type II diabetes and cataracts.  Because the formation of insol. inclusion bodies (IBs) during recombinant protein prodn. in bacteria has been recently shown to share mechanistic features with amyloid self-assembly, bacteria have emerged as a tool to study amyloid aggregation.  Herein we present a fast, simple, inexpensive and quant. method for the screening of potential anti-aggregating drugs.  This method is based on monitoring the changes in the binding of thioflavin-S to intracellular IBs in intact Escherichia coli cells in the presence of small chem. compds.  This in vivo technique fairly recapitulates previous in vitro data.  Here we mainly use the Alzheimer's related β -amyloid peptide as a model system, but the technique can be easily implemented for screening inhibitors relevant for other conformational diseases simply by changing the recombinant amyloid protein target.  Indeed, we show that this methodol. can be also applied to the evaluation of inhibitors of the aggregation of tau protein, another amyloidogenic protein with a key role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcODp_BtMQrVg90H21EOLACvtfcHk0lgME3WA-Sx6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D&md5=c8c28e9aac732ce9000afc90cf7309fd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660256%26sid%3Dliteratum%253Aachs%26aulast%3DPouplana%26aufirst%3DS.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DVentura%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DThioflavin-S%2520staining%2520of%2520bacterial%2520inclusion%2520bodies%2520for%2520the%2520fast%252C%2520simple%252C%2520and%2520inexpensive%2520screening%2520of%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1152%26epage%3D1159%26doi%3D10.2174%2F09298673113206660256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabisky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devidze, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4152-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1523%2FJNEUROSCI.4152-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=21228179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1arsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=700-711&author=E.+D.+Robersonauthor=B.+Halabiskyauthor=J.+W.+Yooauthor=J.+Yaoauthor=J.+Chinauthor=F.+Yanauthor=T.+Wuauthor=P.+Hamtoauthor=N.+Devidzeauthor=G.-Q.+Yuauthor=J.+J.+Palopauthor=J.+L.+Noebelsauthor=L.+Mucke&title=Amyloid-%CE%B2%2FFyn-induced+synaptic%2C+network%2C+and+cognitive+impairments+depend+on+tau+levels+in+multiple+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.4152-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on Tau levels in multiple mouse models of Alzheimer's disease</span></div><div class="casAuthors">Roberson, Erik D.; Halabisky, Brian; Yoo, Jong W.; Yao, Jinghua; Chin, Jeannie; Yan, Fengrong; Wu, Tiffany; Hamto, Patricia; Devidze, Nino; Yu, Gui-Qiu; Palop, Jorge J.; Noebels, Jeffrey L.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">700-711</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), the most common neurodegenerative disorder, is a growing public health problem and still lacks effective treatments.  Recent evidence suggests that microtubule-assocd. protein tau may mediate amyloid-β peptide (Aβ) toxicity by modulating the tyrosine kinase Fyn.  We showed previously that tau redn. prevents, and Fyn overexpression exacerbates, cognitive deficits in human amyloid precursor protein (hAPP) transgenic mice overexpressing Aβ.  However, the mechanisms by which Aβ, tau, and Fyn cooperate in AD-related pathogenesis remain to be fully elucidated.  Here we examd. the synaptic and network effects of this pathogenic triad.  Tau redn. prevented cognitive decline induced by synergistic effects of Aβ and Fyn.  Tau redn. also prevented synaptic transmission and plasticity deficits in hAPP mice.  Using electroencephalog. to examine network effects, we found that tau redn. prevented spontaneous epileptiform activity in multiple lines of hAPP mice.  Tau redn. also reduced the severity of spontaneous and chem. induced seizures in mice overexpressing both Aβ and Fyn.  To better understand these protective effects, we recorded whole-cell currents in acute hippocampal slices from hAPP mice with and without tau.  HAPP mice with tau had increased spontaneous and evoked excitatory currents, reduced inhibitory currents, and NMDA receptor dysfunction.  Tau redn. increased inhibitory currents and normalized excitation/inhibition balance and NMDA receptor-mediated currents in hAPP mice.  Our results indicate that Aβ, tau, and Fyn jointly impair synaptic and network function and suggest that disrupting the copathogenic relationship between these factors could be of therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7unpshrG7_LVg90H21EOLACvtfcHk0lgME3WA-Sx6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1arsrk%253D&md5=5f72439c11fbfcd0fec99c1c1f270782</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4152-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4152-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DHalabisky%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DJ.%2BW.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DHamto%26aufirst%3DP.%26aulast%3DDevidze%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DG.-Q.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAmyloid-%25CE%25B2%252FFyn-induced%2520synaptic%252C%2520network%252C%2520and%2520cognitive%2520impairments%2520depend%2520on%2520tau%2520levels%2520in%2520multiple%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D700%26epage%3D711%26doi%3D10.1523%2FJNEUROSCI.4152-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lgME3WA-Sx6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands – medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.2174/138161209787315594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands+%E2%80%93+medicinal+chemistry+strategies+and+challenges&doi=10.2174%2F138161209787315594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0lgME3WA-Sx6jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%2520%25E2%2580%2593%2520medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600%26doi%3D10.2174%2F138161209787315594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Lynch, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kensel-Hammes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjalieh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matagne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuks, B.</span><span> </span><span class="NLM_article-title">The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">9861</span><span class="NLM_x">–</span> <span class="NLM_lpage">9866</span><span class="refDoi"> DOI: 10.1073/pnas.0308208101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1073%2Fpnas.0308208101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=15210974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=9861-9866&author=B.+A.+Lynchauthor=N.+Lambengauthor=K.+Nockaauthor=P.+Kensel-Hammesauthor=S.+M.+Bajjaliehauthor=A.+Matagneauthor=B.+Fuks&title=The+synaptic+vesicle+protein+SV2A+is+the+binding+site+for+the+antiepileptic+drug+levetiracetam&doi=10.1073%2Fpnas.0308208101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam</span></div><div class="casAuthors">Lynch, Berkley A.; Lambeng, Nathalie; Nocka, Karl; Kensel-Hammes, Patricia; Bajjalieh, Sandra M.; Matagne, Alain; Fuks, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9861-9866</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Here, we show that the synaptic vesicle protein SV2A is the brain binding site of levetiracetam (LEV), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy.  The LEV-binding site is enriched in synaptic vesicles, and photoaffinity labeling of purified synaptic vesicles confirms that it has an apparent mol. mass of ≈90 kDa.  Brain membranes and purified synaptic vesicles from mice lacking SV2A do not bind a tritiated LEV deriv., indicating that SV2A is necessary for LEV binding.  LEV and related compds. bind to SV2A expressed in fibroblasts, indicating that SV2A is sufficient for LEV binding.  No binding was obsd. to the related isoforms SV2B and SV2C.  Furthermore, there is a high degree of correlation between binding affinities of a series of LEV derivs. to SV2A in fibroblasts and to the LEV-binding site in brain.  Finally, there is a strong correlation between the affinity of a compd. for SV2A and its ability to protect against seizures in an audiogenic mouse animal model of epilepsy.  These exptl. results suggest that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A, supporting previous indications that LEV possesses a mechanism of action distinct from that of other antiepileptic drugs.  Further, these results indicate that proteins involved in vesicle exocytosis, and SV2 in particular, are promising targets for the development of new CNS drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbTc72kjZ1rVg90H21EOLACvtfcHk0lijvjEHBr2A9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVahtb8%253D&md5=bb144ccf7cbf44c00cecfa6954216a53</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308208101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308208101%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DB.%2BA.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DKensel-Hammes%26aufirst%3DP.%26aulast%3DBajjalieh%26aufirst%3DS.%2BM.%26aulast%3DMatagne%26aufirst%3DA.%26aulast%3DFuks%26aufirst%3DB.%26atitle%3DThe%2520synaptic%2520vesicle%2520protein%2520SV2A%2520is%2520the%2520binding%2520site%2520for%2520the%2520antiepileptic%2520drug%2520levetiracetam%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D9861%26epage%3D9866%26doi%3D10.1073%2Fpnas.0308208101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Vogl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, G. J.</span><span> </span><span class="NLM_article-title">The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca<sup>2+</sup> channels through an intracellular pathway</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1124/mol.111.076687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1124%2Fmol.111.076687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=199-208&author=C.+Voglauthor=S.+Mochidaauthor=C.+Wolffauthor=B.+J.+Whalleyauthor=G.+J.+Stephens&title=The+synaptic+vesicle+glycoprotein+2A+ligand+levetiracetam+inhibits+presynaptic+Ca2%2B+channels+through+an+intracellular+pathway&doi=10.1124%2Fmol.111.076687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076687%26sid%3Dliteratum%253Aachs%26aulast%3DVogl%26aufirst%3DC.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DC.%26aulast%3DWhalley%26aufirst%3DB.%2BJ.%26aulast%3DStephens%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520synaptic%2520vesicle%2520glycoprotein%25202A%2520ligand%2520levetiracetam%2520inhibits%2520presynaptic%2520Ca2%252B%2520channels%2520through%2520an%2520intracellular%2520pathway%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D199%26epage%3D208%26doi%3D10.1124%2Fmol.111.076687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Farooq, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khasnis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassab, M. Y.</span><span> </span><span class="NLM_article-title">Levetiracetam for managing neurologic and psychiatric disorders</span> <span class="citation_source-journal">Am. J. Health-Syst. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.2146/ajhp070607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2146%2Fajhp070607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19265183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=541-561&author=M.+U.+Farooqauthor=A.+Bhattauthor=A.+Majidauthor=R.+Guptaauthor=A.+Khasnisauthor=M.+Y.+Kassab&title=Levetiracetam+for+managing+neurologic+and+psychiatric+disorders&doi=10.2146%2Fajhp070607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Levetiracetam for managing neurologic and psychiatric disorders</span></div><div class="casAuthors">Farooq, Muhammad U.; Bhatt, Archit; Majid, Arshad; Gupta, Rishi; Khasnis, Atul; Kassab, Mounzer Y.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">541-561</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurol., and psychiatric disorders is discussed.  Summary: Levetiracetam, an antiepileptic drug (AED), was first approved as an adjunctive therapy for the treatment of partial epilepsy in adults.  It is currently being used in the treatment of multiple seizure disorders, including generalized tonic-clonic; absence; myoclonic, esp. juvenile myoclonic; Lennox-Gastaut syndrome; and refractory epilepsy in children and adults.  Data are emerging on possible uses of levetiracetam outside the realm of epilepsy because of its unique mechanisms of action.  There is preliminary evidence about the efficacy of levetiracetam in the treatment of different psychiatric disorders, including anxiety, panic, stress, mood and bipolar, autism, and Tourette's syndrome.  The most serious adverse effects assocd. with levetiracetam use are behavioral in nature and might be more common in patients with a history of psychiatric and neurobehavioral problems.  Conclusion: Levetiracetam is an effective AED with potential benefits in other neurol. and psychiatric disorders.  The benefit-risk ratio in an individual patient with a specific condition should be used to det. its optimal use.  Levetiracetam's use in nonepileptic conditions is not recommended until more data become available from larger trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpWhIpeFFM_LVg90H21EOLACvtfcHk0lijvjEHBr2A9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWlsrc%253D&md5=bfff58a3c5f2473e35c21ecd1996d51f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2146%2Fajhp070607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp070607%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DM.%2BU.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DMajid%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DKhasnis%26aufirst%3DA.%26aulast%3DKassab%26aufirst%3DM.%2BY.%26atitle%3DLevetiracetam%2520for%2520managing%2520neurologic%2520and%2520psychiatric%2520disorders%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2009%26volume%3D66%26spage%3D541%26epage%3D561%26doi%3D10.2146%2Fajhp070607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2012.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.pneurobio.2012.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22459297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=38-51&author=I.+Ferrer&title=Defining+Alzheimer+as+a+common+age-related+neurodegenerative+process+not+inevitably+leading+to+dementia&doi=10.1016%2Fj.pneurobio.2012.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span></div><div class="casAuthors">Ferrer Isidro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the description by Alois Alzheimer, more than 50 years have passed during which senile dementia and pre-senile dementia have been considered Alzheimer disease (AD) on the basis of their common neuropathological and clinical manifestations.  AD now covers pre-senile dementia, senile dementia, mild cognitive impairment and pre-clinical AD, all of them within the context of AD-related pathology.  However, there is still a gray area between normal aging with AD-related pathology and AD.  Here it is proposed that Alzheimer (or alzheimer) is an age-related neurodegenerative process distinguished from normal aging by the presence of senile plaques and neurofibrillary tangles.  Alzheimer affects about 80% of individuals aged 65 years but dementia only occurs in a small percentage of individuals at this age; prevalence of dementia in Alzheimer increases to 25% in individuals aged 80 years.  The concepts derived from the β-amyloid hypothesis support β-amyloid as a conductor in the pathogenesis of familial AD and as a prodding factor in sporadic AD.  Moreover, seeding of β-amyloid and truncated tau explains incorporation, enhancement and perpetuation of AD-related changes.  Therefore, the earliest Alzheimer changes confined to selected regions are the first grounds and the main risk factor for developing dementia.  The term Alzheimer embraces this assumption and likens its meaning to other degenerative biological processes, such as atherosclerosis, that may eventually progress to disease.  In this context, the first stages of Alzheimer should be considered as primary targets of therapeutic intervention in order to prevent progression to diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8RZSMq5h6HMAKB7Fa-xrUfW6udTcc2eZVx3JuUJS84Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D&md5=60276ba23f11747b14a35ea1e18c45bf</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DDefining%2520Alzheimer%2520as%2520a%2520common%2520age-related%2520neurodegenerative%2520process%2520not%2520inevitably%2520leading%2520to%2520dementia%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D97%26spage%3D38%26epage%3D51%26doi%3D10.1016%2Fj.pneurobio.2012.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallàs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1002/cmdc.201000322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fcmdc.201000322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20859987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Badiaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+%CE%B2-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates&doi=10.1002%2Fcmdc.201000322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Huprine Derivatives with Inhibitory Activity toward β-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Gomez, Tania; Galdeano, Carles; Ramirez, Lorena; Ratia, Miriam; Badia, Albert; Clos, M. Victoria; Verdaguer, Ester; Junyent, Felix; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, Maria Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1855-1870</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), AChE-induced and self-induced β-amyloid (Aβ) aggregation and β-secretase (BACE-1), and to cross the blood-brain barrier.  The new heterodimers consist of a unit of racemic or enantiopure huprine Y or X and a donepezil-related 5,6-dimethoxy-2-[(4-piperidinyl)methyl]indane moiety as the active site and peripheral site to mid-gorge-interacting moieties, resp., connected through a short oligomethylene linker.  Mol. dynamics simulations and kinetics studies support the dual site binding to AChE.  The new heterodimers are potent inhibitors of human AChE and moderately potent inhibitors of human BChE, AChE-induced and self-induced Aβ aggregation, and BACE-1, and are predicted to be able to enter the central nervous system (CNS), thus constituting promising multitarget anti-Alzheimer drug candidates with the potential to modify the natural course of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqjappn2Nv7Vg90H21EOLACvtfcHk0lgrzxkBJkqkaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F&md5=1e25a3705b61ce71762508198a10f044</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000322%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870%26doi%3D10.1002%2Fcmdc.201000322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Lassiter, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, S.</span><span> </span><span class="NLM_article-title">Automated measurement of acetylcholinesterase activity in rat peripheral tissues</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1016/S0300-483X(02)00752-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0300-483X%2802%2900752-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2003&pages=241-253&author=T.+L.+Lassiterauthor=R.+S.+Marshallauthor=L.+C.+Jacksonauthor=D.+L.+Hunterauthor=J.+T.+Vuauthor=S.+Padilla&title=Automated+measurement+of+acetylcholinesterase+activity+in+rat+peripheral+tissues&doi=10.1016%2FS0300-483X%2802%2900752-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DLassiter%26aufirst%3DT.%2BL.%26aulast%3DMarshall%26aufirst%3DR.%2BS.%26aulast%3DJackson%26aufirst%3DL.%2BC.%26aulast%3DHunter%26aufirst%3DD.%2BL.%26aulast%3DVu%26aufirst%3DJ.%2BT.%26aulast%3DPadilla%26aufirst%3DS.%26atitle%3DAutomated%2520measurement%2520of%2520acetylcholinesterase%2520activity%2520in%2520rat%2520peripheral%2520tissues%26jtitle%3DToxicology%26date%3D2003%26volume%3D186%26spage%3D241%26epage%3D253%26doi%3D10.1016%2FS0300-483X%2802%2900752-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratovitski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Lare, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80974-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0896-6273%2800%2980974-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=9354339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=939-945&author=D.+R.+Borcheltauthor=T.+Ratovitskiauthor=J.+van+Lareauthor=M.+K.+Leeauthor=V.+Gonzalesauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=D.+L.+Priceauthor=S.+S.+Sisodia&title=Accelerated+amyloid+deposition+in+the+brains+of+transgenic+mice+coexpressing+mutant+presenilin+1+and+amyloid+precursor+proteins&doi=10.1016%2FS0896-6273%2800%2980974-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span></div><div class="casAuthors">Borchelt, David R.; Ratovitski, Tamara; Van Lare, Judy; Lee, Michael K.; Gonzales, Vicki; Jenkins, Nancy A.; Copeland, Neal G.; Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familial Alzheimer's disease (FAD) pedigrees.  In a variety of exptl. in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrilogenic Aβ1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients.  In this report, we demonstrate that transgenic animals that coexpress an FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone.  These results provide evidence for the view that one pathogenic mechanism by which FAD-linked mutant PS1 causes AD is to accelerate the rate of β-amyloid deposition in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6fPtRz3ferVg90H21EOLACvtfcHk0lgrzxkBJkqkaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D&md5=8377c31c3b35cb4cdca7d648f2161062</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980974-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980974-5%26sid%3Dliteratum%253Aachs%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DRatovitski%26aufirst%3DT.%26aulast%3Dvan%2BLare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DGonzales%26aufirst%3DV.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DAccelerated%2520amyloid%2520deposition%2520in%2520the%2520brains%2520of%2520transgenic%2520mice%2520coexpressing%2520mutant%2520presenilin%25201%2520and%2520amyloid%2520precursor%2520proteins%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1016%2FS0896-6273%2800%2980974-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: from 3D structure to function</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+from+3D+structure+to+function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0ljljw5ZZAVBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520from%25203D%2520structure%2520to%2520function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carletti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovaslet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.-Y.</span><span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyrylcholinesterase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.-Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+Elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyrylcholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520Elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyrylcholinesterase%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Olsson, M. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søndergaard, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. H.</span><span> </span><span class="NLM_article-title">PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+Consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0ljljw5ZZAVBBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520Consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-<i>c</i>]quinoline–6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and β-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+Ram%C3%ADrezauthor=E.+G%C3%B3mezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline%E2%80%936-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+%CE%B2-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Munoz-Torrero, Diego; Ramirez, Lorena; Gomez, Elena; Isambert, Nicolas; Lavilla, Rodolfo; Badia, Albert; Clos, M. Victoria; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, M. Isabel; Huertas, Oscar; Dafni, Thomai; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5365-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase, AChE-induced and self-induced β-amyloid (Aβ) aggregation, and β-secretase (BACE-1) and to cross blood-brain barrier.  The new hybrids consist of a unit of 6-chlorotacrine and a multicomponent reaction-derived pyrano[3,2-c]quinoline scaffold as the active-site and peripheral-site interacting moieties, resp., connected through an oligomethylene linker contg. an amido group at variable position.  Indeed, mol. modeling and kinetic studies have confirmed the dual site binding of these compds.  The new hybrids, and particularly I, retain the potent and selective human AChE inhibitory activity of the parent 6-chlorotacrine while exhibiting a significant in vitro inhibitory activity toward the AChE-induced and self-induced Aβ aggregation and toward BACE-1, as well as ability to enter the central nervous system, which makes them promising anti-Alzheimer lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0N9CfOYI1erVg90H21EOLACvtfcHk0lhU-WA7GBqJWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D&md5=f2bfb696419b7634076cf7a16a4ae94b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline%25E2%2580%25936-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520%25CE%25B2-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Ruiz-Carmona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-García, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garmendia-Doval, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juhos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">rDock: A fast, versatile and open source code for docking ligands to proteins and nucleic acids</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003571</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1003571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1371%2Fjournal.pcbi.1003571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24722481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003571&author=S.+Ruiz-Carmonaauthor=D.+Alvarez-Garc%C3%ADaauthor=N.+Foloppeauthor=A.+B.+Garmendia-Dovalauthor=S.+Juhosauthor=P.+Schmidtkeauthor=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=rDock%3A+A+fast%2C+versatile+and+open+source+code+for+docking+ligands+to+proteins+and+nucleic+acids&doi=10.1371%2Fjournal.pcbi.1003571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids</span></div><div class="casAuthors">Ruiz-Carmona, Sergio; Alvarez-Garcia, Daniel; Foloppe, Nicolas; Garmendia-Doval, A. Beatriz; Juhos, Szilveszter; Schmidtke, Peter; Barril, Xavier; Hubbard, Roderick E.; Morley, S. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1003571/1-e1003571/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of chem. compds. with specific biol. activities is an important step in both chem. biol. and drug discovery.  When the structure of the intended target is available, one approach is to use mol. docking programs to assess the chem. complementarity of small mols. with the target; such calcns. provide a qual. measure of affinity that can be used in virtual screening (VS) to rank order a list of compds. according to their potential to be active. rDock is a mol. docking program developed at Vernalis for high-throughput VS (HTVS) applications.  Evolved from RiboDock, the program can be used against proteins and nucleic acids, is designed to be computationally very efficient and allows the user to incorporate addnl. constraints and information as a bias to guide docking.  This article provides an overview of the program structure and features and compares rDock to two ref. programs, AutoDock Vina (open source) and Schrodinger's Glide (com.).  In terms of computational speed for VS, rDock is faster than Vina and comparable to Glide.  For binding mode prediction, rDock and Vina are superior to Glide.  The VS performance of rDock is significantly better than Vina, but inferior to Glide for most systems unless pharmacophore constraints are used; in that case rDock and Glide are of equal performance.  The program is released under the Lesser General Public License and is freely available for download, together with the manuals, example files and the complete test sets, at online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0qXwzBNIxLVg90H21EOLACvtfcHk0lhU-WA7GBqJWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO&md5=e4cb786d6567fdc7f2a46f64955a9992</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1003571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1003571%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carmona%26aufirst%3DS.%26aulast%3DAlvarez-Garc%25C3%25ADa%26aufirst%3DD.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGarmendia-Doval%26aufirst%3DA.%2BB.%26aulast%3DJuhos%26aufirst%3DS.%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DrDock%253A%2520A%2520fast%252C%2520versatile%2520and%2520open%2520source%2520code%2520for%2520docking%2520ligands%2520to%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3De1003571%26doi%3D10.1371%2Fjournal.pcbi.1003571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Kryger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of acetylcholinesterase complexed with E2020 (Aricept): Implications for the design of new anti-Alzheimer drugs</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/S0969-2126(99)80040-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0969-2126%2899%2980040-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10368299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=297-307&author=G.+Krygerauthor=I.+Silmanauthor=J.+L.+Sussman&title=Structure+of+acetylcholinesterase+complexed+with+E2020+%28Aricept%29%3A+Implications+for+the+design+of+new+anti-Alzheimer+drugs&doi=10.1016%2FS0969-2126%2899%2980040-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs</span></div><div class="casAuthors">Kryger, Gitay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: Several cholinesterase inhibitors are either being utilized for symptomatic treatment of Alzheimer's disease or are in advanced clin. trials.  E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized, and evaluated by the Eisai Company in Japan.  These inhibitors were designed on the basis of QSAR studies, prior to elucidation of the 3-dimensional structure of Torpedo californica AChE (TcAChE).  E2020 significantly enhances performance in animal models of cholinergic hypofunction and has a high affinity for AChE, binding to both elec. eel and mouse AChE in the nanomolar range.  Results: The exptl. structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.  It shows that E2020 has an unique orientation along the active-site gorge, extending from the anionic subsite of the active site, at the bottom, to the peripheral anionic site, at the top, via arom. stacking interactions with conserved arom. amino acid residues.  E2020 does not, however, interact directly with either the catalytic triad or the oxyanion hole, but only indirectly via solvent mols.  Conclusions: The study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE vs. butyrylcholinesterase (BChE).  It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgomkZ6v86u7Vg90H21EOLACvtfcHk0lhU-WA7GBqJWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D&md5=e91e20bdfea0a795ced76fac5aee1205</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2899%2980040-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252899%252980040-9%26sid%3Dliteratum%253Aachs%26aulast%3DKryger%26aufirst%3DG.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520acetylcholinesterase%2520complexed%2520with%2520E2020%2520%2528Aricept%2529%253A%2520Implications%2520for%2520the%2520design%2520of%2520new%2520anti-Alzheimer%2520drugs%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D297%26epage%3D307%26doi%3D10.1016%2FS0969-2126%2899%2980040-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Bourne, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchot, P.</span><span> </span><span class="NLM_article-title">Structural insights into ligand interactions at the acetycholinesterase peripheral anionic site</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1093/emboj/cdg005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1093%2Femboj%2Fcdg005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1-12&author=Y.+Bourneauthor=P.+Taylorauthor=Z.+Radicauthor=P.+Marchot&title=Structural+insights+into+ligand+interactions+at+the+acetycholinesterase+peripheral+anionic+site&doi=10.1093%2Femboj%2Fcdg005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg005%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DRadic%26aufirst%3DZ.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DStructural%2520insights%2520into%2520ligand%2520interactions%2520at%2520the%2520acetycholinesterase%2520peripheral%2520anionic%2520site%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1%26epage%3D12%26doi%3D10.1093%2Femboj%2Fcdg005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 41 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">F. Javier Pérez-Areales, María Garrido, Ester Aso, Manuela Bartolini, Angela De Simone, Alba Espargaró, Tiziana Ginex, Raimon Sabate, Belén Pérez, Vincenza Andrisano, Dolors Puigoriol-Illamola, Mercè Pallàs, F. Javier Luque, María Isabel Loza, José Brea, Isidro Ferrer, Francisco Ciruela, Angel Messeguer, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9360-9390. <a href="https://doi.org/10.1021/acs.jmedchem.0c00528" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCentrally%252BActive%252BMultitarget%252BAnti-Alzheimer%252BAgents%252BDerived%252Bfrom%252Bthe%252BAntioxidant%252BLead%252BCR-6%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31032020%26date%3D11082020%26date%3D24072020%26volume%3D63%26issue%3D17%26spage%3D9360%26epage%3D9390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoping Yang</span>. </span><span class="cited-content_cbyCitation_article-title">WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 4787-4799. <a href="https://doi.org/10.1021/acschemneuro.9b00409" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DWBQ5187%25252C%252Ba%252BMultitarget%252BDirected%252BAgent%25252C%252BAmeliorates%252BCognitive%252BImpairment%252Bin%252Ba%252BTransgenic%252BMouse%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BModulates%252BCerebral%252B%2525CE%2525B2-Amyloid%25252C%252BGliosis%25252C%252BcAMP%252BLevels%25252C%252Band%252BNeurodegeneration%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D07112019%26date%3D20112019%26date%3D07112019%26volume%3D10%26issue%3D12%26spage%3D4787%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kristen A. Stout, Amy R. Dunn, Carlie Hoffman, <span class="NLM_string-name hlFld-ContribAuthor">Gary W. Miller</span>. </span><span class="cited-content_cbyCitation_article-title">The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 3927-3938. <a href="https://doi.org/10.1021/acschemneuro.9b00351" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00351%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DThe%252BSynaptic%252BVesicle%252BGlycoprotein%252B2%25253A%252BStructure%25252C%252BFunction%25252C%252Band%252BDisease%252BRelevance%26aulast%3DStout%26aufirst%3DKristen%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20062019%26date%3D08082019%26date%3D23082019%26date%3D08082019%26volume%3D10%26issue%3D9%26spage%3D3927%26epage%3D3938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiyan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 852-862. <a href="https://doi.org/10.1021/acschemneuro.8b00391" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00391%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DReconsideration%252Bof%252BAnticholinesterase%252BTherapeutic%252BStrategies%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DHuan%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D20112018%26date%3D06122018%26volume%3D10%26issue%3D2%26spage%3D852%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dawid Panek, Anna Więckowska, Jakub Jończyk, Justyna Godyń, Marek Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pišlar, Jan Korabecny, Ondrej Soukup, Vendula Sepsova, Raimon Sabaté, Janko Kos, Stanislav Gobec, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 1074-1094. <a href="https://doi.org/10.1021/acschemneuro.7b00461" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00461</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00461%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B1-Benzylamino-2-hydroxyalkyl%252BDerivatives%252Bas%252BNew%252BPotential%252BDisease-Modifying%252BMultifunctional%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%26aulast%3DPanek%26aufirst%3DDawid%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D20112017%26date%3D18012018%26date%3D01022018%26date%3D18012018%26volume%3D9%26issue%3D5%26spage%3D1074%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Jinhui Hu, Xiaoping Yang, Xing Feng, Xingshu Li, Ling Huang, <span class="NLM_string-name hlFld-ContribAuthor">Albert S. C. Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1871-1894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BOrally%252BBioavailable%252BQuinoline%2525E2%252580%252593Indole%252BDerivatives%252Bas%252BInnovative%252BMultitarget-Directed%252BLigands%25253A%252BPromotion%252Bof%252BCell%252BProliferation%252Bin%252Bthe%252BAdult%252BMurine%252BHippocampus%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D23092017%26date%3D15022018%26date%3D08022018%26volume%3D61%26issue%3D5%26spage%3D1871%26epage%3D1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Tiziana  Ginex</span>, <span class="hlFld-ContribAuthor ">Maria del Mar  Vadell</span>, <span class="hlFld-ContribAuthor ">Maria A.  Busquets</span>, <span class="hlFld-ContribAuthor ">Joan  Estelrich</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, and <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>  . </span><span class="cited-content_cbyCitation_article-title">Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2017,</strong> <em>80 </em>
                                    (2)
                                     , 278-289. <a href="https://doi.org/10.1021/acs.jnatprod.6b00643" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.6b00643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.6b00643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.6b00643%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DCombined%252Bin%252BVitro%252BCell-Based%25252Fin%252BSilico%252BScreening%252Bof%252BNaturally%252BOccurring%252BFlavonoids%252Band%252BPhenolic%252BCompounds%252Bas%252BPotential%252BAnti-Alzheimer%252BDrugs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DAlba%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D11072016%26date%3D27012017%26date%3D24022017%26volume%3D80%26issue%3D2%26spage%3D278%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyung-Ran  Kim</span>, <span class="hlFld-ContribAuthor ">Yoonsub  Kim</span>, <span class="hlFld-ContribAuthor ">Hyeon-Ju  Jeong</span>, <span class="hlFld-ContribAuthor ">Jong-Sun  Kang</span>, <span class="hlFld-ContribAuthor ">Sang Hun  Lee</span>, <span class="hlFld-ContribAuthor ">Yujin  Kim</span>, <span class="hlFld-ContribAuthor ">Suk-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Won-Kyung  Ho</span>. </span><span class="cited-content_cbyCitation_article-title">Impaired pattern separation in Tg2576 mice is associated with hyperexcitable dentate gyrus caused by Kv4.1 downregulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Brain</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13041-021-00774-x" title="DOI URL">https://doi.org/10.1186/s13041-021-00774-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13041-021-00774-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13041-021-00774-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Brain%26atitle%3DImpaired%252Bpattern%252Bseparation%252Bin%252BTg2576%252Bmice%252Bis%252Bassociated%252Bwith%252Bhyperexcitable%252Bdentate%252Bgyrus%252Bcaused%252Bby%252BKv4.1%252Bdownregulation%26aulast%3DKim%26aufirst%3DKyung-Ran%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tien-Wei  Yu</span>, <span class="hlFld-ContribAuthor ">Hsien-Yuan  Lane</span>, <span class="hlFld-ContribAuthor ">Chieh-Hsin  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (15)
                                     , 8208. <a href="https://doi.org/10.3390/ijms22158208" title="DOI URL">https://doi.org/10.3390/ijms22158208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22158208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22158208%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNovel%252BTherapeutic%252BApproaches%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BAn%252BUpdated%252BReview%26aulast%3DYu%26aufirst%3DTien-Wei%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D15%26spage%3D8208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luisa  Müller</span>, <span class="hlFld-ContribAuthor ">Timo  Kirschstein</span>, <span class="hlFld-ContribAuthor ">Rüdiger  Köhling</span>, <span class="hlFld-ContribAuthor ">Angela  Kuhla</span>, <span class="hlFld-ContribAuthor ">Stefan  Teipel</span>. </span><span class="cited-content_cbyCitation_article-title">Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2021,</strong> <em>81 </em>
                                    (3)
                                     , 855-869. <a href="https://doi.org/10.3233/JAD-201540" title="DOI URL">https://doi.org/10.3233/JAD-201540</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-201540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-201540%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DNeuronal%252BHyperexcitability%252Bin%252BAPPSWE%25252FPS1dE9%252BMouse%252BModels%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DM%25C3%25BCller%26aufirst%3DLuisa%26date%3D2021%26volume%3D81%26issue%3D3%26spage%3D855%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Malafaia</span>, <span class="hlFld-ContribAuthor ">Hélio M.T.  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Artur M.S.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113209. <a href="https://doi.org/10.1016/j.ejmech.2021.113209" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113209%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmyloid-%2525CE%2525B2%252Band%252Btau%252Baggregation%252Bdual-inhibitors%25253A%252BA%252Bsynthetic%252Band%252Bstructure-activity%252Brelationship%252Bfocused%252Breview%26aulast%3DMalafaia%26aufirst%3DDaniela%26date%3D2021%26volume%3D214%26spage%3D113209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhikun  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengjin  Xia</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 112997. <a href="https://doi.org/10.1016/j.ejmech.2020.112997" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112997%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DROS-responsive%252Band%252Bmultifunctional%252Banti-Alzheimer%252Bprodrugs%25253A%252BTacrine-ibuprofen%252Bhybrids%252Bvia%252Ba%252Bphenyl%252Bboronate%252Blinker%26aulast%3DLiu%26aufirst%3DZhikun%26date%3D2021%26volume%3D212%26spage%3D112997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisha  Wang</span>, <span class="hlFld-ContribAuthor ">Bharti</span>, <span class="hlFld-ContribAuthor ">Rajnish  Kumar</span>, <span class="hlFld-ContribAuthor ">Pavel F.  Pavlov</span>, <span class="hlFld-ContribAuthor ">Bengt  Winblad</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112915. <a href="https://doi.org/10.1016/j.ejmech.2020.112915" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112915</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112915%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252Bmolecule%252Btherapeutics%252Bfor%252Btauopathy%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BWalking%252Bon%252Bthe%252Bpath%252Bof%252Bmost%252Bresistance%26aulast%3DWang%26aufirst%3DLisha%26date%3D2021%26volume%3D209%26spage%3D112915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibaji  Ghosh</span>, <span class="hlFld-ContribAuthor ">Kalyanashis  Jana</span>, <span class="hlFld-ContribAuthor ">Padmaja D.  Wakchaure</span>, <span class="hlFld-ContribAuthor ">Bishwajit  Ganguly</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing the cholinergic inhibition mechanism of Alzheimer’s by galantamine: a metadynamics simulation study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>4 </em>, 1-12. <a href="https://doi.org/10.1080/07391102.2020.1867644" title="DOI URL">https://doi.org/10.1080/07391102.2020.1867644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1867644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1867644%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRevealing%252Bthe%252Bcholinergic%252Binhibition%252Bmechanism%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bby%252Bgalantamine%25253A%252Ba%252Bmetadynamics%252Bsimulation%252Bstudy%26aulast%3DGhosh%26aufirst%3DShibaji%26date%3D2020%26date%3D2020%26volume%3D4%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>. </span><span class="cited-content_cbyCitation_article-title">Huprines — an insight into the synthesis and biological properties. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2020,</strong> <em>89 </em>
                                    (10)
                                     , 999-1039. <a href="https://doi.org/10.1070/RCR4938" title="DOI URL">https://doi.org/10.1070/RCR4938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4938%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DHuprines%252B%2525E2%252580%252594%252Ban%252Binsight%252Binto%252Bthe%252Bsynthesis%252Band%252Bbiological%252Bproperties%26aulast%3DMezeiova%26aufirst%3DEva%26date%3D2020%26date%3D2020%26volume%3D89%26issue%3D10%26spage%3D999%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Zagórska</span>, <span class="hlFld-ContribAuthor ">Anna  Jaromin</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3337. <a href="https://doi.org/10.3390/molecules25153337" title="DOI URL">https://doi.org/10.3390/molecules25153337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153337%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPerspectives%252Bfor%252BNew%252Band%252BMore%252BEfficient%252BMultifunctional%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%2525B2s%252BDisease%252BTherapy%26aulast%3DZag%25C3%25B3rska%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia P. Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Caio Miranda  Damasio</span>, <span class="hlFld-ContribAuthor ">Mayara Chagas  Rosa</span>, <span class="hlFld-ContribAuthor ">Thâmara Gaspar  Campos</span>, <span class="hlFld-ContribAuthor ">Dyecika Souza  Couto</span>, <span class="hlFld-ContribAuthor ">Kris Simone  Tranches Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Neuropharmacology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (5)
                                     , 348-407. <a href="https://doi.org/10.2174/1385272823666191021124443" title="DOI URL">https://doi.org/10.2174/1385272823666191021124443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neuropharmacology%26atitle%3DMolecular%252BHybridization%252Bas%252Ba%252BTool%252Bin%252Bthe%252BDesign%252Bof%252BMulti-target%252BDirected%252BDrug%252BCandidates%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DGontijo%26aufirst%3DVanessa%2BSilva%26date%3D2020%26volume%3D18%26issue%3D5%26spage%3D348%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masakazu  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Akira  Kuzuya</span>, <span class="hlFld-ContribAuthor ">Yasuha  Noda</span>, <span class="hlFld-ContribAuthor ">Sakiho  Ueda</span>, <span class="hlFld-ContribAuthor ">Megumi  Asada-Utsugi</span>, <span class="hlFld-ContribAuthor ">Shinji  Ito</span>, <span class="hlFld-ContribAuthor ">Yoshiyasu  Fukusumi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kawachi</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Takahashi</span>, <span class="hlFld-ContribAuthor ">Ayae  Kinoshita</span>. </span><span class="cited-content_cbyCitation_article-title">Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2020,</strong> <em>75 </em>
                                    (1)
                                     , 173-185. <a href="https://doi.org/10.3233/JAD-200071" title="DOI URL">https://doi.org/10.3233/JAD-200071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-200071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-200071%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSynaptic%252BVesicle%252BProtein%252B2B%252BNegatively%252BRegulates%252Bthe%252BAmyloidogenic%252BProcessing%252Bof%252BA%2525CE%2525B2PP%252Bas%252Ba%252BNovel%252BInteraction%252BPartner%252Bof%252BBACE1%26aulast%3DMiyamoto%26aufirst%3DMasakazu%26date%3D2020%26volume%3D75%26issue%3D1%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tayfun  Arslan</span>, <span class="hlFld-ContribAuthor ">M.  Buğrahan Ceylan</span>, <span class="hlFld-ContribAuthor ">Hüseyin  Baş</span>, <span class="hlFld-ContribAuthor ">Zekeriya  Biyiklioglu</span>, <span class="hlFld-ContribAuthor ">Murat  Senturk</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE/BChE) and carbonic anhydrases (hCA I, II and IX). </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (1)
                                     , 203-209. <a href="https://doi.org/10.1039/C9DT03897C" title="DOI URL">https://doi.org/10.1039/C9DT03897C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT03897C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT03897C%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bcharacterization%252Bof%252Bperipherally%252Btetra-pyridine-triazole-substituted%252Bphthalocyanines%252Band%252Btheir%252Binhibitory%252Beffects%252Bon%252Bcholinesterases%252B%252528AChE%25252FBChE%252529%252Band%252Bcarbonic%252Banhydrases%252B%252528hCA%252BI%25252C%252BII%252Band%252BIX%252529%26aulast%3DArslan%26aufirst%3DTayfun%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D1%26spage%3D203%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Andreea L.  Turcu</span>, <span class="hlFld-ContribAuthor ">Marta  Barniol-Xicota</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Deborah  Pivetta</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Francesc X.  Sureda</span>, <span class="hlFld-ContribAuthor ">Santiago  Vázquez</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 613-626. <a href="https://doi.org/10.1016/j.ejmech.2019.07.051" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnovel%252Bclass%252Bof%252Bmultitarget%252Banti-Alzheimer%252Bbenzohomoadamantane%2525E2%252580%252592chlorotacrine%252Bhybrids%252Bmodulating%252Bcholinesterases%252Band%252Bglutamate%252BNMDA%252Breceptors%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy R.  Dunn</span>, <span class="hlFld-ContribAuthor ">Catherine C.  Kaczorowski</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer’s disease, and genetic diversity. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Learning and Memory</span><span> <strong>2019,</strong> <em>164 </em>, 107069. <a href="https://doi.org/10.1016/j.nlm.2019.107069" title="DOI URL">https://doi.org/10.1016/j.nlm.2019.107069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nlm.2019.107069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nlm.2019.107069%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Learning%2520and%2520Memory%26atitle%3DRegulation%252Bof%252Bintrinsic%252Bexcitability%25253A%252BRoles%252Bfor%252Blearning%252Band%252Bmemory%25252C%252Baging%252Band%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25252C%252Band%252Bgenetic%252Bdiversity%26aulast%3DDunn%26aufirst%3DAmy%2BR.%26date%3D2019%26volume%3D164%26spage%3D107069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana B.  Caballero</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Maria Antònia  Busquets</span>, <span class="hlFld-ContribAuthor ">Joan  Estelrich</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Patrick  Gamez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>. </span><span class="cited-content_cbyCitation_article-title">Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods. </span><span class="cited-content_cbyCitation_journal-name">Current Protein & Peptide Science</span><span> <strong>2019,</strong> <em>20 </em>
                                    (6)
                                     , 563-576. <a href="https://doi.org/10.2174/1389203720666190329120007" title="DOI URL">https://doi.org/10.2174/1389203720666190329120007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389203720666190329120007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389203720666190329120007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Protein%2520%2526%2520Peptide%2520Science%26atitle%3DBacterial%252BInclusion%252BBodies%252Bfor%252BAnti-Amyloid%252BDrug%252BDiscovery%25253A%252BCurrent%252Band%252BFuture%252BScreening%252BMethods%26aulast%3DCaballero%26aufirst%3DAna%2BB.%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D563%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj  Mishra</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Gautam  Panda</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (6)
                                     , 895-930. <a href="https://doi.org/10.1016/j.bmc.2019.01.025" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.01.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.01.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAnti-cholinesterase%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252B%2525281998%2525E2%252580%2525932018%252529%26aulast%3DMishra%26aufirst%3DPankaj%26date%3D2019%26volume%3D27%26issue%3D6%26spage%3D895%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Małgorzata  Girek</span>, <span class="hlFld-ContribAuthor ">Paweł  Szymański</span>. </span><span class="cited-content_cbyCitation_article-title">Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2019,</strong> <em>73 </em>
                                    (2)
                                     , 269-289. <a href="https://doi.org/10.1007/s11696-018-0590-8" title="DOI URL">https://doi.org/10.1007/s11696-018-0590-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-018-0590-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-018-0590-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DTacrine%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Binfluence%252Bof%252Bchemical%252Bstructures%252Bon%252Bbiological%252Bactivities%26aulast%3DGirek%26aufirst%3DMa%25C5%2582gorzata%26date%3D2019%26date%3D2018%26volume%3D73%26issue%3D2%26spage%3D269%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Relat</span>, <span class="hlFld-ContribAuthor ">Julio  Come</span>, <span class="hlFld-ContribAuthor ">Belen  Perez</span>, <span class="hlFld-ContribAuthor ">Pelayo  Camps</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Albert  Badia</span>, <span class="hlFld-ContribAuthor ">Lydia  Gimenez-Llort</span>, <span class="hlFld-ContribAuthor ">M.  Clos</span>. </span><span class="cited-content_cbyCitation_article-title">Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (9)
                                     , 2615. <a href="https://doi.org/10.3390/ijms19092615" title="DOI URL">https://doi.org/10.3390/ijms19092615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19092615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19092615%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNeuroprotective%252BEffects%252Bof%252Bthe%252BMultitarget%252BAgent%252BAVCRI104P3%252Bin%252BBrain%252Bof%252BMiddle-Aged%252BMice%26aulast%3DRelat%26aufirst%3DJulia%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D9%26spage%3D2615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy L.  Jones</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Britton</span>, <span class="hlFld-ContribAuthor ">Melissa M.  Blessing</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Parisi</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Cascino</span>. </span><span class="cited-content_cbyCitation_article-title">Chronic traumatic encephalopathy in an epilepsy surgery cohort. </span><span class="cited-content_cbyCitation_journal-name">Neurology</span><span> <strong>2018,</strong> <em>90 </em>
                                    (6)
                                     , e474-e478. <a href="https://doi.org/10.1212/WNL.0000000000004927" title="DOI URL">https://doi.org/10.1212/WNL.0000000000004927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1212/WNL.0000000000004927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1212%2FWNL.0000000000004927%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurology%26atitle%3DChronic%252Btraumatic%252Bencephalopathy%252Bin%252Ban%252Bepilepsy%252Bsurgery%252Bcohort%26aulast%3DJones%26aufirst%3DAmy%2BL.%26date%3D2018%26date%3D2018%26volume%3D90%26issue%3D6%26spage%3De474%26epage%3De478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 347. <a href="https://doi.org/10.3390/molecules23020347" title="DOI URL">https://doi.org/10.3390/molecules23020347</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020347%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B2-%252528Benzylamino-2-Hydroxyalkyl%252529Isoindoline-1%25252C3-Diones%252BDerivatives%252Bas%252BPotential%252BDisease-Modifying%252BMultifunctional%252BAnti-Alzheimer%252BAgents%26aulast%3DPanek%26aufirst%3DDawid%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń </span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1835-1854. <a href="https://doi.org/10.4155/fmc-2017-0094" title="DOI URL">https://doi.org/10.4155/fmc-2017-0094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0094%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Btoward%252Bmultifunctional%252Bcholinesterase%252Band%252B%2525CE%2525B2-amyloid%252Baggregation%252Binhibitors%26aulast%3DPanek%26aufirst%3DDawid%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1835%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesús M.  Roldán-Peña</span>, <span class="hlFld-ContribAuthor ">Daniel  Alejandre-Ramos</span>, <span class="hlFld-ContribAuthor ">Óscar  López</span>, <span class="hlFld-ContribAuthor ">Inés  Maya</span>, <span class="hlFld-ContribAuthor ">Irene  Lagunes</span>, <span class="hlFld-ContribAuthor ">José M.  Padrón</span>, <span class="hlFld-ContribAuthor ">Luis Emiliano  Peña-Altamira</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>, <span class="hlFld-ContribAuthor ">José G.  Fernández-Bolaños</span>. </span><span class="cited-content_cbyCitation_article-title">New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 761-773. <a href="https://doi.org/10.1016/j.ejmech.2017.06.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Btacrine%252Bdimers%252Bwith%252Bantioxidant%252Blinkers%252Bas%252Bdual%252Bdrugs%25253A%252BAnti-Alzheimer%252527s%252Band%252Bantiproliferative%252Bagents%26aulast%3DRold%25C3%25A1n-Pe%25C3%25B1a%26aufirst%3DJes%25C3%25BAs%2BM.%26date%3D2017%26volume%3D138%26spage%3D761%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco Javier  Pérez-Areales</span>, <span class="hlFld-ContribAuthor ">Nibal  Betari</span>, <span class="hlFld-ContribAuthor ">Antonio  Viayna</span>, <span class="hlFld-ContribAuthor ">Caterina  Pont</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">José Fernando  Rinaldi Alvarenga</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Lamuela-Raventós</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Francisco Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , 965-981. <a href="https://doi.org/10.4155/fmc-2017-0049" title="DOI URL">https://doi.org/10.4155/fmc-2017-0049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0049%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmultitarget%252Bbiological%252Bprofiling%252Bof%252Bsecond-generation%252Banti-Alzheimer%252Brhein%2525E2%252580%252593huprine%252Bhybrids%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DFrancisco%2BJavier%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3D965%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leticia  Monjas</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Arce</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic and solid-phase synthesis of new donepezil-based L- and d -glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 60-72. <a href="https://doi.org/10.1016/j.ejmech.2017.02.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnzymatic%252Band%252Bsolid-phase%252Bsynthesis%252Bof%252Bnew%252Bdonepezil-based%252BL-%252Band%252Bd%252B-glutamic%252Bacid%252Bderivatives%252Band%252Btheir%252Bpharmacological%252Bevaluation%252Bin%252Bmodels%252Brelated%252Bto%252BAlzheimer%252527s%252Bdisease%252Band%252Bcerebral%252Bischemia%26aulast%3DMonjas%26aufirst%3DLeticia%26date%3D2017%26volume%3D130%26spage%3D60%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lydia  Giménez-Llort</span>, <span class="hlFld-ContribAuthor ">Miriam  Ratia</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Pelayo  Camps</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Albert  Badia</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Clos</span>. </span><span class="cited-content_cbyCitation_article-title">Behavioural effects of novel multitarget anticholinesterasic derivatives in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Pharmacology</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2 and 3)
                                     , 124-131. <a href="https://doi.org/10.1097/FBP.0000000000000292" title="DOI URL">https://doi.org/10.1097/FBP.0000000000000292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FBP.0000000000000292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFBP.0000000000000292%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Pharmacology%26atitle%3DBehavioural%252Beffects%252Bof%252Bnovel%252Bmultitarget%252Banticholinesterasic%252Bderivatives%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGim%25C3%25A9nez-Llort%26aufirst%3DLydia%26date%3D2017%26volume%3D28%26issue%3D2%2520and%25203%26spage%3D124%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Anti-Alzheimer Hybrid Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 167-192. <a href="https://doi.org/10.1016/B978-0-08-101011-2.00006-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-101011-2.00006-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101011-2.00006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101011-2.00006-4%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget%252BAnti-Alzheimer%252BHybrid%252BCompounds%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DDiego%26date%3D2017%26spage%3D167%26epage%3D192%26pub%3DElsevier%26atitle%3DDesign%252Bof%252BHybrid%252BMolecules%252Bfor%252BDrug%252BDevelopment%26date%3D2017%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monali  Dawange</span>, <span class="hlFld-ContribAuthor ">Nikita  Parekh</span>, <span class="hlFld-ContribAuthor ">Avinash  Kumbhar</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>, <span class="hlFld-ContribAuthor ">Radhika  Kusurkar</span>. </span><span class="cited-content_cbyCitation_article-title">A synthetic route towards 3,4-disubstituted pyrrolidin-2-ones via a Michael addition and reductive ring closing strategy. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (9)
                                     , 3612-3618. <a href="https://doi.org/10.1039/C6NJ04051A" title="DOI URL">https://doi.org/10.1039/C6NJ04051A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ04051A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ04051A%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DA%252Bsynthetic%252Broute%252Btowards%252B3%25252C4-disubstituted%252Bpyrrolidin-2-ones%252Bvia%252Ba%252BMichael%252Baddition%252Band%252Breductive%252Bring%252Bclosing%252Bstrategy%26aulast%3DDawange%26aufirst%3DMonali%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D9%26spage%3D3612%26epage%3D3618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Marcin  Kołaczkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Bucki</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Monika  Marcinkowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Więckowski</span>, <span class="hlFld-ContribAuthor ">Paula  Zaręba</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Kazek</span>, <span class="hlFld-ContribAuthor ">Monika  Głuch-Lutwin</span>, <span class="hlFld-ContribAuthor ">Paweł  Mierzejewski</span>, <span class="hlFld-ContribAuthor ">Przemysław  Bienkowski</span>, <span class="hlFld-ContribAuthor ">Halina  Sienkiewicz-Jarosz</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 63-81. <a href="https://doi.org/10.1016/j.ejmech.2016.08.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bmulti-target-directed%252Bligands%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252BCombining%252Bcholinesterase%252Binhibitors%252Band%252B5-HT%252B6%252Breceptor%252Bantagonists.%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2016%26volume%3D124%26spage%3D63%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Aina  Medina</span>, <span class="hlFld-ContribAuthor ">Ornella  Di Pietro</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabate</span>. </span><span class="cited-content_cbyCitation_article-title">Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep23349" title="DOI URL">https://doi.org/10.1038/srep23349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep23349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep23349%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DUltra%252Brapid%252Bin%252Bvivo%252Bscreening%252Bfor%252Banti-Alzheimer%252Banti-amyloid%252Bdrugs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DAlba%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michalina  Hebda</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 410. <a href="https://doi.org/10.3390/molecules21040410" title="DOI URL">https://doi.org/10.3390/molecules21040410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21040410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21040410%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BMolecular%252BModelling%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BHeterodimeric%25252C%252BMultiple%252BLigands%252BTargeting%252BCholinesterases%252Band%252BAmyloid%252BBeta%26aulast%3DHebda%26aufirst%3DMichalina%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Elena  Simoni</span>, <span class="hlFld-ContribAuthor ">Roberta  Caporaso</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (6)
                                     , 697-711. <a href="https://doi.org/10.4155/fmc-2016-0003" title="DOI URL">https://doi.org/10.4155/fmc-2016-0003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0003%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultitarget%252Bstrategies%252Bin%252BAlzheimer%252527s%252Bdisease%25253A%252Bbenefits%252Band%252Bchallenges%252Bon%252Bthe%252Broad%252Bto%252Btherapeutics%26aulast%3DRosini%26aufirst%3DMichela%26date%3D2016%26volume%3D8%26issue%3D6%26spage%3D697%26epage%3D711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sovy  Chao</span>, <span class="hlFld-ContribAuthor ">Eric  Krejci</span>, <span class="hlFld-ContribAuthor ">Véronique  Bernard</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Leroy</span>, <span class="hlFld-ContribAuthor ">Ludovic  Jean</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Renard</span>. </span><span class="cited-content_cbyCitation_article-title">A selective and sensitive near-infrared fluorescent probe for acetylcholinesterase imaging. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (77)
                                     , 11599-11602. <a href="https://doi.org/10.1039/C6CC05936H" title="DOI URL">https://doi.org/10.1039/C6CC05936H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC05936H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC05936H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bselective%252Band%252Bsensitive%252Bnear-infrared%252Bfluorescent%252Bprobe%252Bfor%252Bacetylcholinesterase%252Bimaging%26aulast%3DChao%26aufirst%3DSovy%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D77%26spage%3D11599%26epage%3D11602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noemí  Vila</span>, <span class="hlFld-ContribAuthor ">Pedro  Besada</span>, <span class="hlFld-ContribAuthor ">Dolores  Viña</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, <span class="hlFld-ContribAuthor ">Carmen  Terán</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modeling studies of phthalazin-1(2H)-one derivatives as novel cholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (52)
                                     , 46170-46185. <a href="https://doi.org/10.1039/C6RA03841G" title="DOI URL">https://doi.org/10.1039/C6RA03841G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA03841G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA03841G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bstudies%252Bof%252Bphthalazin-1%2525282H%252529-one%252Bderivatives%252Bas%252Bnovel%252Bcholinesterase%252Binhibitors%26aulast%3DVila%26aufirst%3DNoem%25C3%25AD%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D52%26spage%3D46170%26epage%3D46185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof  Sendrowski</span>, <span class="hlFld-ContribAuthor ">Wojciech  Sobaniec</span>. </span><span class="cited-content_cbyCitation_article-title">Antiepileptic drugs as a new therapeutic concept for the prevention of cognitive impairment and Alzheimer’s disease. Recent advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Epileptology</span><span> <strong>2015,</strong> <em>23 </em>
                                    (2)
                                     , 139-147. <a href="https://doi.org/10.1515/joepi-2015-0035" title="DOI URL">https://doi.org/10.1515/joepi-2015-0035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/joepi-2015-0035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjoepi-2015-0035%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Epileptology%26atitle%3DAntiepileptic%252Bdrugs%252Bas%252Ba%252Bnew%252Btherapeutic%252Bconcept%252Bfor%252Bthe%252Bprevention%252Bof%252Bcognitive%252Bimpairment%252Band%252BAlzheimer%2525E2%252580%252599s%252Bdisease.%252BRecent%252Badvances%26aulast%3DSendrowski%26aufirst%3DKrzysztof%26date%3D2015%26volume%3D23%26issue%3D2%26spage%3D139%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of levetiracetam.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Levetiracetam–Tacrine Hybrids (±)-<b>5</b>, (<i>S</i>)-<b>5</b>, (<i>R</i>)-<b>5</b>, and (±)-<b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (±)-<b>4</b>, (<i>S</i>)-<b>4</b> or (<i>R</i>)-<b>4</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then amine <b>2</b> or <b>3</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 93% [(±)-<b>5</b>], 60% [(<i>S</i>)-<b>5</b>], 27% [(<i>R</i>)-<b>5</b>], 78% [(±)-<b>6</b>].</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Levetiracetam–Huprine Hybrids (2<i>S</i>,7‴<i>S</i>,11‴<i>S</i>)-<b>10</b> and (2<i>S</i>,7‴<i>R</i>,11‴<i>R</i>)-<b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaOH (3.3 equiv), 4 Å molecular sieves, DMSO, rt, 2 h; then 7-bromoheptanenitrile (1.2 equiv), DMSO, rt, overnight, 52% [(7<i>S</i>,11<i>S</i>)-<b>8</b>], 55% [(7<i>R</i>,11<i>R</i>)-<b>8</b>]; (ii) LiAlH<sub>4</sub> (6 equiv), Et<sub>2</sub>O, 0 °C to rt, 20 h at rt, 91% [(7<i>S</i>,11<i>S</i>)-<b>9</b>], 45% [(7<i>R</i>,11<i>R</i>)-<b>9</b>]; (iii) (<i>S</i>)-<b>4</b> (1 equiv), ClCO<sub>2</sub>Et (1 equiv), Et<sub>3</sub>N (2 equiv), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 30 min; then amine (7<i>S</i>,11<i>S</i>)-<b>9</b> or (7<i>R</i>,11<i>R</i>)-<b>9</b> (1 equiv), CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 days, 30% (<b>10</b>), 56% (<b>11</b>).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Representation of the binding mode of hybrid <b>10</b> in hAChE. The huprine moiety fills the catalytic binding site, and the levetiracetam moiety is bound to the PAS, where the hydroxyl group of Tyr72 can form a hydrogen bond with either the (A) NH or (B) carbonyl group of the amide function.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Memory performance in the two-object recognition test of wild-type (WT) and APP/PS1 mice after chronic treatment with the novel levetiracetam-based hybrids <b>5</b>, <b>6</b>, <b>10</b>, and <b>11</b> (5 mg kg<sup>–1</sup> day<sup>–1</sup>, 4 weeks, ip). APP/PS1 mice chronically treated with vehicle (Veh), <b>6</b>, and <b>11</b> exhibit a significant reduction in the recognition index when compared to corresponding wild-type littermates. In contrast, chronic administration of <b>5</b> and <b>10</b> induces memory improvement in APP/PS1 mice, as demonstrated by the significant increase in the recognition index compared to transgenic mice treated with vehicle: (★★) <i>p</i> < 0.01 genotype effect; (☆) <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Left: Aβ burden was significantly reduced in cortex of APP/PS1 mice treated with hybrid <b>10</b>. Right: Representative images of Aβ immunoreactivity in cortical sections of APP/PS1 mice subjected to chronic treatment with vehicle (Veh), <b>5</b>, and <b>10</b>. Scale bar represents 200 μm. (B) Soluble Aβ40 and Aβ42 levels were not significantly modified by chronic treatment with <b>5</b> or <b>10</b> in cortical homogenates from APP/PS1 mice, despite a tendency to decrease both peptides in mice treated with <b>10</b>. Data are expressed as the mean values ± SEM: (☆) <i>p</i> < 0.05 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/medium/jm-2015-00624k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Representative images of double GFAP (upper panels, red) or Iba1 (lower panels, red) and Aβ (green) immunoreactivity in cortical sections of APP/PS1 mice chronically treated with vehicle (Veh), <b>5</b>, and <b>10</b>. Scale bars represent 50 μm. Quantification of the glial staining around the Aβ plaques reveals a significant reduction of the astroglial (B) and microglial (C) response in APP/PS1 mice chronically treated with hybrid <b>10</b>. Data are expressed as the mean values ± SEM: (☆☆) <i>p</i> < 0.01 compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-15/acs.jmedchem.5b00624/20150807/images/large/jm-2015-00624k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00624&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 74 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Prince, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, C. P.</span><span> </span><span class="NLM_article-title">The global prevalence of dementia: A systematic review and metaanalysis</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.jalz.2012.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23305823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC3s3osVemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=63-75&author=M.+Princeauthor=R.+Bryceauthor=E.+Albaneseauthor=A.+Wimoauthor=W.+Ribeiroauthor=C.+P.+Ferri&title=The+global+prevalence+of+dementia%3A+A+systematic+review+and+metaanalysis&doi=10.1016%2Fj.jalz.2012.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global prevalence of dementia: a systematic review and metaanalysis</span></div><div class="casAuthors">Prince Martin; Bryce Renata; Albanese Emiliano; Wimo Anders; Ribeiro Wagner; Ferri Cleusa P</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-75.e2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The evidence base on the prevalence of dementia is expanding rapidly, particularly in countries with low and middle incomes.  A reappraisal of global prevalence and numbers is due, given the significant implications for social and public policy and planning.  METHODS:  In this study we provide a systematic review of the global literature on the prevalence of dementia (1980-2009) and metaanalysis to estimate the prevalence and numbers of those affected, aged ≥60 years in 21 Global Burden of Disease regions.  RESULTS:  Age-standardized prevalence for those aged ≥60 years varied in a narrow band, 5%-7% in most world regions, with a higher prevalence in Latin America (8.5%), and a distinctively lower prevalence in the four sub-Saharan African regions (2%-4%).  It was estimated that 35.6 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050.  In 2010, 58% of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63% in 2030 and 71% in 2050.  CONCLUSION:  The detailed estimates in this study constitute the best current basis for policymaking, planning, and allocation of health and welfare resources in dementia care.  The age-specific prevalence of dementia varies little between world regions, and may converge further.  Future projections of numbers of people with dementia may be modified substantially by preventive interventions (lowering incidence), improvements in treatment and care (prolonging survival), and disease-modifying interventions (preventing or slowing progression).  All countries need to commission nationally representative surveys that are repeated regularly to monitor trends.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDDwrf5YqtWIIRAdBLKY41fW6udTcc2eY73i2NOVu6u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3osVemsQ%253D%253D&md5=cbf1b2107d191f459ba6fe3e6194b3ec</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DM.%26aulast%3DBryce%26aufirst%3DR.%26aulast%3DAlbanese%26aufirst%3DE.%26aulast%3DWimo%26aufirst%3DA.%26aulast%3DRibeiro%26aufirst%3DW.%26aulast%3DFerri%26aufirst%3DC.%2BP.%26atitle%3DThe%2520global%2520prevalence%2520of%2520dementia%253A%2520A%2520systematic%2520review%2520and%2520metaanalysis%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D63%26epage%3D75%26doi%3D10.1016%2Fj.jalz.2012.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Alzheimer’s Association (<a href="http://www.alz.org" class="extLink">www.alz.org</a>). 2015 Alzheimer’s disease facts and figures. <a href="https://www.alz.org/facts/downloads/facts_figures_2015.pdf" class="extLink">https://www.alz.org/facts/downloads/facts_figures_2015.pdf</a>. Accessed on March 26,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+%28www.alz.org%29.+2015+Alzheimer%E2%80%99s+disease+facts+and+figures.+https%3A%2F%2Fwww.alz.org%2Ffacts%2Fdownloads%2Ffacts_figures_2015.pdf.+Accessed+on+March+26%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangialasche, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreasen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacobini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantua, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mecocci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span> </span><span class="NLM_article-title">Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014</span> <span class="citation_source-journal">J. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1111/joim.12191</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fjoim.12191" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24605808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2014&pages=251-283&author=L.+S.+Schneiderauthor=F.+Mangialascheauthor=N.+Andreasenauthor=H.+Feldmanauthor=E.+Giacobiniauthor=R.+Jonesauthor=V.+Mantuaauthor=P.+Mecocciauthor=L.+Paniauthor=B.+Winbladauthor=M.+Kivipelto&title=Clinical+trials+and+late-stage+drug+development+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+from+1984+to+2014&doi=10.1111%2Fjoim.12191"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014</span></div><div class="casAuthors">Schneider L S; Mangialasche F; Andreasen N; Feldman H; Giacobini E; Jones R; Mantua V; Mecocci P; Pani L; Winblad B; Kivipelto M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of internal medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The modern era of drug development for Alzheimer's disease began with the proposal of the cholinergic hypothesis of memory impairment and the 1984 research criteria for Alzheimer's disease.  Since then, despite the evaluation of numerous potential treatments in clinical trials, only four cholinesterase inhibitors and memantine have shown sufficient safety and efficacy to allow marketing approval at an international level.  Although this is probably because the other drugs tested were ineffective, inadequate clinical development methods have also been blamed for the failures.  Here, we review the development of treatments for Alzheimer's disease during the past 30 years, considering the drugs, potential targets, late-stage clinical trials, development methods, emerging use of biomarkers and evolution of regulatory considerations in order to summarize advances and anticipate future developments.  We have considered late-stage Alzheimer's disease drug development from 1984 to 2013, including individual clinical trials, systematic and qualitative reviews, meta-analyses, methods, commentaries, position papers and guidelines.  We then review the evolution of drugs in late clinical development, methods, biomarkers and regulatory issues.  Although a range of small molecules and biological products against many targets have been investigated in clinical trials, the predominant drug targets have been the cholinergic system and the amyloid cascade.  Trial methods have evolved incrementally: inclusion criteria have largely remained focused on mild-to-moderate Alzheimer's disease criteria, recently extending to early or prodromal Alzheimer disease or 'mild cognitive impairment due to Alzheimer's disease', for drugs considered to be disease modifying.  The duration of trials has remained at 6-12 months for drugs intended to improve symptoms; 18- to 24-month trials have been established for drugs expected to attenuate clinical course.  Cognitive performance, activities of daily living, global change and severity ratings have persisted as the primary clinically relevant outcomes.  Regulatory guidance and oversight have evolved to allow for enrichment of early-stage Alzheimer's disease trial samples using biomarkers and phase-specific outcomes.  In conclusion, validated drug targets for Alzheimer's disease remain to be developed.  Only drugs that affect an aspect of cholinergic function have shown consistent, but modest, clinical effects in late-phase trials.  There is opportunity for substantial improvements in drug discovery and clinical development methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiLqeiU50WDCA3UY9EwTNrfW6udTcc2eYonBBc4rZ5SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crhsFaqug%253D%253D&md5=7e34762560c7cb2ce25084827c348cdc</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjoim.12191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjoim.12191%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMangialasche%26aufirst%3DF.%26aulast%3DAndreasen%26aufirst%3DN.%26aulast%3DFeldman%26aufirst%3DH.%26aulast%3DGiacobini%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMantua%26aufirst%3DV.%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPani%26aufirst%3DL.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DKivipelto%26aufirst%3DM.%26atitle%3DClinical%2520trials%2520and%2520late-stage%2520drug%2520development%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520from%25201984%2520to%25202014%26jtitle%3DJ.%2520Intern.%2520Med.%26date%3D2014%26volume%3D275%26spage%3D251%26epage%3D283%26doi%3D10.1111%2Fjoim.12191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lgKgIm_eEstHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mucke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Neurotoxicity of amyloid-β protein: Synaptic and network dysfunction</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006338</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1101%2Fcshperspect.a006338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006338&author=L.+Muckeauthor=D.+J.+Selkoe&title=Neurotoxicity+of+amyloid-%CE%B2+protein%3A+Synaptic+and+network+dysfunction&doi=10.1101%2Fcshperspect.a006338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006338%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DNeurotoxicity%2520of%2520amyloid-%25CE%25B2%2520protein%253A%2520Synaptic%2520and%2520network%2520dysfunction%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006338%26doi%3D10.1101%2Fcshperspect.a006338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the amyloid cascade hypothesis of Alzheimer’s disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span><span class="refDoi"> DOI: 10.1016/j.biocel.2008.12.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+amyloid+cascade+hypothesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.biocel.2008.12.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0liQJTYCaaKeXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520amyloid%2520cascade%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268%26doi%3D10.1016%2Fj.biocel.2008.12.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">For reviews see refs <a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">7−12</a>.</p></div><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span><span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0liQJTYCaaKeXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieckowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.2174/0929867321666141106122628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F0929867321666141106122628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25386820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=373-404&author=N.+Guziorauthor=A.+Wieckowskaauthor=D.+Panekauthor=B.+Malawska&title=Recent+development+of+multifunctional+agents+as+potential+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867321666141106122628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimerμs Disease</span></div><div class="casAuthors">Guzior, Natalia; Wieckowska, Anna; Panek, Dawid; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-404</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder.  The available therapy is limited to the symptomatic treatment and its efficacy remains unsatisfactory.  In view of the prevalence and expected increase in the incidence of AD, the development of an effective therapy is crucial for public health.  Due to the multifactorial etiol. of this disease, the multi-target-directed ligand (MTDL) approach is a promising method in search for new drugs for AD.  This review updates information on the development of multifunctional potential anti-AD agents published within the last three years.  The majority of the recently reported structures are acetylcholinesterase inhibitors, often endowed with some addnl. properties.  These properties enrich the pharmacol. profile of the compds. giving hope for not only symptomatic but also causal treatment of the disease.  Among these advantageous properties, the most often reported are an amyloid-β antiaggregation activity, inhibition of β-secretase and monoamine oxidase, an antioxidant and metal chelating activity, NOreleasing ability and interaction with cannabinoid, NMDA or histamine H3 receptors.  The majority of novel mols. possess heterodimeric structures, able to interact with multiple targets by combining different pharmacophores, original or derived from natural products or existing therapeutics (tacrine, donepezil, galantamine, memantine).  Among the described compds., several seem to be promising drug candidates, while others may serve as a valuable inspiration in the search for new effective therapies for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Eztutww8UbVg90H21EOLACvtfcHk0liQJTYCaaKeXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSrurs%253D&md5=acca283f8e4bf5fae5011523d0639314</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141106122628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141106122628%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DRecent%2520development%2520of%2520multifunctional%2520agents%2520as%2520potential%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D373%26epage%3D404%26doi%3D10.2174%2F0929867321666141106122628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span> </span><span class="NLM_article-title">Rationally designed multi-targeted agents against neurodegenerative diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1672</span><span class="refDoi"> DOI: 10.2174/09298673113209990112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F09298673113209990112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23410161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1662-1672&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Rationally+designed+multi-targeted+agents+against+neurodegenerative+diseases&doi=10.2174%2F09298673113209990112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Rationally designed multi-targeted agents against neurodegenerative diseases</span></div><div class="casAuthors">Geldenhuys, W. J.; Van der Schyf, C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1662-1672</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are complex disorders with several pathoetiol. pathways leading to cell death.  Rationally designed multi-targeted agents, or "multi-targeted designed drugs" (MTDD) show significant promise in preclin. studies as neuroprotective and disease-modifying agents.  In this review, we highlight the use of chem. scaffolds that lend themselves exquisitely to the development of MTDDs in neurodegeneration.  Notably, synthetic polycyclic cage compds. have served as scaffolds for novel voltage-gated calcium channel blockers, NMDA receptor antagonists, and sigma-receptor ligands - attractive targets in neurodegeneration.  In an entirely different approach, compds. contg. the thiazolidinedione moiety (referred to as glitazones) alter mitochondrial function through the mitochondrial protein mitoNEET, an attractive new drug target for the treatment of neurodegenerative diseases.  The design strategy for yet another agent, ladostigil, employed the amalgamation of active chem. moieties of the AChE inhibitor rivastigmine, and the monoamine oxidase-B (MAO-B) inhibitor rasagiline, leading to a single compd. that targets both enzymes simultaneously.  Natural products have also served as design templates for several MTDD design studies.  In particular, the stilbene scaffold has become popular in particular due to the neuroprotective effects of the non-flavonoid natural product resveratrol.  Recently, stilbene scaffold-based compds. were developed to reduce - through chelation with metal ions that interact with beta-amyloid - both metal-induced beta-amyloid protein aggregation, and ROS generated from this aggregate.  Other subtle modifications of the stilbene motif led to the creation of reversible, non-competitive MAO inhibitors.  Finally, compds. derived from the xanthine scaffold afford neuroprotection in Parkinson's disease through mechanisms that include dual adenosine A2A receptor antagonism and MAO-B inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqZJN4lAGwOrVg90H21EOLACvtfcHk0lir-Aoivl-gwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbw%253D&md5=626f69acb3b3ff995e31b042e48dfba3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990112%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DRationally%2520designed%2520multi-targeted%2520agents%2520against%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1662%26epage%3D1672%26doi%3D10.2174%2F09298673113209990112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Multi-target compounds acting in the central nervous system designed from natural products</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.2174/0929867311320130007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F0929867311320130007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23410166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1673-1685&author=X.+Chenauthor=M.+Decker&title=Multi-target+compounds+acting+in+the+central+nervous+system+designed+from+natural+products&doi=10.2174%2F0929867311320130007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target compounds acting in the central nervous system designed from natural products</span></div><div class="casAuthors">Chen, X.; Decker, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1673-1685</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Modern medicinal chem. has come to its bottleneck and is full of challenges, specially when facing with long-term central nervous system (CNS) disorders induced by several factors, such as Alzheimer's disease (AD) or Parkinson's disease (PD).  In order to probe these challenges, multi-target directed ligands (MTDLs) design has been applied recently by medicinal scientists trying to get single compds. that can simultaneously modulate multiple targets.  In addn., natural products have drawn the attention of drug developers again in recent years, as they have been used by human race for thousands of years and are full of diversity with their concomitant high potential to exhibit biol. activities.  We hereby review some of the research within the last few years focusing on multiple-target compds. acting in the CNS using natural products as lead resources.  The target compds. obtained and described here represent bioactive hybrids either covalently connected or obtained by fusion of different bioactive moieties with at least one part derived from or representing directly natural products, along with some natural compds. themselves showing multiple pharmacol. activities.  We describe suitable ways to connect the drug components chem., how to use the approach to enhance biol. activity and selectivity, as well as potential drawbacks of the hybrid approach.  This review will also show the rationale that these MTDLs are more than just the sum of their components but in many cases should be considered as new pharmacol. entities in their own respect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJPeb-9Q6fbVg90H21EOLACvtfcHk0lir-Aoivl-gwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2jtbo%253D&md5=f4176c96cf0837f4e391770c6d033f90</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2174%2F0929867311320130007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320130007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DMulti-target%2520compounds%2520acting%2520in%2520the%2520central%2520nervous%2520system%2520designed%2520from%2520natural%2520products%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D1673%26epage%3D1685%26doi%3D10.2174%2F0929867311320130007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">The multifactorial nature of Alzheimer’s disease for developing potential therapeutics</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1745</span><span class="NLM_x">–</span> <span class="NLM_lpage">1770</span><span class="refDoi"> DOI: 10.2174/15680266113139990135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1745-1770&author=M.+C.+Carreirasauthor=E.+Mendesauthor=M.+J.+Perryauthor=A.+P.+Franciscoauthor=J.+Marco-Contelles&title=The+multifactorial+nature+of+Alzheimer%E2%80%99s+disease+for+developing+potential+therapeutics&doi=10.2174%2F15680266113139990135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics</span></div><div class="casAuthors">Carreiras, M. Carmo; Mendes, Eduarda; Perry, M. Jesus; Francisco, Ana Paula; Marco-Contelles, J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1745-1770</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with several target proteins contributing to its etiol.  Pathol., genetic, biochem., and modeling studies all point to a crit. role of Aβ aggregation in AD.  Though there are still many enigmatic aspects of the Aβ cascade, none of the gaps invalidate the hypothesis.  The amyloid hypothesis dets. that the prodn., aggregation and accumulation of Aβ in the brain gives rise to a cascade of neurotoxic events that proceed to neuronal degeneration.  Different targets of the disease include APP pathogenic cleavage, cytoskeletal destabilization, neurotransmitter and ion dyshomeostasis, metal ion accumulation, protein misfolding, oxidative stress, neuronal death and gene mutations.  Thus, disease-modifying treatments for AD must interfere with the pathogenic steps responsible for the clin. symptoms: the deposition of extracellular Aβ plaques, the intracellular neurofibrillary tangles, inflammation, oxidative stress, iron deregulation, among others.  The observations supporting the development of multifunctional compds. in assocn. with the perception that several dual binding site AChEIs were able to reach different targets guided the development of a new drug design strategy, the multi-target-directed-ligand (MTDL) approach.  This may be regarded as the buildup of hybrid mols. composed of distinct pharmacophores of different drugs.  Thus, each pharmacophore of the new hybrid drug would preserve the capacity of interacting with their specific sites on the targets and, therefore, generate multiple specific pharmacol. responses which would enable the treatment of multi-factorial diseases.  This review summarizes a few current therapeutic trends on MTDL strategy intended to halt or revert the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv2AQj0ZD1CbVg90H21EOLACvtfcHk0lir-Aoivl-gwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjs73F&md5=875ba6e404accc11098651f6ca5b0435</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990135%26sid%3Dliteratum%253Aachs%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMendes%26aufirst%3DE.%26aulast%3DPerry%26aufirst%3DM.%2BJ.%26aulast%3DFrancisco%26aufirst%3DA.%2BP.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DThe%2520multifactorial%2520nature%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520for%2520developing%2520potential%2520therapeutics%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1745%26epage%3D1770%26doi%3D10.2174%2F15680266113139990135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span> </span><span class="NLM_article-title">Emerging targets in neurodegeneration: New opportunities for Alzheimer’s disease treatment?</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1904</span><span class="refDoi"> DOI: 10.2174/15680266113139990143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990143" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFequ73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1879-1904&author=A.+Rampaauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Bisi&title=Emerging+targets+in+neurodegeneration%3A+New+opportunities+for+Alzheimer%E2%80%99s+disease+treatment%3F&doi=10.2174%2F15680266113139990143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging Targets in Neurodegeneration: New Opportunities for Alzheimer's Disease Treatment?</span></div><div class="casAuthors">Rampa, Angela; Gobbi, Silvia; Belluti, Federica; Bisi, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1879-1904</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain assocd. with memory impairment, progressive cognitive decline and changes in personality and behavior, with rising incidence among elderly people.  Reflecting the world population ageing, the scenario is expected to worsen in the next decades if novel drugs or mechanisms that help to counteract neurodegeneration will not be identified.  The complex neuropathol. of AD is characterized by cholinergic loss, extracellular deposition of amyloid- plaques, formation of intracellular neurofibrillary tangles, chronic brain inflammation and oxidative damage.  To date, there are no effective treatments that can slow or halt the disease, and currently approved drugs only seem to act as palliative by temporary ameliorating cognitive impairment.  On the other hand, the role played by other biol. systems in the pathogenetic process is now clearly growing and, as knowledge on how AD develops and triggers brain damage proceeds, drug discovery attempts to identify new potential therapeutic targets.  This review will focus on these emerging strategies, some of which could open new therapeutic perspectives in Alzheimer's disease, adding new elements for the medicinal chemist to handle and combine for the design of novel multi-target-directed ligands able to simultaneously modulate "old classic" and newly identified targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRRMXNZHI-7Vg90H21EOLACvtfcHk0ljWHDHQQNgvFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFequ73L&md5=8720c73d56defcd67375ade38ae5dc35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990143%26sid%3Dliteratum%253Aachs%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26atitle%3DEmerging%2520targets%2520in%2520neurodegeneration%253A%2520New%2520opportunities%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520treatment%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1879%26epage%3D1904%26doi%3D10.2174%2F15680266113139990143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">For recent examples see refs <a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18 ref19">13−19</a>.</p></div><span class="NLM_contrib-group">Prati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisignano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Summa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzirani, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castillo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massenzio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polito, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottegoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span> </span><span class="NLM_article-title">Multitarget drug discovery for Alzheimer’s disease: Triazinones as BACE-1 and GSK-3β inhibidors</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1578</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span><span class="refDoi"> DOI: 10.1002/anie.201410456</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fanie.201410456" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=1578-1582&author=F.+Pratiauthor=A.+De+Simoneauthor=P.+Bisignanoauthor=A.+Armirottiauthor=M.+Summaauthor=D.+Pizziraniauthor=R.+Scarpelliauthor=D.+I.+Perezauthor=V.+Andrisanoauthor=A.+Perez-Castilloauthor=B.+Montiauthor=F.+Massenzioauthor=L.+Politoauthor=M.+Racchiauthor=A.+D.+Faviaauthor=G.+Bottegoniauthor=A.+Martinezauthor=M.+L.+Bolognesiauthor=A.+Cavalli&title=Multitarget+drug+discovery+for+Alzheimer%E2%80%99s+disease%3A+Triazinones+as+BACE-1+and+GSK-3%CE%B2+inhibidors&doi=10.1002%2Fanie.201410456"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.201410456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201410456%26sid%3Dliteratum%253Aachs%26aulast%3DPrati%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DBisignano%26aufirst%3DP.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DSumma%26aufirst%3DM.%26aulast%3DPizzirani%26aufirst%3DD.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DMassenzio%26aufirst%3DF.%26aulast%3DPolito%26aufirst%3DL.%26aulast%3DRacchi%26aufirst%3DM.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DBottegoni%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCavalli%26aufirst%3DA.%26atitle%3DMultitarget%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Triazinones%2520as%2520BACE-1%2520and%2520GSK-3%25CE%25B2%2520inhibidors%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D1578%26epage%3D1582%26doi%3D10.1002%2Fanie.201410456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rochais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecoutey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubost, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genest, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yahiaoui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freret, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauphin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sopkova de Oliveira Santos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballandonne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corvaisier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malzert-Fréon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulouard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claeysen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dallemagne, P.</span><span> </span><span class="NLM_article-title">Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT<sub>4</sub>R) agonist activities as potential agents against Alzheimer’s disease: The design of donecopride</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3172</span><span class="NLM_x">–</span> <span class="NLM_lpage">3187</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3172-3187&author=C.+Rochaisauthor=C.+Lecouteyauthor=F.+Gavenauthor=P.+Giannoniauthor=K.+Hamidoucheauthor=D.+Hedouauthor=E.+Dubostauthor=D.+Genestauthor=S.+Yahiaouiauthor=T.+Freretauthor=V.+Bouetauthor=F.+Dauphinauthor=J.+Sopkova+de+Oliveira+Santosauthor=C.+Ballandonneauthor=S.+Corvaisierauthor=A.+Malzert-Fr%C3%A9onauthor=R.+Legayauthor=M.+Boulouardauthor=S.+Claeysenauthor=P.+Dallemagne&title=Novel+multitarget-directed+ligands+%28MTDLs%29+with+acetylcholinesterase+%28AChE%29+inhibitory+and+serotonergic+subtype+4+receptor+%285-HT4R%29+agonist+activities+as+potential+agents+against+Alzheimer%E2%80%99s+disease%3A+The+design+of+donecopride&doi=10.1021%2Facs.jmedchem.5b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride</span></div><div class="casAuthors">Rochais, Christophe; Lecoutey, Cedric; Gaven, Florence; Giannoni, Patrizia; Hamidouche, Katia; Hedou, Damien; Dubost, Emmanuelle; Genest, David; Yahiaoui, Samir; Freret, Thomas; Bouet, Valentine; Dauphin, Francois; Sopkova de Oliveira Santos, Jana; Ballandonne, Celine; Corvaisier, Sophie; Malzert-Freon, Aurelie; Legay, Remi; Boulouard, Michel; Claeysen, Sylvie; Dallemagne, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3172-3187</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the synthesis and in vitro evaluation of a novel series of multitarget-directed ligands (MTDL) displaying both nanomolar dual-binding site (DBS) acetylcholinesterase inhibitory effects and partial 5-HT4R agonist activity, among which donecopride was selected for further in vivo evaluations in mice.  The latter displayed procognitive and antiamnesic effects and enhanced sAPPα release, accounting for a potential symptomatic and disease-modifying therapeutic benefit in the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmfqjY4Tl4ObVg90H21EOLACvtfcHk0ljWHDHQQNgvFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvFWjsrw%253D&md5=435652a2503e322ad880bd9607838103</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26aulast%3DRochais%26aufirst%3DC.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DGaven%26aufirst%3DF.%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DHamidouche%26aufirst%3DK.%26aulast%3DHedou%26aufirst%3DD.%26aulast%3DDubost%26aufirst%3DE.%26aulast%3DGenest%26aufirst%3DD.%26aulast%3DYahiaoui%26aufirst%3DS.%26aulast%3DFreret%26aufirst%3DT.%26aulast%3DBouet%26aufirst%3DV.%26aulast%3DDauphin%26aufirst%3DF.%26aulast%3DSopkova%2Bde%2BOliveira%2BSantos%26aufirst%3DJ.%26aulast%3DBallandonne%26aufirst%3DC.%26aulast%3DCorvaisier%26aufirst%3DS.%26aulast%3DMalzert-Fr%25C3%25A9on%26aufirst%3DA.%26aulast%3DLegay%26aufirst%3DR.%26aulast%3DBoulouard%26aufirst%3DM.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DDallemagne%26aufirst%3DP.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520%2528MTDLs%2529%2520with%2520acetylcholinesterase%2520%2528AChE%2529%2520inhibitory%2520and%2520serotonergic%2520subtype%25204%2520receptor%2520%25285-HT4R%2529%2520agonist%2520activities%2520as%2520potential%2520agents%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520The%2520design%2520of%2520donecopride%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3172%26epage%3D3187%26doi%3D10.1021%2Facs.jmedchem.5b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Guzior, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrok, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurpiewska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewinski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pislar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malawska, B.</span><span> </span><span class="NLM_article-title">Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">738</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25621991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=738-749&author=N.+Guziorauthor=M.+Bajdaauthor=M.+Skrokauthor=K.+Kurpiewskaauthor=K.+Lewinskiauthor=B.+Brusauthor=A.+Pislarauthor=J.+Kosauthor=S.+Gobecauthor=B.+Malawska&title=Development+of+multifunctional%2C+heterodimeric+isoindoline-1%2C3-dione+derivatives+as+cholinesterase+and+%CE%B2-amyloid+aggregation+inhibitors+with+neuroprotective+properties&doi=10.1016%2Fj.ejmech.2015.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties</span></div><div class="casAuthors">Guzior, Natalia; Bajda, Marek; Skrok, Miroslaw; Kurpiewska, Katarzyna; Lewinski, Krzysztof; Brus, Boris; Pislar, Anja; Kos, Janko; Gobec, Stanislav; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">738-749</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The presented study describes the synthesis, pharmacol. evaluation (AChE and BuChE inhibition, beta amyloid anti-aggregation effect and neuroprotective effect), mol. modeling and crystallog. studies of a novel series of isoindoline-1,3-dione derivs.  The target compds. were designed as dual binding site acetylcholinesterase inhibitors with an arylalkylamine moiety binding at the catalytic site of the enzyme and connected via an alkyl chain to a heterocyclic fragment, capable of binding at the peripheral anionic site of AChE.  Among these mols., compd. I was found to be the most potent and selective AChE inhibitor (IC50EeAChE = 0.034 μM).  Moreover, compd. II in addn. to AChE inhibition (IC50 EeAChE = 0.219 μM) possesses addnl. properties, such as the ability to inhibit Aβ aggregation (65.96% at 10 μM) and a neuroprotective effect against Aβ toxicity at 1 and 3 μM.  Compd. II emerges as a promising multi-target ligand for the further development of the therapy for age-related neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7pUEAUjEtsbVg90H21EOLACvtfcHk0liYnbZWa6Cnng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCitw%253D%253D&md5=a545fb00b9719881affc9db4cfd560dc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DBajda%26aufirst%3DM.%26aulast%3DSkrok%26aufirst%3DM.%26aulast%3DKurpiewska%26aufirst%3DK.%26aulast%3DLewinski%26aufirst%3DK.%26aulast%3DBrus%26aufirst%3DB.%26aulast%3DPislar%26aufirst%3DA.%26aulast%3DKos%26aufirst%3DJ.%26aulast%3DGobec%26aufirst%3DS.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DDevelopment%2520of%2520multifunctional%252C%2520heterodimeric%2520isoindoline-1%252C3-dione%2520derivatives%2520as%2520cholinesterase%2520and%2520%25CE%25B2-amyloid%2520aggregation%2520inhibitors%2520with%2520neuroprotective%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D92%26spage%3D738%26epage%3D749%26doi%3D10.1016%2Fj.ejmech.2015.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Xie, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L.-Y.</span><span> </span><span class="NLM_article-title">Multifunctional tacrine–trolox hybrids for the treatment of Alzheimer’s disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.01.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.01.058" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2015&pages=42-50&author=S.-S.+Xieauthor=J.-S.+Lanauthor=X.-B.+Wangauthor=N.+Jiangauthor=G.+Dongauthor=Z.-R.+Liauthor=K.+D.+G.+Wangauthor=P.-P.+Guoauthor=L.-Y.+Kong&title=Multifunctional+tacrine%E2%80%93trolox+hybrids+for+the+treatment+of+Alzheimer%E2%80%99s+disease+with+cholinergic%2C+antioxidant%2C+neuroprotective+and+hepatoprotective+properties&doi=10.1016%2Fj.ejmech.2015.01.058"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.01.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.01.058%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DJiang%26aufirst%3DN.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.-R.%26aulast%3DWang%26aufirst%3DK.%2BD.%2BG.%26aulast%3DGuo%26aufirst%3DP.-P.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMultifunctional%2520tacrine%25E2%2580%2593trolox%2520hybrids%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520cholinergic%252C%2520antioxidant%252C%2520neuroprotective%2520and%2520hepatoprotective%2520properties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D93%26spage%3D42%26epage%3D50%26doi%3D10.1016%2Fj.ejmech.2015.01.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">366</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.02.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2015.02.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25778991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVertrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=348-366&author=Z.+Sangauthor=X.+Qiangauthor=Y.+Liauthor=W.+Yuanauthor=Q.+Liuauthor=Y.+Shiauthor=A.+Weiauthor=Y.+Luoauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+scutellarein-O-alkylamines+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.02.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Sang, Zhipei; Qiang, Xiaoming; Li, Yan; Yuan, Wen; Liu, Qiang; Shi, Yikun; Wei, Ang; Luo, Youfu; Tan, Zhenghuai; Deng, Yong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">348-366</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of scutellarein-O-alkylamine derivs. were designed, synthesized and tested as multifunctional agents for the treatment of Alzheimer's disease (AD).  The results showed that most of these compds. exhibited good multifunctional activities.  Among them, compd. 16d demonstrated significant metal chelating properties, moderate acetylcholinesterase (AChE) inhibitory and anti-oxidative activity, and excellent inhibitory effects on self-induced Aβ1-42 aggregation, Cu2+-induced Aβ1-42 aggregation, human AChE-induced Aβ1-40 aggregation and disassembled Cu2+-induced aggregation of the well-structured Aβ1-42 fibrils.  Both kinetic anal. of AChE inhibition and mol. modeling study suggested that 16d binds simultaneously to the catalytic active site and peripheral anionic site of AChE.  Moreover, compd. 16d showed a good protective effect against H2O2-induced PC12 cell injury, with low toxicity in SH-SY5Y cells.  Furthermore, the step-down passive avoidance test showed this compd. significantly reversed scopolamine-induced memory deficit in mice.  Thus, 16d was shown to be an interesting multifunctional lead compd. worthy of further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKl89ID7O2fbVg90H21EOLACvtfcHk0liYnbZWa6Cnng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVertrs%253D&md5=31fb4dd317c08e80bec9a3004fc60b10</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.063%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DZ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520scutellarein-O-alkylamines%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D348%26epage%3D366%26doi%3D10.1016%2Fj.ejmech.2015.02.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Benchekroun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pudlo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refouvelet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andrés, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Arozamena, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismaili, L.</span><span> </span><span class="NLM_article-title">Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: A synthetic renewal in tacrine–ferulic acid hybrids</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">539</span><span class="refDoi"> DOI: 10.1002/cmdc.201402409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fcmdc.201402409" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=523-539&author=M.+Benchekrounauthor=M.+Bartoliniauthor=J.+Egeaauthor=A.+Romeroauthor=E.+Sorianoauthor=M.+Pudloauthor=V.+Luzetauthor=V.+Andrisanoauthor=M.-L.+Jimenoauthor=M.+G.+L%C3%B3pezauthor=S.+Wehleauthor=T.+Gharbiauthor=B.+Refouveletauthor=L.+de+Andr%C3%A9sauthor=C.+Herrera-Arozamenaauthor=B.+Montiauthor=M.+L.+Bolognesiauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+Deckerauthor=J.+Marco-Contellesauthor=L.+Ismaili&title=Novel+tacrine-grafted+Ugi+adducts+as+multipotent+anti-Alzheimer+drugs%3A+A+synthetic+renewal+in+tacrine%E2%80%93ferulic+acid+hybrids&doi=10.1002%2Fcmdc.201402409"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402409%26sid%3Dliteratum%253Aachs%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DEgea%26aufirst%3DJ.%26aulast%3DRomero%26aufirst%3DA.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DPudlo%26aufirst%3DM.%26aulast%3DLuzet%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DJimeno%26aufirst%3DM.-L.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DWehle%26aufirst%3DS.%26aulast%3DGharbi%26aufirst%3DT.%26aulast%3DRefouvelet%26aufirst%3DB.%26aulast%3Dde%2BAndr%25C3%25A9s%26aufirst%3DL.%26aulast%3DHerrera-Arozamena%26aufirst%3DC.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DIsmaili%26aufirst%3DL.%26atitle%3DNovel%2520tacrine-grafted%2520Ugi%2520adducts%2520as%2520multipotent%2520anti-Alzheimer%2520drugs%253A%2520A%2520synthetic%2520renewal%2520in%2520tacrine%25E2%2580%2593ferulic%2520acid%2520hybrids%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D523%26epage%3D539%26doi%3D10.1002%2Fcmdc.201402409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of chromone-2-carboxamidoalkylbenzylamines as multifunctional agents for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">923</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bmc.2015.01.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=911-923&author=Q.+Liuauthor=X.+Qiangauthor=Y.+Liauthor=Z.+Sangauthor=Y.+Liauthor=Z.+Tanauthor=Y.+Deng&title=Design%2C+synthesis+and+evaluation+of+chromone-2-carboxamidoalkylbenzylamines+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2015.01.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DQiang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520chromone-2-carboxamidoalkylbenzylamines%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D911%26epage%3D923%26doi%3D10.1016%2Fj.bmc.2015.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Brogi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maramai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verga, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lorenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamponi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemma, S.</span><span> </span><span class="NLM_article-title">Disease-modifying anti-Alzheimer’s drugs: Inhibitors of human cholinesterases interfering with β-amyloid aggregation</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">632</span><span class="refDoi"> DOI: 10.1111/cns.12290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fcns.12290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24935788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVWktLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=624-632&author=S.+Brogiauthor=S.+Butiniauthor=S.+Maramaiauthor=R.+Colomboauthor=L.+Vergaauthor=C.+Lanniauthor=E.+De+Lorenziauthor=S.+Lamponiauthor=M.+Andreassiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=E.+Novellinoauthor=G.+Campianiauthor=M.+Brindisiauthor=S.+Gemma&title=Disease-modifying+anti-Alzheimer%E2%80%99s+drugs%3A+Inhibitors+of+human+cholinesterases+interfering+with+%CE%B2-amyloid+aggregation&doi=10.1111%2Fcns.12290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Disease-Modifying Anti-Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β-Amyloid Aggregation</span></div><div class="casAuthors">Brogi, Simone; Butini, Stefania; Maramai, Samuele; Colombo, Raffaella; Verga, Laura; Lanni, Cristina; De Lorenzi, Ersilia; Lamponi, Stefania; Andreassi, Marco; Bartolini, Manuela; Andrisano, Vincenza; Novellino, Ettore; Campiani, Giuseppe; Brindisi, Margherita; Gemma, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">624-632</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Aims : We recently described multifunctional tools (2a-c) as potent inhibitors of human Cholinesterases (ChEs) also able to modulate events correlated with Aβ aggregation.  We herein propose a thorough biol. and computational anal. aiming at understanding their mechanism of action at the mol. level.  Methods : We detd. the inhibitory potency of 2a-c on Aβ1-42 self-aggregation, the interference of 2a with the toxic Aβ oligomeric species and with the postaggregation states by capillary electrophoresis anal. and transmission electron microscopy.  The modulation of Aβ toxicity was assessed for 2a and 2b on human neuroblastoma cells.  The key interactions of 2a with Aβ and with the Aβ-preformed fibrils were computationally analyzed. 2a-c toxicity profile was also assessed (human hepatocytes and mouse fibroblasts).  Results : Our prototypical pluripotent analog 2a interferes with Aβ oligomerization process thus reducing Aβ oligomers-mediated toxicity in human neuroblastoma cells. 2a also disrupts preformed fibrils.  Computational studies highlighted the bases governing the diversified activities of 2a.  Conclusion : Converging anal., biol., and in silico data explained the mechanism of action of 2a on Aβ1-42 oligomers formation and against Aβ-preformed fibrils.  This evidence, combined with toxicity data, will orient the future design of safer analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXZfHUZuTBbVg90H21EOLACvtfcHk0li5pWm19M9snw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVWktLzM&md5=29880e30e1d7f9a9c8727798dac60550</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fcns.12290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12290%26sid%3Dliteratum%253Aachs%26aulast%3DBrogi%26aufirst%3DS.%26aulast%3DButini%26aufirst%3DS.%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DVerga%26aufirst%3DL.%26aulast%3DLanni%26aufirst%3DC.%26aulast%3DDe%2BLorenzi%26aufirst%3DE.%26aulast%3DLamponi%26aufirst%3DS.%26aulast%3DAndreassi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DBrindisi%26aufirst%3DM.%26aulast%3DGemma%26aufirst%3DS.%26atitle%3DDisease-modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%253A%2520Inhibitors%2520of%2520human%2520cholinesterases%2520interfering%2520with%2520%25CE%25B2-amyloid%2520aggregation%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2014%26volume%3D20%26spage%3D624%26epage%3D632%26doi%3D10.1111%2Fcns.12290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1842</span><span class="refDoi"> DOI: 10.2174/15680266113139990139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F15680266113139990139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23931440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1820-1842&author=E.+Viaynaauthor=R.+Sabateauthor=D.+Mu%C3%B1oz-Torrero&title=Dual+inhibitors+of+%CE%B2-amyloid+aggregation+and+acetylcholinesterase+as+multi-target+anti-Alzheimer+drug+candidates&doi=10.2174%2F15680266113139990139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of β-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Sabate, Raimon; Muaoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1820-1842</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Notwithstanding the functional role that the aggregates of some amyloidogenic proteins can play in different organisms, protein aggregation plays a pivotal role in the pathogenesis of a large no. of human diseases.  One of such diseases is Alzheimer's disease (AD), where the overprodn. and aggregation of the β-amyloid peptide (A β) are regarded as early crit. factors.  Another protein that seems to occupy a prominent position within the complex pathol. network of AD is the enzyme acetylcholinesterase (AChE), with classical and non-classical activities involved at the late (cholinergic deficit) and early (A β aggregation) phases of the disease.  Dual inhibitors of A aggregation and AChE are thus emerging as promising multi-target agents with potential to efficiently modify the natural course of AD.  In the initial phases of the drug discovery process of such compds., in vitro evaluation of the inhibition of Aβ β aggregation is rather troublesome, as it is very sensitive to exptl. assay conditions, and requires expensive synthetic Aβ peptides, which makes cost-prohibitive the screening of large compd. libraries.  Herein, we review recently developed multitarget anti-Alzheimer compds. that exhibit both Aβ aggregation and AChE inhibitory activities, and, in some cases also addnl. valuable activities such as BACE-1 inhibition or antioxidant properties.  We also discuss the development of simplified in vivo methods for the rapid, simple, reliable, unexpensive, and high-throughput amenable screening of Aβ aggregation inhibitors that rely on the overexpression of Aβ42 alone or fused with reporter proteins in Escherichia coli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIyUwDaYut4bVg90H21EOLACvtfcHk0li5pWm19M9snw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFCjsr3M&md5=5df3642ce69af587b82d1dac92014f0d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990139%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DDual%2520inhibitors%2520of%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520acetylcholinesterase%2520as%2520multi-target%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1820%26epage%3D1842%26doi%3D10.2174%2F15680266113139990139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80108-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0896-6273%2800%2980108-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=8608006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+accelerates+assembly+of+amyloid-%CE%B2-peptides+into+Alzheimer%E2%80%99s+fibrils%3A+possible+role+of+the+peripheral+site+of+the+enzyme&doi=10.1016%2FS0896-6273%2800%2980108-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme</span></div><div class="casAuthors">Inestrosa, Nibaldo C.; Alvarez, Alejandra; Perez, Cristian A.; Moreno, Ricardo D.; Vicente, Matias; Linker, Claudia; Casanueva, Olivia I.; Soto, Claudio; Garrido, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">881-891</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE), an important component of cholinergic synapses, colocalizes with amyloid-β peptide (Aβ) deposits of Alzheimer's brain.  The authors report here that bovine brain AChE, as well as the human and mouse recombinant enzyme, accelerates amyloid formation from wild-type Aβ and a mutant Aβ peptide, which alone produces few amyloid-like fibrils.  The action of AChE was independent of the subunit array of the enzyme, was not affected by edrophonium, an active site inhibitor, but it was affected by propidium, a peripheral anionic binding site ligand.  Butyrylcholinesterase, an enzyme that lacks the peripheral site, did not affect amyloid formation.  Furthermore, AChE is a potent amyloid-promoting factor when compared with other Aβ-assocd. proteins.  Thus, in addn. to its role in cholinergic synapses, AChE may function by accelerating Aβ formation and could play a role during amyloid deposition in Alzheimer's brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx2wsrjgQa0LVg90H21EOLACvtfcHk0liFhaF4UJjfow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XislCmsLk%253D&md5=299031351f764e5376b98407c3dc7278</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980108-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980108-7%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520accelerates%2520assembly%2520of%2520amyloid-%25CE%25B2-peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520fibrils%253A%2520possible%2520role%2520of%2520the%2520peripheral%2520site%2520of%2520the%2520enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891%26doi%3D10.1016%2FS0896-6273%2800%2980108-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canales, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">10447</span><span class="NLM_x">–</span> <span class="NLM_lpage">10457</span><span class="refDoi"> DOI: 10.1021/bi0101392</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0101392" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=10447-10457&author=G.+V.+De+Ferrariauthor=M.+A.+Canalesauthor=I.+Shinauthor=L.+M.+Weinerauthor=I.+Silmanauthor=N.+C.+Inestrosa&title=A+structural+motif+of+acetylcholinesterase+that+promotes+amyloid+beta-peptide+fibril+formation&doi=10.1021%2Fbi0101392"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi0101392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0101392%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26aulast%3DCanales%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DI.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DA%2520structural%2520motif%2520of%2520acetylcholinesterase%2520that%2520promotes%2520amyloid%2520beta-peptide%2520fibril%2520formation%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D10447%26epage%3D10457%26doi%3D10.1021%2Fbi0101392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Epilepsy and cognitive impairments in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1001/archneurol.2009.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1001%2Farchneurol.2009.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19204149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BD1M3nsVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=435-440&author=J.+J.+Palopauthor=L.+Mucke&title=Epilepsy+and+cognitive+impairments+in+Alzheimer+disease&doi=10.1001%2Farchneurol.2009.15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Epilepsy and cognitive impairments in Alzheimer disease</span></div><div class="casAuthors">Palop Jorge J; Mucke Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">435-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer disease (AD) is associated with cognitive decline and increased incidence of seizures.  Seizure activity in AD has been widely interpreted as a secondary process resulting from advanced stages of neurodegeneration, perhaps in combination with other age-related factors.  However, recent findings in animal models of AD have challenged this notion, raising the possibility that aberrant excitatory neuronal activity represents a primary upstream mechanism that may contribute to cognitive deficits in these models.  The following observations suggest that such activity may play a similar role in humans with AD: (1) patients with sporadic AD have an increased incidence of seizures that appears to be independent of disease stage and highest in cases with early onset; (2) seizures are part of the natural history of many pedigrees with autosomal dominant early-onset AD, including those with mutations in presenilin-1, presenilin-2, or the amyloid precursor protein, or with duplications of wild-type amyloid precursor protein; (3) inheritance of the major known genetic risk factor for AD, apolipoprotein E4, is associated with subclinical epileptiform activity in carriers without dementia; and (4) some cases of episodic amnestic wandering and disorientation in AD are associated with epileptiform activity and can be prevented with antiepileptic drugs.  Here we review recent experimental data demonstrating that high levels of beta-amyloid in the brain can cause epileptiform activity and cognitive deficits in transgenic mouse models of AD.  We conclude that beta-amyloid peptides may contribute to cognitive decline in AD by eliciting similar aberrant neuronal activity in humans and discuss potential clinical and therapeutic implications of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQY55la9yVoz8zK395ZObgVfW6udTcc2ebgFhdstpBP5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3nsVCjsA%253D%253D&md5=f537495f95da17a06c1f38a674e24b62</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2009.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2009.15%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DEpilepsy%2520and%2520cognitive%2520impairments%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D435%26epage%3D440%26doi%3D10.1001%2Farchneurol.2009.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1038/nn.2583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1038%2Fnn.2583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20581818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFSgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=812-818&author=J.+J.+Palopauthor=L.+Mucke&title=Amyloid-%CE%B2-induced+neuronal+dysfunction+in+Alzheimer%E2%80%99s+disease%3A+from+synapses+toward+neural+networks&doi=10.1038%2Fnn.2583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks</span></div><div class="casAuthors">Palop, Jorge J.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-818</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the most frequent neurodegenerative disorder and the most common cause of dementia in the elderly.  Diverse lines of evidence suggest that amyloid-β (Aβ) peptides have a causal role in its pathogenesis, but the underlying mechanisms remain uncertain.  Here we discuss recent evidence that Aβ may be part of a mechanism controlling synaptic activity, acting as a pos. regulator presynaptically and a neg. regulator postsynaptically.  The pathol. accumulation of oligomeric Aβ assemblies depresses excitatory transmission at the synaptic level, but also triggers aberrant patterns of neuronal circuit activity and epileptiform discharges at the network level.  Aβ-induced dysfunction of inhibitory interneurons likely increases synchrony among excitatory principal cells and contributes to the destabilization of neuronal networks.  Strategies that block these Aβ effects may prevent cognitive decline in Alzheimer's disease.  Potential obstacles and next steps toward this goal are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LiGQBN055bVg90H21EOLACvtfcHk0liFhaF4UJjfow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFSgtr0%253D&md5=12f7dfe712d2b2c1d7087f9a45224a96</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnn.2583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2583%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAmyloid-%25CE%25B2-induced%2520neuronal%2520dysfunction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520from%2520synapses%2520toward%2520neural%2520networks%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D812%26epage%3D818%26doi%3D10.1038%2Fnn.2583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Vossel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beagle, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naasan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornes, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeley, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorno-Tempini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirsch, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Seizures and epileptiform activity in the early stages of Alzheimer disease</span> <span class="citation_source-journal">JAMA Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1166</span><span class="refDoi"> DOI: 10.1001/jamaneurol.2013.136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1001%2Fjamaneurol.2013.136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23835471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC3sjovFOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=1158-1166&author=K.+A.+Vosselauthor=A.+J.+Beagleauthor=G.+D.+Rabinoviciauthor=H.+Shuauthor=S.+E.+Leeauthor=G.+Naasanauthor=M.+Hegdeauthor=S.+B.+Cornesauthor=M.+L.+Henryauthor=A.+B.+Nelsonauthor=W.+W.+Seeleyauthor=M.+D.+Geschwindauthor=M.+L.+Gorno-Tempiniauthor=T.+Shihauthor=H.+E.+Kirschauthor=P.+A.+Garciaauthor=B.+L.+Millerauthor=L.+Mucke&title=Seizures+and+epileptiform+activity+in+the+early+stages+of+Alzheimer+disease&doi=10.1001%2Fjamaneurol.2013.136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Seizures and epileptiform activity in the early stages of Alzheimer disease</span></div><div class="casAuthors">Vossel Keith A; Beagle Alexander J; Rabinovici Gil D; Shu Huidy; Lee Suzee E; Naasan Georges; Hegde Manu; Cornes Susannah B; Henry Maya L; Nelson Alexandra B; Seeley William W; Geschwind Michael D; Gorno-Tempini Maria L; Shih Tina; Kirsch Heidi E; Garcia Paul A; Miller Bruce L; Mucke Lennart</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1158-66</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IMPORTANCE:  Epileptic activity associated with Alzheimer disease (AD) deserves increased attention because it has a harmful impact on these patients, can easily go unrecognized and untreated, and may reflect pathogenic processes that also contribute to other aspects of the illness.  We report key features of AD-related seizures and epileptiform activity that are instructive for clinical practice and highlight similarities between AD and transgenic animal models of the disease.  OBJECTIVE:  To describe common clinical characteristics and treatment outcomes of patients with amnestic mild cognitive impairment (aMCI) or early AD who also have epilepsy or subclinical epileptiform activity.  DESIGN:  Retrospective observational study from 2007 to 2012.  SETTING Memory and Aging Center, University of California, San Francisco.  PATIENTS:  We studied 54 patients with a diagnosis of aMCI plus epilepsy (n = 12), AD plus epilepsy (n = 35), and AD plus subclinical epileptiform activity (n = 7).  MAIN OUTCOMES AND MEASURES:  Clinical and demographic data, electroencephalogram (EEG) readings, and treatment responses to antiepileptic medications.  RESULTS:  Patients with aMCI who had epilepsy presented with symptoms of cognitive decline 6.8 years earlier than patients with aMCI who did not have epilepsy (64.3 vs 71.1 years; P = .02).  Patients with AD who had epilepsy presented with cognitive decline 5.5 years earlier than patients with AD who did not have epilepsy (64.8 vs 70.3 years; P = .001).  Patients with AD who had subclinical epileptiform activity also had an early onset of cognitive decline (58.9 years).  The timing of seizure onset in patients with aMCI and AD was nonuniform (P < .001), clustering near the onset of cognitive decline.  Epilepsies were most often complex partial seizures (47%) and more than half were nonconvulsive (55%).  Serial or extended EEG monitoring appeared to be more effective than routine EEG at detecting interictal and subclinical epileptiform activity.  Epileptic foci were predominantly unilateral and temporal.  Of the most commonly prescribed antiepileptics, treatment outcomes appeared to be better for lamotrigine and levetiracetam than for phenytoin.  CONCLUSIONS AND RELEVANCE:  Common clinical features of patients with aMCI- or AD-associated epilepsy at our center included early age at onset of cognitive decline, early incidence of seizures in the disease course, unilateral temporal epileptic foci detected by serial/extended EEG, transient cognitive dysfunction, and good seizure control and tolerability with lamotrigine and levetiracetam.  Careful identification and treatment of epilepsy in such patients may improve their clinical course.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROB3JO8qkWLUBuFdjgVNKSfW6udTcc2ea1eN9HEcYPpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjovFOmtA%253D%253D&md5=76d111f46f35cded57a44e631d10dac2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2013.136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2013.136%26sid%3Dliteratum%253Aachs%26aulast%3DVossel%26aufirst%3DK.%2BA.%26aulast%3DBeagle%26aufirst%3DA.%2BJ.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DShu%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%2BE.%26aulast%3DNaasan%26aufirst%3DG.%26aulast%3DHegde%26aufirst%3DM.%26aulast%3DCornes%26aufirst%3DS.%2BB.%26aulast%3DHenry%26aufirst%3DM.%2BL.%26aulast%3DNelson%26aufirst%3DA.%2BB.%26aulast%3DSeeley%26aufirst%3DW.%2BW.%26aulast%3DGeschwind%26aufirst%3DM.%2BD.%26aulast%3DGorno-Tempini%26aufirst%3DM.%2BL.%26aulast%3DShih%26aufirst%3DT.%26aulast%3DKirsch%26aufirst%3DH.%2BE.%26aulast%3DGarcia%26aufirst%3DP.%2BA.%26aulast%3DMiller%26aufirst%3DB.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DSeizures%2520and%2520epileptiform%2520activity%2520in%2520the%2520early%2520stages%2520of%2520Alzheimer%2520disease%26jtitle%3DJAMA%2520Neurol.%26date%3D2013%26volume%3D70%26spage%3D1158%26epage%3D1166%26doi%3D10.1001%2Fjamaneurol.2013.136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McCarron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, C.</span><span> </span><span class="NLM_article-title">Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia</span> <span class="citation_source-journal">J. Intellect. Disabil. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1111/j.1365-2788.2005.00704.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fj.1365-2788.2005.00704.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=15966964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BD2MzhvFWgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=560-566&author=M.+McCarronauthor=M.+Gillauthor=P.+McCallionauthor=C.+Begley&title=Health+co-morbidities+in+ageing+persons+with+Down+syndrome+and+Alzheimer%E2%80%99s+dementia&doi=10.1111%2Fj.1365-2788.2005.00704.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia</span></div><div class="casAuthors">McCarron M; Gill M; McCallion P; Begley C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of intellectual disability research : JIDR</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">Pt 7</span>),
    <span class="NLM_cas:pages">560-6</span>
        ISSN:<span class="NLM_cas:issn">0964-2633</span>.
    </div><div class="casAbstract">BACKGROUND:  Consideration of the relationship between physical and mental health co-morbidities in ageing persons with Down syndrome (DS) and Alzheimer's dementia (AD) is of clinical importance both from a care and resource perspective.  AIM To investigate and measure health co-morbidities in ageing persons with Down syndrome with and without AD.  METHODS:  Recorded physical and mental health needs were ascertained for 124 persons with DS>35 years through a systematic and detailed search of individual medical and nursing case records.  Differences in persons with and without AD were investigated, by stage of dementia and by level of intellectual disability (ID).  A summed score for health co-morbidities was created and compared using t-tests.  RESULTS:  Persons with AD had significantly higher co-morbidity scores than persons without AD (t=-8.992, d.f.=121, P<0.0001).  There was also a significant difference in summed co-morbidity scores for persons at end-stage vs. persons at mid-stage AD (t=-6.429, d.f.=56, P<0.0001).  No differences were found by level of ID.  CONCLUSIONS:  Increasing health co-morbidities in persons with DS and AD have important implications for care and resources.  Appropriate environmental supports combined with competent skilled staff are crucial and will have an important impact on the quality of life for this increasingly at risk population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2XV3lckz1m9enUz0lpNqnfW6udTcc2ea1eN9HEcYPpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzhvFWgsQ%253D%253D&md5=92d3eeac14fd302535ab57d6f0638e07</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2788.2005.00704.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2788.2005.00704.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarron%26aufirst%3DM.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DMcCallion%26aufirst%3DP.%26aulast%3DBegley%26aufirst%3DC.%26atitle%3DHealth%2520co-morbidities%2520in%2520ageing%2520persons%2520with%2520Down%2520syndrome%2520and%2520Alzheimer%25E2%2580%2599s%2520dementia%26jtitle%3DJ.%2520Intellect.%2520Disabil.%2520Res.%26date%3D2005%26volume%3D49%26spage%3D560%26epage%3D566%26doi%3D10.1111%2Fj.1365-2788.2005.00704.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thwin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bien-Ly, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">697</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.07.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.neuron.2007.07.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=17785178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtV2qtrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=697-711&author=J.+J.+Palopauthor=J.+Chinauthor=E.+D.+Robersonauthor=J.+Wangauthor=M.+T.+Thwinauthor=N.+Bien-Lyauthor=J.+Yooauthor=K.+O.+Hoauthor=G.+Q.+Yuauthor=A.+Kreitzerauthor=S.+Finkbeinerauthor=J.+L.+Noebelsauthor=L.+Mucke&title=Aberrant+excitatory+neuronal+activity+and+compensatory+remodeling+of+inhibitory+hippocampal+circuits+in+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuron.2007.07.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease</span></div><div class="casAuthors">Palop, Jorge J.; Chin, Jeannie; Roberson, Erik D.; Wang, Jun; Thwin, Myo T.; Bien-Ly, Nga; Yoo, Jong; Ho, Kaitlyn O.; Yu, Gui-Qiu; Kreitzer, Anatol; Finkbeiner, Steven; Noebels, Jeffrey L.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">697-711</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Neural network dysfunction may play an important role in Alzheimer's disease (AD).  Neuronal circuits vulnerable to AD are also affected in human amyloid precursor protein (hAPP) transgenic mice.  HAPP mice with high levels of amyloid-β peptides in the brain develop AD-like abnormalities, including cognitive deficits and depletions of calcium-related proteins in the dentate gyrus, a region critically involved in learning and memory.  Here, we report that hAPP mice have spontaneous nonconvulsive seizure activity in cortical and hippocampal networks, which is assocd. with GABAergic sprouting, enhanced synaptic inhibition, and synaptic plasticity deficits in the dentate gyrus.  Many Aβ-induced neuronal alterations could be simulated in nontransgenic mice by excitotoxin challenge and prevented in hAPP mice by blocking overexcitation.  Aberrant increases in network excitability and compensatory inhibitory mechanisms in the hippocampus may contribute to Aβ-induced neurol. deficits in hAPP mice and, possibly, also in humans with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyANoCdgosrbVg90H21EOLACvtfcHk0lj30Dq7bpA2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtV2qtrfO&md5=11507c966f258bef0b1f8d2a3641bd8d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.07.025%26sid%3Dliteratum%253Aachs%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DThwin%26aufirst%3DM.%2BT.%26aulast%3DBien-Ly%26aufirst%3DN.%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DK.%2BO.%26aulast%3DYu%26aufirst%3DG.%2BQ.%26aulast%3DKreitzer%26aufirst%3DA.%26aulast%3DFinkbeiner%26aufirst%3DS.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAberrant%2520excitatory%2520neuronal%2520activity%2520and%2520compensatory%2520remodeling%2520of%2520inhibitory%2520hippocampal%2520circuits%2520in%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2007%26volume%3D55%26spage%3D697%26epage%3D711%26doi%3D10.1016%2Fj.neuron.2007.07.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bakker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krauss, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speck, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yassa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassett, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, M.</span><span> </span><span class="NLM_article-title">Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1016/j.neuron.2012.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.neuron.2012.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22578498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFantr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2012&pages=467-474&author=A.+Bakkerauthor=G.+L.+Kraussauthor=M.+S.+Albertauthor=C.+L.+Speckauthor=L.+R.+Jonesauthor=C.+E.+Starkauthor=M.+A.+Yassaauthor=S.+S.+Bassettauthor=A.+L.+Sheltonauthor=M.+Gallagher&title=Reduction+of+hippocampal+hyperactivity+improves+cognition+in+amnestic+mild+cognitive+impairment&doi=10.1016%2Fj.neuron.2012.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment</span></div><div class="casAuthors">Bakker, Arnold; Krauss, Gregory L.; Albert, Marilyn S.; Speck, Caroline L.; Jones, Lauren R.; Stark, Craig E.; Yassa, Michael A.; Bassett, Susan S.; Shelton, Amy L.; Gallagher, Michela</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">467-474</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Elevated hippocampal activation is obsd. in conditions that confer risk for Alzheimer's disease, including amnestic mild cognitive impairment (aMCI).  Studies in relevant animal models have indicated that overactivity in selective hippocampal circuits contributes to cognitive impairment.  Here, we tested the effect of reducing hippocampal activation in aMCI.  Under placebo treatment, hippocampal activation in the dentate gyrus/CA3 was elevated in aMCI patients compared to a healthy control group.  By using a low dose of the antiepileptic levetiracetam hippocampal activation in aMCI was reduced to a level that did not differ from the control group.  Compared to aMCI memory performance under placebo, performance in the scanning task was significantly improved under drug treatment.  Contrary to the view that greater hippocampal activation might serve a beneficial function, these results support the view that increased hippocampal activation in aMCI is a dysfunctional condition and that targeting excess hippocampal activity has therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7GcrYTocgkLVg90H21EOLACvtfcHk0lj30Dq7bpA2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFantr4%253D&md5=290b84cad5dc37686c8199d3ed389ca1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2012.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2012.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DBakker%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DG.%2BL.%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DSpeck%26aufirst%3DC.%2BL.%26aulast%3DJones%26aufirst%3DL.%2BR.%26aulast%3DStark%26aufirst%3DC.%2BE.%26aulast%3DYassa%26aufirst%3DM.%2BA.%26aulast%3DBassett%26aufirst%3DS.%2BS.%26aulast%3DShelton%26aufirst%3DA.%2BL.%26aulast%3DGallagher%26aufirst%3DM.%26atitle%3DReduction%2520of%2520hippocampal%2520hyperactivity%2520improves%2520cognition%2520in%2520amnestic%2520mild%2520cognitive%2520impairment%26jtitle%3DNeuron%26date%3D2012%26volume%3D74%26spage%3D467%26epage%3D474%26doi%3D10.1016%2Fj.neuron.2012.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sanchez, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vossel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrito, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devidze, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2895</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2903</span><span class="refDoi"> DOI: 10.1073/pnas.1121081109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1073%2Fpnas.1121081109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22869752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1WmsbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E2895-E2903&author=P.+E.+Sanchezauthor=L.+Zhuauthor=L.+Verretauthor=K.+A.+Vosselauthor=A.+G.+Orrauthor=J.+R.+Cirritoauthor=N.+Devidzeauthor=K.+Hoauthor=G.-Q.+Yuauthor=J.+J.+Palopauthor=L.+Mucke&title=Levetiracetam+suppresses+neuronal+network+dysfunction+and+reverses+synaptic+and+cognitive+deficits+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1073%2Fpnas.1121081109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model</span></div><div class="casAuthors">Sanchez, Pascal E.; Zhu, Lei; Verret, Laure; Vossel, Keith A.; Orr, Anna G.; Cirrito, John R.; Devidze, Nino; Ho, Kaitlyn; Yu, Gui-Qiu; Palop, Jorge J.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">E2895-E2903, SE2895/1-SE2895/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">In light of the rising prevalence of Alzheimer's disease (AD), new strategies to prevent, halt, and reverse this condition are needed urgently.  Perturbations of brain network activity are obsd. in AD patients and in conditions that increase the risk of developing AD, suggesting that aberrant network activity might contribute to AD-related cognitive decline.  Human amyloid precursor protein (hAPP) transgenic mice simulate key aspects of AD, including pathol. elevated levels of amyloid-β peptides in brain, aberrant neural network activity, remodeling of hippocampal circuits, synaptic deficits, and behavioral abnormalities.  Whether these alterations are linked in a causal chain remains unknown.  To explore whether hAPP/amyloid-β-induced aberrant network activity contributes to synaptic and cognitive deficits, we treated hAPP mice with different antiepileptic drugs.  Among the drugs tested, only levetiracetam (LEV) effectively reduced abnormal spike activity detected by electroencephalog.  Chronic treatment with LEV also reversed hippocampal remodeling, behavioral abnormalities, synaptic dysfunction, and deficits in learning and memory in hAPP mice.  Our findings support the hypothesis that aberrant network activity contributes causally to synaptic and cognitive deficits in hAPP mice.  LEV might also help ameliorate related abnormalities in people who have or are at risk for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUfooUianbtLVg90H21EOLACvtfcHk0lj30Dq7bpA2mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1WmsbjK&md5=3d9c87f1c9c1738c4734432af89fc9ea</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1121081109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1121081109%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DP.%2BE.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DVerret%26aufirst%3DL.%26aulast%3DVossel%26aufirst%3DK.%2BA.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DDevidze%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DG.-Q.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DLevetiracetam%2520suppresses%2520neuronal%2520network%2520dysfunction%2520and%2520reverses%2520synaptic%2520and%2520cognitive%2520deficits%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE2895%26epage%3DE2903%26doi%3D10.1073%2Fpnas.1121081109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Shi, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-D.</span><span> </span><span class="NLM_article-title">Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">881</span><span class="refDoi"> DOI: 10.1111/cns.12144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1111%2Fcns.12144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23889921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Gku7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=871-881&author=J.-Q.+Shiauthor=B.-R.+Wangauthor=Y.-Y.+Tianauthor=J.+Xuauthor=L.+Gaoauthor=S.-L.+Zhaoauthor=T.+Jiangauthor=H.-G.+Xieauthor=Y.-D.+Zhang&title=Antiepileptics+topiramate+and+levetiracetam+alleviate+behavioral+deficits+and+reduce+neuropathology+in+APPswe%2FPS1dE9+transgenic+mice&doi=10.1111%2Fcns.12144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice</span></div><div class="casAuthors">Shi, Jian-Quan; Wang, Bian-Rong; Tian, You-Yong; Xu, Jun; Gao, Li; Zhao, Shu-Li; Jiang, Teng; Xie, Hong-Guang; Zhang, Ying-Dong</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">871-881</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: The close relationship between epileptic seizure and Alzheimer's disease (AD) has been demonstrated in the past decade.  Valproic acid, a traditional first-line antiepileptic drug, exerted protective effects in transgenic models of AD.  It remains uncertain whether new antiepileptic drugs could reverse neuropathol. and behavioral deficits in AD transgenic mice.  Aims: APPswe/PS1dE9 transgenic mice were used in this study, which over express the Swedish mutation of amyloid precursor protein together with presenilin 1 deleted in exon 9. 7-mo-old APPswe/PS1dE9 transgenic mice were treated daily with 20 mg/kg topiramate (TPM) and 50 mg/kg levetiracetam (LEV) for 30 days by i.p. injection to explore the effects of TPM and LEV on the neuropathol. and behavioral deficits.  Results: The results indicated that TPM and LEV alleviated behavioral deficits and reduced amyloid plaques in APPswe/PS1dE9 transgenic mice.  TPM and LEV increased Aβ clearance and up-regulated Aβ transport and autophagic degrdn.  TPM and LEV inhibited Aβ generation and suppressed γ-secretase activity.  TPM and LEV inhibited GSK-3β activation and increased the activation of AMPK/Akt activation.  Further, TPM and LEV inhibited histone deacetylase activity in vivo.  Conclusions: Therefore, TPM and LEV might have the potential to treat AD effectively in patient care.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlOJf22rLb7Vg90H21EOLACvtfcHk0ljgsEpzAayTMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Gku7bE&md5=af18b87a1722b432431ebb6b1a6784e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fcns.12144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcns.12144%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.-Q.%26aulast%3DWang%26aufirst%3DB.-R.%26aulast%3DTian%26aufirst%3DY.-Y.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DS.-L.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DH.-G.%26aulast%3DZhang%26aufirst%3DY.-D.%26atitle%3DAntiepileptics%2520topiramate%2520and%2520levetiracetam%2520alleviate%2520behavioral%2520deficits%2520and%2520reduce%2520neuropathology%2520in%2520APPswe%252FPS1dE9%2520transgenic%2520mice%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2013%26volume%3D19%26spage%3D871%26epage%3D881%26doi%3D10.1111%2Fcns.12144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mucke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Neurotoxicity of amyloid-β protein: Synaptic and network dysfunction</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">a006338</span><span class="refDoi"> DOI: 10.1101/cshperspect.a006338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1101%2Fcshperspect.a006338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=a006338&author=L.+Muckeauthor=D.+J.+Selkoe&title=Neurotoxicity+of+amyloid-%CE%B2+protein%3A+Synaptic+and+network+dysfunction&doi=10.1101%2Fcshperspect.a006338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a006338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a006338%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DNeurotoxicity%2520of%2520amyloid-%25CE%25B2%2520protein%253A%2520Synaptic%2520and%2520network%2520dysfunction%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2012%26volume%3D2%26spage%3Da006338%26doi%3D10.1101%2Fcshperspect.a006338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Font-Bardia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solans, X.</span><span> </span><span class="NLM_article-title">Enantioselective synthesis of tacrine–huperzine A hybrids. Preparative chiral MPLC separation of their racemic mixtures and absolute configuration assignments by X-ray diffraction analysis</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span><span class="refDoi"> DOI: 10.1016/S0957-4166(98)00029-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0957-4166%2898%2900029-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=835-849&author=P.+Campsauthor=J.+Contrerasauthor=M.+Font-Bardiaauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=X.+Solans&title=Enantioselective+synthesis+of+tacrine%E2%80%93huperzine+A+hybrids.+Preparative+chiral+MPLC+separation+of+their+racemic+mixtures+and+absolute+configuration+assignments+by+X-ray+diffraction+analysis&doi=10.1016%2FS0957-4166%2898%2900029-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0957-4166%2898%2900029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0957-4166%252898%252900029-9%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DJ.%26aulast%3DFont-Bardia%26aufirst%3DM.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSolans%26aufirst%3DX.%26atitle%3DEnantioselective%2520synthesis%2520of%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids.%2520Preparative%2520chiral%2520MPLC%2520separation%2520of%2520their%2520racemic%2520mixtures%2520and%2520absolute%2520configuration%2520assignments%2520by%2520X-ray%2520diffraction%2520analysis%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1998%26volume%3D9%26spage%3D835%26epage%3D849%26doi%3D10.1016%2FS0957-4166%2898%2900029-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baños, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivas, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">New tacrine–huperzine A hybrids (huprines): Highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4657</span><span class="NLM_x">–</span> <span class="NLM_lpage">4666</span><span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine%E2%80%93huperzine+A+hybrids+%28huprines%29%3A+Highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0ljgsEpzAayTMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine%25E2%2580%2593huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520Highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Achab, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morral, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span> </span><span class="NLM_article-title">Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=409-417&author=P.+Campsauthor=B.+Cusackauthor=W.+D.+Mallenderauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=T.+L.+Rosenberry&title=Huprine+X+is+a+novel+high-affinity+inhibitor+of+acetylcholinesterase+that+is+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DCusack%26aufirst%3DB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26atitle%3DHuprine%2520X%2520is%2520a%2520novel%2520high-affinity%2520inhibitor%2520of%2520acetylcholinesterase%2520that%2520is%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D57%26spage%3D409%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">3D Structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamics correlates</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2970</span><span class="NLM_x">–</span> <span class="NLM_lpage">2981</span><span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+Structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+Kinetic+and+molecular+dynamics+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0lihAHiuWySi0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520Structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520Kinetic%2520and%2520molecular%2520dynamics%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapia-Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">2549</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lihAHiuWySi0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juárez-Jiménez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Tetrahydrobenzo[<i>h</i>][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+hybrids+as+a+new+family+of+anti-Alzheimer+agents+targeting+%CE%B2-amyloid%2C+tau%2C+and+cholinesterase+pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0lg-X4pNsKUeqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520hybrids%2520as%2520a%2520new%2520family%2520of%2520anti-Alzheimer%2520agents%2520targeting%2520%25CE%25B2-amyloid%252C%2520tau%252C%2520and%2520cholinesterase%2520pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Pérez-Areales, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallverdú-Queralt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragusa, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabaté, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamuela-Raventós, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Shogaol–huprine hybrids: Dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5298</span><span class="NLM_x">–</span> <span class="NLM_lpage">5307</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.07.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bmc.2014.07.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5298-5307&author=F.+J.+P%C3%A9rez-Arealesauthor=O.+Di+Pietroauthor=A.+Espargar%C3%B3author=A.+Vallverd%C3%BA-Queraltauthor=C.+Galdeanoauthor=I.+M.+Ragusaauthor=E.+Viaynaauthor=C.+Guillouauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Sabat%C3%A9author=R.+M.+Lamuela-Ravent%C3%B3sauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Shogaol%E2%80%93huprine+hybrids%3A+Dual+antioxidant+and+anticholinesterase+agents+with+%CE%B2-amyloid+and+tau+anti-aggregating+properties&doi=10.1016%2Fj.bmc.2014.07.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DVallverd%25C3%25BA-Queralt%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRagusa%26aufirst%3DI.%2BM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DGuillou%26aufirst%3DC.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLamuela-Ravent%25C3%25B3s%26aufirst%3DR.%2BM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DShogaol%25E2%2580%2593huprine%2520hybrids%253A%2520Dual%2520antioxidant%2520and%2520anticholinesterase%2520agents%2520with%2520%25CE%25B2-amyloid%2520and%2520tau%2520anti-aggregating%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5298%26epage%3D5307%26doi%3D10.1016%2Fj.bmc.2014.07.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Relat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minguillón, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Muñoz, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0lg-X4pNsKUeqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Pang, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiram, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelacic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brimijoin, S.</span><span> </span><span class="NLM_article-title">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">23646</span><span class="NLM_x">–</span> <span class="NLM_lpage">23649</span><span class="refDoi"> DOI: 10.1074/jbc.271.39.23646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1074%2Fjbc.271.39.23646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=8798583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=23646-23649&author=Y.-P.+Pangauthor=P.+Quiramauthor=T.+Jelacicauthor=F.+Hongauthor=S.+Brimijoin&title=Highly+potent%2C+selective%2C+and+low+cost+bis-tetrahydroaminacrine+inhibitors+of+acetylcholinesterase&doi=10.1074%2Fjbc.271.39.23646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase. Steps toward novel drugs for treating Alzheimer's disease</span></div><div class="casAuthors">Pang, Yuan-Ping; Quiram, Polly; Jelacic, Tanya; Hong, Feng; Brimijoin, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">23646-23649</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">We report highly potent, selective, and low cost bifunctional acetylcholinesterase (AChE) inhibitors developed by our two-step prototype optimization strategy utilizing computer modeling of ligand docking with target proteins: (1) identify low affinity sites normally missed by x-ray crystallog.; and (2) design bifunctional analogs capable of simultaneous binding at the computer-detd. low affinity site and the x-ray-identified high affinity site.  Applying this strategy to 9-amino-1,2,3,4-tetrahydroacridine (THA), a drug for Alzheimer's disease, we obtained alkylene linked bis-THA analogs.  These analogs were up to 10,000-fold more selective and 1,000-fold more potent than THA in inhibiting rat AChE and yet required one simple reaction to synthesize.  Addnl., alkylene linked benzyl-THA analogs were developed to examine the specificity of the docking-derived low affinity THA peripheral site in AChE.  The present work and our previous computational studies strongly suggest that a low affinity THA peripheral site exists in AChE.  This peripheral site provides a structural basis for design of improved cholinesterase ligands for treating Alzheimer's disease and for other health-related purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMjTElkdbiv7Vg90H21EOLACvtfcHk0lhaIcoPXjGjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlvFSltL0%253D&md5=d8ff73789f75d61060df44c3d5edc769</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.39.23646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.39.23646%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DY.-P.%26aulast%3DQuiram%26aufirst%3DP.%26aulast%3DJelacic%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DBrimijoin%26aufirst%3DS.%26atitle%3DHighly%2520potent%252C%2520selective%252C%2520and%2520low%2520cost%2520bis-tetrahydroaminacrine%2520inhibitors%2520of%2520acetylcholinesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D23646%26epage%3D23649%26doi%3D10.1074%2Fjbc.271.39.23646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Li, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, K. K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. F.</span><span> </span><span class="NLM_article-title">East meets West in the search for Alzheimer’s therapeutics - Novel dimeric inhibitors from tacrine and huperzine A</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span><span class="refDoi"> DOI: 10.2174/156720507781788918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F156720507781788918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=17908041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=386-396&author=W.+M.+Liauthor=K.+K.+W.+Kanauthor=P.+R.+Carlierauthor=Y.+P.+Pangauthor=Y.+F.+Han&title=East+meets+West+in+the+search+for+Alzheimer%E2%80%99s+therapeutics+-+Novel+dimeric+inhibitors+from+tacrine+and+huperzine+A&doi=10.2174%2F156720507781788918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">East meets west in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A</span></div><div class="casAuthors">Li, W. M.; Kan, K. K. W.; Carlier, P. R.; Pang, Y. P.; Han, Y. F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-396</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is linked to cholinergic deficiency and the overactivation of glutamate receptors.  The acetylcholinesterase (AChE) inhibition treatment approach has produced the most encouraging results in clin. practice, and memantine, a moderate antagonist of N-methyl-D-aspartate (NMDA) receptors, has been approved for treating AD.  However, AChE inhibitors have limited success as they only improve memory in mild dementia but cannot stop the process of neurodegeneration; while memantine possesses neuroprotective effects only with a little ability in memory enhancement.  There has been a major rush among neuroscience research institutions and pharmaceutical firms worldwide to search for safer and more effective therapeutic agents for AD.  The novel dimers, derived from tacrine and the fragment of huperzine A (HA'), have been demonstrated to be potent and selective reversible inhibitors of AChE.  Bis(7)-tacrine, bis(12)-hypyridone (E12E) and HA'(10)-tacrine, are representatives of three series of novel dimers.  According to the pre-clin. studies, these compds. have been shown to have low toxicity and high efficacy for improving cognitive deficits in several animal models.  More interestingly, bis(7)-tacrine, similar to memantine, prevents glutamate-induced neurotoxicity by moderately blocking glutamate receptor NMDA subtype.  Furthermore, bis(7)-tacrine, as well as E12E, possesses multiple neuroprotective effects in vitro and in vivo.  Taking together, these dimeric AChE inhibitors, esp. bis(7)-tacrine, E12E and HA'(10)-tacrine, may provide beneficial effects in AD and other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonIecPwLr6X7Vg90H21EOLACvtfcHk0lhaIcoPXjGjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSitL7F&md5=41a0ab662f6a7b9c28fcaee9d981db77</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2174%2F156720507781788918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720507781788918%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%2BM.%26aulast%3DKan%26aufirst%3DK.%2BK.%2BW.%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DPang%26aufirst%3DY.%2BP.%26aulast%3DHan%26aufirst%3DY.%2BF.%26atitle%3DEast%2520meets%2520West%2520in%2520the%2520search%2520for%2520Alzheimer%25E2%2580%2599s%2520therapeutics%2520-%2520Novel%2520dimeric%2520inhibitors%2520from%2520tacrine%2520and%2520huperzine%2520A%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2007%26volume%3D4%26spage%3D386%26epage%3D396%26doi%3D10.2174%2F156720507781788918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Boschi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes-Franchini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sánchez, L.</span><span> </span><span class="NLM_article-title">A synthesis of levetiracetam based on (<i>S</i>)-<i>N</i>-phenylpantolactam as a chiral auxiliary</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3745</span><span class="refDoi"> DOI: 10.1016/j.tetasy.2005.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.tetasy.2005.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GitbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=3739-3745&author=F.+Boschiauthor=P.+Campsauthor=M.+Comes-Franchiniauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Ricciauthor=L.+S%C3%A1nchez&title=A+synthesis+of+levetiracetam+based+on+%28S%29-N-phenylpantolactam+as+a+chiral+auxiliary&doi=10.1016%2Fj.tetasy.2005.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A synthesis of levetiracetam based on (S)-N-phenylpantolactam as a chiral auxiliary</span></div><div class="casAuthors">Boschi, Francesca; Camps, Pelayo; Comes-Franchini, Mauro; Munoz-Torrero, Diego; Ricci, Alfredo; Sanchez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3739-3745</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis of levetiracetam and its enantiomer was carried out by deracemization of (±)-2-bromobutyric acid using either (S)- or (R)-N-phenylpantolactam as chiral auxiliaries followed by SN2 substitution of the bromine atom by a 2-oxopyrrolidin-1-yl group and amidation of the carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ0bMzKAvxBbVg90H21EOLACvtfcHk0lhaIcoPXjGjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GitbfM&md5=cce521c0a9c96d5ff4839a8a2e5405bf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2005.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2005.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DBoschi%26aufirst%3DF.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DComes-Franchini%26aufirst%3DM.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DL.%26atitle%3DA%2520synthesis%2520of%2520levetiracetam%2520based%2520on%2520%2528S%2529-N-phenylpantolactam%2520as%2520a%2520chiral%2520auxiliary%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2005%26volume%3D16%26spage%3D3739%26epage%3D3745%26doi%3D10.1016%2Fj.tetasy.2005.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Carlier, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, E. S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yazal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Y.-P.</span><span> </span><span class="NLM_article-title">Heterodimeric tacrine-based acetylcholinesterase inhibitors: Investigating ligand–peripheral site interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1021/jm990224w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990224w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4225-4231&author=P.+R.+Carlierauthor=E.+S.-H.+Chowauthor=Y.+Hanauthor=J.+Liuauthor=J.+El+Yazalauthor=Y.-P.+Pang&title=Heterodimeric+tacrine-based+acetylcholinesterase+inhibitors%3A+Investigating+ligand%E2%80%93peripheral+site+interactions&doi=10.1021%2Fjm990224w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm990224w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990224w%26sid%3Dliteratum%253Aachs%26aulast%3DCarlier%26aufirst%3DP.%2BR.%26aulast%3DChow%26aufirst%3DE.%2BS.-H.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DEl%2BYazal%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.-P.%26atitle%3DHeterodimeric%2520tacrine-based%2520acetylcholinesterase%2520inhibitors%253A%2520Investigating%2520ligand%25E2%2580%2593peripheral%2520site%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4225%26epage%3D4231%26doi%3D10.1021%2Fjm990224w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Muñoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millán, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usán, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: New disease-modifying agents for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span><span class="refDoi"> DOI: 10.1021/jm0503289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+New+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm0503289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease</span></div><div class="casAuthors">Munoz-Ruiz, Pilar; Rubio, Laura; Garcia-Palomero, Esther; Dorronsoro, Isabel; Monte-Millan, Maria del; Valenzuela, Rita; Usan, Paola; de Austria, Celia; Bartolini, Manuela; Andrisano, Vincenza; Bidon-Chanal, Axel; Orozco, Modesto; Luque, F. Javier; Medina, Miguel; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7223-7233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New dual binding site acetylcholinesterase (AChE) inhibitors have been designed and synthesized as new potent drugs that may simultaneously alleviate cognitive deficits and behave as disease-modifying agents by inhibiting the β-amyloid (Aβ) peptide aggregation through binding to both catalytic and peripheral sites of the enzyme.  Particularly, compds. 5 and 6 emerged as the most potent heterodimers reported so far, displaying IC50 values for AChE inhibition of 20 and 60 pM, resp.  More importantly, these dual AChE inhibitors inhibit the AChE-induced Aβ peptide aggregation with IC50 values 1 order of magnitude lower than that of propidium, thus being the most potent derivs. with this activity reported up to date.  We therefore conclude that these compds. are very promising disease-modifying agents for the treatment of Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryN7Kwa5OXZ7Vg90H21EOLACvtfcHk0ljMyHl-VNBrZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO&md5=bb5781896d759075a46bbe2222bbca03</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520New%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233%26doi%3D10.1021%2Fjm0503289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romeo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diomede, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colantuono, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter-Paier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Multigram synthesis and <i>in vivo</i> efficacy studies of a novel multitarget anti-Alzheimer compound</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4492</span><span class="NLM_x">–</span> <span class="NLM_lpage">4515</span><span class="refDoi"> DOI: 10.3390/molecules20034492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.3390%2Fmolecules20034492" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=4492-4515&author=I.+Solaauthor=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=M.+Cassinaauthor=P.+Campsauthor=M.+Romeoauthor=L.+Diomedeauthor=M.+Salmonaauthor=P.+Francoauthor=M.+Schaefferauthor=D.+Colantuonoauthor=D.+Robinauthor=D.+Brunnerauthor=N.+Taubauthor=B.+Hutter-Paierauthor=D.+Mu%C3%B1oz-Torrero&title=Multigram+synthesis+and+in+vivo+efficacy+studies+of+a+novel+multitarget+anti-Alzheimer+compound&doi=10.3390%2Fmolecules20034492"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20034492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20034492%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DCassina%26aufirst%3DM.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRomeo%26aufirst%3DM.%26aulast%3DDiomede%26aufirst%3DL.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DP.%26aulast%3DSchaeffer%26aufirst%3DM.%26aulast%3DColantuono%26aufirst%3DD.%26aulast%3DRobin%26aufirst%3DD.%26aulast%3DBrunner%26aufirst%3DD.%26aulast%3DTaub%26aufirst%3DN.%26aulast%3DHutter-Paier%26aufirst%3DB.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMultigram%2520synthesis%2520and%2520in%2520vivo%2520efficacy%2520studies%2520of%2520a%2520novel%2520multitarget%2520anti-Alzheimer%2520compound%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D4492%26epage%3D4515%26doi%3D10.3390%2Fmolecules20034492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Lane, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1017/S1461145705005833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1017%2FS1461145705005833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=16083515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=101-124&author=R.+M.+Laneauthor=S.+G.+Potkinauthor=A.+Enz&title=Targeting+acetylcholinesterase+and+butyrylcholinesterase+in+dementia&doi=10.1017%2FS1461145705005833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase and butyrylcholinesterase in dementia</span></div><div class="casAuthors">Lane, Roger M.; Potkin, Steven G.; Enz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-124</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review.  The cholinesterase inhibitors (ChE-Is) attenuate the cholinergic deficit underlying the cognitive and neuropsychiatric dysfunctions in patients with AD.  Inhibition of brain acetylcholinesterase (AChE) has been the major therapeutic target of ChE-I treatment strategies for Alzheimer's disease (AD).  AChE-pos. neurons project diffusely to the cortex, modulating cortical processing and responses to new and relevant stimuli.  Butyrylcholinesterase (BuChE)-pos. neurons project specifically to the frontal cortex, and may have roles in attention, executive function, emotional memory and behavior.  Furthermore, BuChE activity progressively increases as the severity of dementia advances, while AChE activity declines.  Therefore, inhibition of BuChE may provide addnl. benefits.  The two cholinesterase (ChE) enzymes that metabolize acetylcholine (ACh) differ significantly in substrate specificity, enzyme kinetics, expression and activity in different brain regions, and complexity of gene regulation.  In addn., recent evidence suggests that AChE and BuChE may have roles beyond classical' co-regulatory esterase functions in terminating ACh-mediated neurotransmission.  Non-classical' roles in modulating the activity of other proteins, regional cerebral blood flow, tau phosphorylation, and the amyloid cascade may affect rates of AD progression.  If these addnl. mechanisms are demonstrated to underlie clin. meaningful effects, modification of the over-simplistic cholinergic hypothesis in AD that is limited to symptomatic treatment, ignoring the potential of cholinergic therapies to modify the disease process, may be appropriate.  The specificity of ChE inhibitory activity, up-regulation of AChE activity and changes in the compn. of AChE mol. forms over time, selectivity for AD-relevant ChE mol. forms, brain vs. peripheral selectivity, and pharmacokinetic profile may be important determinants of the acute and long-term efficacy, safety and tolerability profiles of the different ChE-Is.  This review focuses on new evidence for the roles of BuChE and AChE in symptom generation and rate of underlying disease progression in dementia, and argues that it may be appropriate to re-evaluate the place of ChE-Is in the treatment of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYzIuEFXpTS7Vg90H21EOLACvtfcHk0ljMyHl-VNBrZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1ehtw%253D%253D&md5=b5871dacc777b6c8769be565106cb988</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1017%2FS1461145705005833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705005833%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DR.%2BM.%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DEnz%26aufirst%3DA.%26atitle%3DTargeting%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520in%2520dementia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26spage%3D101%26epage%3D124%26doi%3D10.1017%2FS1461145705005833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Macdonald, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvesh, S.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibition in Alzheimer’s disease: Is specificity the answer?</span> <span class="citation_source-journal">J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.3233/JAD-140219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.3233%2FJAD-140219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24898642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=379-384&author=I.+R.+Macdonaldauthor=K.+Rockwoodauthor=E.+Martinauthor=S.+Darvesh&title=Cholinesterase+inhibition+in+Alzheimer%E2%80%99s+disease%3A+Is+specificity+the+answer%3F&doi=10.3233%2FJAD-140219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?</span></div><div class="casAuthors">Macdonald, Ian R.; Rockwood, Kenneth; Martin, Earl; Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinesterase inhibitors are the std. of care for Alzheimer's disease (AD).  Acetylcholinesterase (AChE) catalyzes the hydrolysis of the cholinergic neurotransmitter acetylcholine.  However, the related enzyme butyrylcholinesterase (BuChE) also breaks down acetylcholine and is likewise targeted by the same clin. cholinesterase inhibitors.  The lack of clin. efficacy for the highly specific and potent AChE inhibitor, (-) huperzine A, is intriguing, given the known cholinergic deficit in AD.  Based on the proven efficacy of inhibitors affecting both cholinesterases and the apparent failure of specific AChE inhibition, focused BuChE inhibition seems important for more effective treatment of AD.  Therefore, BuChE-selective inhibitors provide promise for improved benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0L1sVpCa_7Vg90H21EOLACvtfcHk0lj9bnLbgZL4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M&md5=010bac9c291fd9c4d44e97fb5fa065f0</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.3233%2FJAD-140219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-140219%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DI.%2BR.%26aulast%3DRockwood%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DCholinesterase%2520inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Is%2520specificity%2520the%2520answer%253F%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D379%26epage%3D384%26doi%3D10.3233%2FJAD-140219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Featherstone, R. M.</span><span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lj9bnLbgZL4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span> </span><span class="NLM_article-title">SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: Synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2007</span><span class="NLM_x">–</span> <span class="NLM_lpage">2018</span><span class="refDoi"> DOI: 10.1021/jm990971t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2007-2018&author=M.+Recanatiniauthor=A.+Cavalliauthor=F.+Bellutiauthor=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=V.+Cavrini&title=SAR+of+9-amino-1%2C2%2C3%2C4-tetrahydroacridine-based+acetylcholinesterase+inhibitors%3A+Synthesis%2C+enzyme+inhibitory+activity%2C+QSAR%2C+and+structure-based+CoMFA+of+tacrine+analogues&doi=10.1021%2Fjm990971t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues</span></div><div class="casAuthors">Recanatini, Maurizio; Cavalli, Andrea; Belluti, Federica; Piazzi, Lorna; Rampa, Angela; Bisi, Alessandra; Gobbi, Silvia; Valenti, Piero; Andrisano, Vincenza; Bartolini, Manuela; Cavrini, Vanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2007-2018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we attempted to derive a comprehensive SAR picture for the class of acetylcholinesterase (AChE) inhibitors related to tacrine, a drug currently in use for the treatment of the Alzheimer's disease.  Toward this aim, we synthesized and tested a series of 9-amino-1,2,3,4-tetrahydroacridine derivs. substituted at positions 6 and 7 of the acridine nucleus and bearing selected groups on the 9-amino function.  By means of the Hansch approach, QSAR equations were obtained, quant. accounting for both the detrimental steric effect of substituents in position 7 and the favorable electron-attracting effect exerted by substituents in positions 6 and 7 of the 9-amino-1,2,3,4-tetrahydroacridine derivs.  The three-dimensional (3D) properties of the inhibitors were taken into consideration by performing a comparative mol. field anal. (CoMFA) on the series of AChE inhibitors made by twelve 9-amino-1,2,3,4-tetrahydroacridines and thirteen 11H-indeno[1,2-b]quinolin-10-ylamines previously developed in our lab.  The alignment of the mols. to be submitted to the CoMFA procedure was carried out by taking advantage of docking models calcd. for the interactions of both the unsubstituted 9-amino-1,2,3,4-tetrahydroacridine and 11H-indeno[1,2-b]quinolin-10-ylamine with the target enzyme.  A highly significant CoMFA model was obtained using the steric field alone, and the features of such a 3D QSAR model were compared with the classical QSAR equations previously calcd.  The two models appeared to be consistent with one another, with the following main aspects in common: (a) individuation of the strongly neg. contribution of substituents in position 7 of tacrine, and (b) tentative assignment of hydrophobic character to the favorable effect exerted by the substituents in position 6.  Finally, to test the predictive ability of the QSAR models, 6-bromo-9-amino-1,2,3,4-tetrahydroacridine, a new tacrine deriv. designed on the basis of both classical and 3D QSAR equations was synthesized and kinetically evaluated.  This compd. was predicted to have a pIC50 value of 7.31 by the classical QSAR model and 7.40 by the CoMFA model; its exptl. IC50 value was equal to 0.066 (±0.009) μM, which corresponds to a pIC50 of 7.18, and shows reasonable agreement with the predicted AChE inhibition data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DgmKhtx11LVg90H21EOLACvtfcHk0lj9bnLbgZL4lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D&md5=f9e8a7eb7bb347bfd80953e2870a789c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm990971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990971t%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26atitle%3DSAR%2520of%25209-amino-1%252C2%252C3%252C4-tetrahydroacridine-based%2520acetylcholinesterase%2520inhibitors%253A%2520Synthesis%252C%2520enzyme%2520inhibitory%2520activity%252C%2520QSAR%252C%2520and%2520structure-based%2520CoMFA%2520of%2520tacrine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2007%26epage%3D2018%26doi%3D10.1021%2Fjm990971t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Wlodek, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antosiewicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCammon, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straatsma, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilson, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:1<109::AID-BIP9>3.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Savini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaeta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalanotti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiasserini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKissic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span><span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0lj1itfnp9Xo6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Elsinghorst, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tränkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gütschow, M.</span><span> </span><span class="NLM_article-title">First gallamine–tacrine hybrid: Design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5685</span><span class="NLM_x">–</span> <span class="NLM_lpage">5695</span><span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine%E2%80%93tacrine+hybrid%3A+Design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0lj1itfnp9Xo6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine%25E2%2580%2593tacrine%2520hybrid%253A%2520Design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">New perspectives on the role of tau in Alzheimer’s disease. Implicactions for therapy</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1016/j.bcp.2014.01.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.bcp.2014.01.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=540-547&author=M.+Medinaauthor=J.+Avila&title=New+perspectives+on+the+role+of+tau+in+Alzheimer%E2%80%99s+disease.+Implicactions+for+therapy&doi=10.1016%2Fj.bcp.2014.01.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DNew%2520perspectives%2520on%2520the%2520role%2520of%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease.%2520Implicactions%2520for%2520therapy%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D88%26spage%3D540%26epage%3D547%26doi%3D10.1016%2Fj.bcp.2014.01.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Lansdall, C. J.</span><span> </span><span class="NLM_article-title">An effective treatment for Alzheimer’s disease must consider both amyloid and tau</span> <span class="citation_source-journal">Biosci. Horiz.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">hzu002</span><span class="refDoi"> DOI: 10.1093/biohorizons/hzu002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1093%2Fbiohorizons%2Fhzu002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=hzu002&author=C.+J.+Lansdall&title=An+effective+treatment+for+Alzheimer%E2%80%99s+disease+must+consider+both+amyloid+and+tau&doi=10.1093%2Fbiohorizons%2Fhzu002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1093%2Fbiohorizons%2Fhzu002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbiohorizons%252Fhzu002%26sid%3Dliteratum%253Aachs%26aulast%3DLansdall%26aufirst%3DC.%2BJ.%26atitle%3DAn%2520effective%2520treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520must%2520consider%2520both%2520amyloid%2520and%2520tau%26jtitle%3DBiosci.%2520Horiz.%26date%3D2014%26volume%3D7%26spage%3Dhzu002%26doi%3D10.1093%2Fbiohorizons%2Fhzu002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Villar-Piqué, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, S.</span><span> </span><span class="NLM_article-title">Modeling amyloids in bacteria</span> <span class="citation_source-journal">Microb. Cell Fact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="refDoi"> DOI: 10.1186/1475-2859-11-166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1186%2F1475-2859-11-166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=23272903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFyit7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=166&author=A.+Villar-Piqu%C3%A9author=S.+Ventura&title=Modeling+amyloids+in+bacteria&doi=10.1186%2F1475-2859-11-166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling amyloids in bacteria</span></div><div class="casAuthors">Villar-Pique, Anna; Ventura, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Microbial Cell Factories</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">166</span>CODEN:
                <span class="NLM_cas:coden">MCFICT</span>;
        ISSN:<span class="NLM_cas:issn">1475-2859</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of proteins are being shown to assemble into amyloid structures, self-seeding fibrillar aggregates that may lead to pathol. states or play essential biol. functions in organisms.  Bacterial cell factories have raised as privileged model systems to understand the mechanisms behind amyloid assembly and the cellular fitness cost assocd. to the formation of these aggregates.  In the near future, these bacterial systems will allow implementing high-throughput screening approaches to identify effective modulators of amyloid aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSzDOb6azsY7Vg90H21EOLACvtfcHk0lhNtay4d3rOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFyit7k%253D&md5=ab71613fc0fe2b57df0a7c6f107483e2</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1186%2F1475-2859-11-166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2859-11-166%26sid%3Dliteratum%253Aachs%26aulast%3DVillar-Piqu%25C3%25A9%26aufirst%3DA.%26aulast%3DVentura%26aufirst%3DS.%26atitle%3DModeling%2520amyloids%2520in%2520bacteria%26jtitle%3DMicrob.%2520Cell%2520Fact.%26date%3D2012%26volume%3D11%26spage%3D166%26doi%3D10.1186%2F1475-2859-11-166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Pouplana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espargaró, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, R.</span><span> </span><span class="NLM_article-title">Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span><span class="refDoi"> DOI: 10.2174/09298673113206660256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F09298673113206660256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24059241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1152-1159&author=S.+Pouplanaauthor=A.+Espargar%C3%B3author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=S.+Venturaauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Thioflavin-S+staining+of+bacterial+inclusion+bodies+for+the+fast%2C+simple%2C+and+inexpensive+screening+of+amyloid+aggregation+inhibitors&doi=10.2174%2F09298673113206660256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors</span></div><div class="casAuthors">Pouplana, S.; Espargaro, A.; Galdeano, C.; Viayna, E.; Sola, I.; Ventura, S.; Munoz-Torrero, D.; Sabate, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid aggregation is linked to a large no. of human disorders, from neurodegenerative diseases as Alzheimer's disease (AD) or spongiform encephalopathies to non-neuropathic localized diseases as type II diabetes and cataracts.  Because the formation of insol. inclusion bodies (IBs) during recombinant protein prodn. in bacteria has been recently shown to share mechanistic features with amyloid self-assembly, bacteria have emerged as a tool to study amyloid aggregation.  Herein we present a fast, simple, inexpensive and quant. method for the screening of potential anti-aggregating drugs.  This method is based on monitoring the changes in the binding of thioflavin-S to intracellular IBs in intact Escherichia coli cells in the presence of small chem. compds.  This in vivo technique fairly recapitulates previous in vitro data.  Here we mainly use the Alzheimer's related β -amyloid peptide as a model system, but the technique can be easily implemented for screening inhibitors relevant for other conformational diseases simply by changing the recombinant amyloid protein target.  Indeed, we show that this methodol. can be also applied to the evaluation of inhibitors of the aggregation of tau protein, another amyloidogenic protein with a key role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcODp_BtMQrVg90H21EOLACvtfcHk0lhNtay4d3rOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D&md5=c8c28e9aac732ce9000afc90cf7309fd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660256%26sid%3Dliteratum%253Aachs%26aulast%3DPouplana%26aufirst%3DS.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DVentura%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DThioflavin-S%2520staining%2520of%2520bacterial%2520inclusion%2520bodies%2520for%2520the%2520fast%252C%2520simple%252C%2520and%2520inexpensive%2520screening%2520of%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1152%26epage%3D1159%26doi%3D10.2174%2F09298673113206660256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halabisky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devidze, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palop, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">711</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4152-10.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1523%2FJNEUROSCI.4152-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=21228179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1arsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=700-711&author=E.+D.+Robersonauthor=B.+Halabiskyauthor=J.+W.+Yooauthor=J.+Yaoauthor=J.+Chinauthor=F.+Yanauthor=T.+Wuauthor=P.+Hamtoauthor=N.+Devidzeauthor=G.-Q.+Yuauthor=J.+J.+Palopauthor=J.+L.+Noebelsauthor=L.+Mucke&title=Amyloid-%CE%B2%2FFyn-induced+synaptic%2C+network%2C+and+cognitive+impairments+depend+on+tau+levels+in+multiple+mouse+models+of+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.4152-10.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on Tau levels in multiple mouse models of Alzheimer's disease</span></div><div class="casAuthors">Roberson, Erik D.; Halabisky, Brian; Yoo, Jong W.; Yao, Jinghua; Chin, Jeannie; Yan, Fengrong; Wu, Tiffany; Hamto, Patricia; Devidze, Nino; Yu, Gui-Qiu; Palop, Jorge J.; Noebels, Jeffrey L.; Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">700-711</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), the most common neurodegenerative disorder, is a growing public health problem and still lacks effective treatments.  Recent evidence suggests that microtubule-assocd. protein tau may mediate amyloid-β peptide (Aβ) toxicity by modulating the tyrosine kinase Fyn.  We showed previously that tau redn. prevents, and Fyn overexpression exacerbates, cognitive deficits in human amyloid precursor protein (hAPP) transgenic mice overexpressing Aβ.  However, the mechanisms by which Aβ, tau, and Fyn cooperate in AD-related pathogenesis remain to be fully elucidated.  Here we examd. the synaptic and network effects of this pathogenic triad.  Tau redn. prevented cognitive decline induced by synergistic effects of Aβ and Fyn.  Tau redn. also prevented synaptic transmission and plasticity deficits in hAPP mice.  Using electroencephalog. to examine network effects, we found that tau redn. prevented spontaneous epileptiform activity in multiple lines of hAPP mice.  Tau redn. also reduced the severity of spontaneous and chem. induced seizures in mice overexpressing both Aβ and Fyn.  To better understand these protective effects, we recorded whole-cell currents in acute hippocampal slices from hAPP mice with and without tau.  HAPP mice with tau had increased spontaneous and evoked excitatory currents, reduced inhibitory currents, and NMDA receptor dysfunction.  Tau redn. increased inhibitory currents and normalized excitation/inhibition balance and NMDA receptor-mediated currents in hAPP mice.  Our results indicate that Aβ, tau, and Fyn jointly impair synaptic and network function and suggest that disrupting the copathogenic relationship between these factors could be of therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7unpshrG7_LVg90H21EOLACvtfcHk0lhNtay4d3rOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1arsrk%253D&md5=5f72439c11fbfcd0fec99c1c1f270782</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4152-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4152-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DHalabisky%26aufirst%3DB.%26aulast%3DYoo%26aufirst%3DJ.%2BW.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DChin%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DHamto%26aufirst%3DP.%26aulast%3DDevidze%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DG.-Q.%26aulast%3DPalop%26aufirst%3DJ.%2BJ.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DAmyloid-%25CE%25B2%252FFyn-induced%2520synaptic%252C%2520network%252C%2520and%2520cognitive%2520impairments%2520depend%2520on%2520tau%2520levels%2520in%2520multiple%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D700%26epage%3D711%26doi%3D10.1523%2FJNEUROSCI.4152-10.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/S0169-409X(96)00423-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2896%2900423-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0likp7uQnTt38g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25%26doi%3D10.1016%2FS0169-409X%2896%2900423-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designing multiple ligands – medicinal chemistry strategies and challenges</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.2174/138161209787315594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2174%2F138161209787315594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19199984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=587-600&author=R.+Morphyauthor=Z.+Rankovic&title=Designing+multiple+ligands+%E2%80%93+medicinal+chemistry+strategies+and+challenges&doi=10.2174%2F138161209787315594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Designing multiple ligands - medicinal chemistry strategies and challenges</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">587-600</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It has been widely recognized over the recent years that parallel modulation of multiple biol. targets can be beneficial for treatment of diseases with complex etiologies such as cancer asthma, and psychiatric disease.  In this article, current strategies for the generation of ligands with a specific multi-target profile (designed multiple ligands or DMLs) are described and a no. of illustrative example are given.  Designing multiple ligands is frequently a challenging endeavor for medicinal chemists, with the need to appropriately balance affinity for 2 or more targets while obtaining physicochem. and pharmacokinetic properties that are consistent with the administration of an oral drug.  Given that the properties of DMLs are influenced to a large extent by the proteomic superfamily to which the targets belong and the lead generation strategy that is pursued, an early assessment of the feasibility of any given DML project is essential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUo6NjoK5D-LVg90H21EOLACvtfcHk0likp7uQnTt38g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSns70%253D&md5=fa34039be6e9c3b489f530fc74fd0346</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F138161209787315594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787315594%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigning%2520multiple%2520ligands%2520%25E2%2580%2593%2520medicinal%2520chemistry%2520strategies%2520and%2520challenges%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D587%26epage%3D600%26doi%3D10.2174%2F138161209787315594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Lynch, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kensel-Hammes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajjalieh, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matagne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuks, B.</span><span> </span><span class="NLM_article-title">The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">9861</span><span class="NLM_x">–</span> <span class="NLM_lpage">9866</span><span class="refDoi"> DOI: 10.1073/pnas.0308208101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1073%2Fpnas.0308208101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=15210974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVahtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=9861-9866&author=B.+A.+Lynchauthor=N.+Lambengauthor=K.+Nockaauthor=P.+Kensel-Hammesauthor=S.+M.+Bajjaliehauthor=A.+Matagneauthor=B.+Fuks&title=The+synaptic+vesicle+protein+SV2A+is+the+binding+site+for+the+antiepileptic+drug+levetiracetam&doi=10.1073%2Fpnas.0308208101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam</span></div><div class="casAuthors">Lynch, Berkley A.; Lambeng, Nathalie; Nocka, Karl; Kensel-Hammes, Patricia; Bajjalieh, Sandra M.; Matagne, Alain; Fuks, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9861-9866</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Here, we show that the synaptic vesicle protein SV2A is the brain binding site of levetiracetam (LEV), a new antiepileptic drug with a unique activity profile in animal models of seizure and epilepsy.  The LEV-binding site is enriched in synaptic vesicles, and photoaffinity labeling of purified synaptic vesicles confirms that it has an apparent mol. mass of ≈90 kDa.  Brain membranes and purified synaptic vesicles from mice lacking SV2A do not bind a tritiated LEV deriv., indicating that SV2A is necessary for LEV binding.  LEV and related compds. bind to SV2A expressed in fibroblasts, indicating that SV2A is sufficient for LEV binding.  No binding was obsd. to the related isoforms SV2B and SV2C.  Furthermore, there is a high degree of correlation between binding affinities of a series of LEV derivs. to SV2A in fibroblasts and to the LEV-binding site in brain.  Finally, there is a strong correlation between the affinity of a compd. for SV2A and its ability to protect against seizures in an audiogenic mouse animal model of epilepsy.  These exptl. results suggest that SV2A is the binding site of LEV in the brain and that LEV acts by modulating the function of SV2A, supporting previous indications that LEV possesses a mechanism of action distinct from that of other antiepileptic drugs.  Further, these results indicate that proteins involved in vesicle exocytosis, and SV2 in particular, are promising targets for the development of new CNS drug therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbTc72kjZ1rVg90H21EOLACvtfcHk0likp7uQnTt38g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVahtb8%253D&md5=bb144ccf7cbf44c00cecfa6954216a53</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308208101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308208101%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DB.%2BA.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DKensel-Hammes%26aufirst%3DP.%26aulast%3DBajjalieh%26aufirst%3DS.%2BM.%26aulast%3DMatagne%26aufirst%3DA.%26aulast%3DFuks%26aufirst%3DB.%26atitle%3DThe%2520synaptic%2520vesicle%2520protein%2520SV2A%2520is%2520the%2520binding%2520site%2520for%2520the%2520antiepileptic%2520drug%2520levetiracetam%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D9861%26epage%3D9866%26doi%3D10.1073%2Fpnas.0308208101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Vogl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, G. J.</span><span> </span><span class="NLM_article-title">The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca<sup>2+</sup> channels through an intracellular pathway</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1124/mol.111.076687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1124%2Fmol.111.076687" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=199-208&author=C.+Voglauthor=S.+Mochidaauthor=C.+Wolffauthor=B.+J.+Whalleyauthor=G.+J.+Stephens&title=The+synaptic+vesicle+glycoprotein+2A+ligand+levetiracetam+inhibits+presynaptic+Ca2%2B+channels+through+an+intracellular+pathway&doi=10.1124%2Fmol.111.076687"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076687%26sid%3Dliteratum%253Aachs%26aulast%3DVogl%26aufirst%3DC.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DC.%26aulast%3DWhalley%26aufirst%3DB.%2BJ.%26aulast%3DStephens%26aufirst%3DG.%2BJ.%26atitle%3DThe%2520synaptic%2520vesicle%2520glycoprotein%25202A%2520ligand%2520levetiracetam%2520inhibits%2520presynaptic%2520Ca2%252B%2520channels%2520through%2520an%2520intracellular%2520pathway%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D199%26epage%3D208%26doi%3D10.1124%2Fmol.111.076687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Farooq, M. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khasnis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassab, M. Y.</span><span> </span><span class="NLM_article-title">Levetiracetam for managing neurologic and psychiatric disorders</span> <span class="citation_source-journal">Am. J. Health-Syst. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.2146/ajhp070607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.2146%2Fajhp070607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=19265183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=541-561&author=M.+U.+Farooqauthor=A.+Bhattauthor=A.+Majidauthor=R.+Guptaauthor=A.+Khasnisauthor=M.+Y.+Kassab&title=Levetiracetam+for+managing+neurologic+and+psychiatric+disorders&doi=10.2146%2Fajhp070607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Levetiracetam for managing neurologic and psychiatric disorders</span></div><div class="casAuthors">Farooq, Muhammad U.; Bhatt, Archit; Majid, Arshad; Gupta, Rishi; Khasnis, Atul; Kassab, Mounzer Y.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Health-System Pharmacy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">541-561</span>CODEN:
                <span class="NLM_cas:coden">AHSPEK</span>;
        ISSN:<span class="NLM_cas:issn">1079-2082</span>.
    
            (<span class="NLM_cas:orgname">American Society of Health-System Pharmacists</span>)
        </div><div class="casAbstract">A review.  Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurol., and psychiatric disorders is discussed.  Summary: Levetiracetam, an antiepileptic drug (AED), was first approved as an adjunctive therapy for the treatment of partial epilepsy in adults.  It is currently being used in the treatment of multiple seizure disorders, including generalized tonic-clonic; absence; myoclonic, esp. juvenile myoclonic; Lennox-Gastaut syndrome; and refractory epilepsy in children and adults.  Data are emerging on possible uses of levetiracetam outside the realm of epilepsy because of its unique mechanisms of action.  There is preliminary evidence about the efficacy of levetiracetam in the treatment of different psychiatric disorders, including anxiety, panic, stress, mood and bipolar, autism, and Tourette's syndrome.  The most serious adverse effects assocd. with levetiracetam use are behavioral in nature and might be more common in patients with a history of psychiatric and neurobehavioral problems.  Conclusion: Levetiracetam is an effective AED with potential benefits in other neurol. and psychiatric disorders.  The benefit-risk ratio in an individual patient with a specific condition should be used to det. its optimal use.  Levetiracetam's use in nonepileptic conditions is not recommended until more data become available from larger trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpWhIpeFFM_LVg90H21EOLACvtfcHk0ljsDnRBe9XUeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWlsrc%253D&md5=bfff58a3c5f2473e35c21ecd1996d51f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2146%2Fajhp070607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2146%252Fajhp070607%26sid%3Dliteratum%253Aachs%26aulast%3DFarooq%26aufirst%3DM.%2BU.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DMajid%26aufirst%3DA.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DKhasnis%26aufirst%3DA.%26aulast%3DKassab%26aufirst%3DM.%2BY.%26atitle%3DLevetiracetam%2520for%2520managing%2520neurologic%2520and%2520psychiatric%2520disorders%26jtitle%3DAm.%2520J.%2520Health-Syst.%2520Pharm.%26date%3D2009%26volume%3D66%26spage%3D541%26epage%3D561%26doi%3D10.2146%2Fajhp070607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Ferrer, I.</span><span> </span><span class="NLM_article-title">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2012.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.pneurobio.2012.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=22459297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2012&pages=38-51&author=I.+Ferrer&title=Defining+Alzheimer+as+a+common+age-related+neurodegenerative+process+not+inevitably+leading+to+dementia&doi=10.1016%2Fj.pneurobio.2012.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia</span></div><div class="casAuthors">Ferrer Isidro</div><div class="citationInfo"><span class="NLM_cas:title">Progress in neurobiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Since the description by Alois Alzheimer, more than 50 years have passed during which senile dementia and pre-senile dementia have been considered Alzheimer disease (AD) on the basis of their common neuropathological and clinical manifestations.  AD now covers pre-senile dementia, senile dementia, mild cognitive impairment and pre-clinical AD, all of them within the context of AD-related pathology.  However, there is still a gray area between normal aging with AD-related pathology and AD.  Here it is proposed that Alzheimer (or alzheimer) is an age-related neurodegenerative process distinguished from normal aging by the presence of senile plaques and neurofibrillary tangles.  Alzheimer affects about 80% of individuals aged 65 years but dementia only occurs in a small percentage of individuals at this age; prevalence of dementia in Alzheimer increases to 25% in individuals aged 80 years.  The concepts derived from the β-amyloid hypothesis support β-amyloid as a conductor in the pathogenesis of familial AD and as a prodding factor in sporadic AD.  Moreover, seeding of β-amyloid and truncated tau explains incorporation, enhancement and perpetuation of AD-related changes.  Therefore, the earliest Alzheimer changes confined to selected regions are the first grounds and the main risk factor for developing dementia.  The term Alzheimer embraces this assumption and likens its meaning to other degenerative biological processes, such as atherosclerosis, that may eventually progress to disease.  In this context, the first stages of Alzheimer should be considered as primary targets of therapeutic intervention in order to prevent progression to diseased states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8RZSMq5h6HMAKB7Fa-xrUfW6udTcc2ebnW7oLkLbtZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rgs1GgtA%253D%253D&md5=60276ba23f11747b14a35ea1e18c45bf</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2012.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2012.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DDefining%2520Alzheimer%2520as%2520a%2520common%2520age-related%2520neurodegenerative%2520process%2520not%2520inevitably%2520leading%2520to%2520dementia%26jtitle%3DProg.%2520Neurobiol.%26date%3D2012%26volume%3D97%26spage%3D38%26epage%3D51%26doi%3D10.1016%2Fj.pneurobio.2012.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdaguer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junyent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camins, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallàs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span><span class="refDoi"> DOI: 10.1002/cmdc.201000322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1002%2Fcmdc.201000322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20859987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1855-1870&author=E.+Viaynaauthor=T.+G%C3%B3mezauthor=C.+Galdeanoauthor=L.+Ram%C3%ADrezauthor=M.+Ratiaauthor=A.+Badiaauthor=M.+V.+Closauthor=E.+Verdaguerauthor=F.+Junyentauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+huprine+derivatives+with+inhibitory+activity+toward+%CE%B2-amyloid+aggregation+and+formation+as+disease-modifying+anti-Alzheimer+drug+candidates&doi=10.1002%2Fcmdc.201000322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Huprine Derivatives with Inhibitory Activity toward β-Amyloid Aggregation and Formation as Disease-Modifying Anti-Alzheimer Drug Candidates</span></div><div class="casAuthors">Viayna, Elisabet; Gomez, Tania; Galdeano, Carles; Ramirez, Lorena; Ratia, Miriam; Badia, Albert; Clos, M. Victoria; Verdaguer, Ester; Junyent, Felix; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, Maria Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1855-1870</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), AChE-induced and self-induced β-amyloid (Aβ) aggregation and β-secretase (BACE-1), and to cross the blood-brain barrier.  The new heterodimers consist of a unit of racemic or enantiopure huprine Y or X and a donepezil-related 5,6-dimethoxy-2-[(4-piperidinyl)methyl]indane moiety as the active site and peripheral site to mid-gorge-interacting moieties, resp., connected through a short oligomethylene linker.  Mol. dynamics simulations and kinetics studies support the dual site binding to AChE.  The new heterodimers are potent inhibitors of human AChE and moderately potent inhibitors of human BChE, AChE-induced and self-induced Aβ aggregation, and BACE-1, and are predicted to be able to enter the central nervous system (CNS), thus constituting promising multitarget anti-Alzheimer drug candidates with the potential to modify the natural course of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHqjappn2Nv7Vg90H21EOLACvtfcHk0liKigoZC9yrRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlClu73F&md5=1e25a3705b61ce71762508198a10f044</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000322%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DVerdaguer%26aufirst%3DE.%26aulast%3DJunyent%26aufirst%3DF.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520huprine%2520derivatives%2520with%2520inhibitory%2520activity%2520toward%2520%25CE%25B2-amyloid%2520aggregation%2520and%2520formation%2520as%2520disease-modifying%2520anti-Alzheimer%2520drug%2520candidates%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1855%26epage%3D1870%26doi%3D10.1002%2Fcmdc.201000322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Lassiter, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, S.</span><span> </span><span class="NLM_article-title">Automated measurement of acetylcholinesterase activity in rat peripheral tissues</span> <span class="citation_source-journal">Toxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span><span class="refDoi"> DOI: 10.1016/S0300-483X(02)00752-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0300-483X%2802%2900752-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2003&pages=241-253&author=T.+L.+Lassiterauthor=R.+S.+Marshallauthor=L.+C.+Jacksonauthor=D.+L.+Hunterauthor=J.+T.+Vuauthor=S.+Padilla&title=Automated+measurement+of+acetylcholinesterase+activity+in+rat+peripheral+tissues&doi=10.1016%2FS0300-483X%2802%2900752-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0300-483X%2802%2900752-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0300-483X%252802%252900752-7%26sid%3Dliteratum%253Aachs%26aulast%3DLassiter%26aufirst%3DT.%2BL.%26aulast%3DMarshall%26aufirst%3DR.%2BS.%26aulast%3DJackson%26aufirst%3DL.%2BC.%26aulast%3DHunter%26aufirst%3DD.%2BL.%26aulast%3DVu%26aufirst%3DJ.%2BT.%26aulast%3DPadilla%26aufirst%3DS.%26atitle%3DAutomated%2520measurement%2520of%2520acetylcholinesterase%2520activity%2520in%2520rat%2520peripheral%2520tissues%26jtitle%3DToxicology%26date%3D2003%26volume%3D186%26spage%3D241%26epage%3D253%26doi%3D10.1016%2FS0300-483X%2802%2900752-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratovitski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Lare, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span> </span><span class="NLM_article-title">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">939</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80974-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0896-6273%2800%2980974-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=9354339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=939-945&author=D.+R.+Borcheltauthor=T.+Ratovitskiauthor=J.+van+Lareauthor=M.+K.+Leeauthor=V.+Gonzalesauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=D.+L.+Priceauthor=S.+S.+Sisodia&title=Accelerated+amyloid+deposition+in+the+brains+of+transgenic+mice+coexpressing+mutant+presenilin+1+and+amyloid+precursor+proteins&doi=10.1016%2FS0896-6273%2800%2980974-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span></div><div class="casAuthors">Borchelt, David R.; Ratovitski, Tamara; Van Lare, Judy; Lee, Michael K.; Gonzales, Vicki; Jenkins, Nancy A.; Copeland, Neal G.; Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familial Alzheimer's disease (FAD) pedigrees.  In a variety of exptl. in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrilogenic Aβ1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients.  In this report, we demonstrate that transgenic animals that coexpress an FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone.  These results provide evidence for the view that one pathogenic mechanism by which FAD-linked mutant PS1 causes AD is to accelerate the rate of β-amyloid deposition in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6fPtRz3ferVg90H21EOLACvtfcHk0liKigoZC9yrRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D&md5=8377c31c3b35cb4cdca7d648f2161062</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980974-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980974-5%26sid%3Dliteratum%253Aachs%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DRatovitski%26aufirst%3DT.%26aulast%3Dvan%2BLare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DGonzales%26aufirst%3DV.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DAccelerated%2520amyloid%2520deposition%2520in%2520the%2520brains%2520of%2520transgenic%2520mice%2520coexpressing%2520mutant%2520presenilin%25201%2520and%2520amyloid%2520precursor%2520proteins%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1016%2FS0896-6273%2800%2980974-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Dvir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: from 3D structure to function</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.cbi.2010.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=20138030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dvirauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+from+3D+structure+to+function&doi=10.1016%2Fj.cbi.2010.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: From 3D structure to function</span></div><div class="casAuthors">Dvir, Hay; Silman, Israel; Harel, Michal; Rosenberry, Terrone L.; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">10-22</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  By rapid hydrolysis of the neurotransmitter, acetylcholine, acetylcholinesterase (AChE) terminates neurotransmission at cholinergic synapses.  AChE is a very fast enzyme, functioning at a rate approaching that of a diffusion-controlled reaction.  The powerful toxicity of organophosphate poisons is attributed primarily to their potent inhibition of AChE.  AChE inhibitors are utilized in the treatment of various neurol. disorders, and are the principal drugs approved thus far by the FDA for management of Alzheimer's disease.  Many organophosphates and carbamates serve as potent insecticides, by selectively inhibiting insect AChE.  The detn. of the crystal structure of Torpedo californica AChE permitted visualization, for the 1st time, at at. resoln., of a binding pocket for acetylcholine.  It also allowed identification of the active site of AChE, which, unexpectedly, is located at the bottom of a deep gorge lined largely by arom. residues.  The crystal structure of recombinant human AChE in its apo-state is similar in its overall features to that of the Torpedo enzyme; however, the unique crystal packing reveals a novel peptide sequence which blocks access to the active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnLqJTiC2TYrVg90H21EOLACvtfcHk0liKigoZC9yrRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXps1Wgsbc%253D&md5=9a6121388b34b77af442d1f039ba9a9c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520from%25203D%2520structure%2520to%2520function%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22%26doi%3D10.1016%2Fj.cbi.2010.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Nachon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carletti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovaslet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolet, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jean, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renard, P.-Y.</span><span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyrylcholinesterase</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span><span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.-Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+Elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyrylcholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520Elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyrylcholinesterase%26jtitle%3DBiochem.%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Olsson, M. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søndergaard, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, J. H.</span><span> </span><span class="NLM_article-title">PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions</span> <span class="citation_source-journal">J. Chem. Theory Comput.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+Consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0ljS_a6TFGOpkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520Consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Camps, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formosa, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramírez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arce, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huertas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dafni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Pyrano[3,2-<i>c</i>]quinoline–6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and β-amyloid-directed anti-Alzheimer compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5365</span><span class="NLM_x">–</span> <span class="NLM_lpage">5379</span><span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+Ram%C3%ADrezauthor=E.+G%C3%B3mezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=O.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline%E2%80%936-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+%CE%B2-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Munoz-Torrero, Diego; Ramirez, Lorena; Gomez, Elena; Isambert, Nicolas; Lavilla, Rodolfo; Badia, Albert; Clos, M. Victoria; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, M. Isabel; Huertas, Oscar; Dafni, Thomai; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5365-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase, AChE-induced and self-induced β-amyloid (Aβ) aggregation, and β-secretase (BACE-1) and to cross blood-brain barrier.  The new hybrids consist of a unit of 6-chlorotacrine and a multicomponent reaction-derived pyrano[3,2-c]quinoline scaffold as the active-site and peripheral-site interacting moieties, resp., connected through an oligomethylene linker contg. an amido group at variable position.  Indeed, mol. modeling and kinetic studies have confirmed the dual site binding of these compds.  The new hybrids, and particularly I, retain the potent and selective human AChE inhibitory activity of the parent 6-chlorotacrine while exhibiting a significant in vitro inhibitory activity toward the AChE-induced and self-induced Aβ aggregation and toward BACE-1, as well as ability to enter the central nervous system, which makes them promising anti-Alzheimer lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0N9CfOYI1erVg90H21EOLACvtfcHk0ljS_a6TFGOpkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D&md5=f2bfb696419b7634076cf7a16a4ae94b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRam%25C3%25ADrez%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3DO.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline%25E2%2580%25936-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520%25CE%25B2-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Ruiz-Carmona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-García, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garmendia-Doval, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juhos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidtke, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morley, S. D.</span><span> </span><span class="NLM_article-title">rDock: A fast, versatile and open source code for docking ligands to proteins and nucleic acids</span> <span class="citation_source-journal">PLoS Comput. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1003571</span><span class="refDoi"> DOI: 10.1371/journal.pcbi.1003571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1371%2Fjournal.pcbi.1003571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=24722481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e1003571&author=S.+Ruiz-Carmonaauthor=D.+Alvarez-Garc%C3%ADaauthor=N.+Foloppeauthor=A.+B.+Garmendia-Dovalauthor=S.+Juhosauthor=P.+Schmidtkeauthor=X.+Barrilauthor=R.+E.+Hubbardauthor=S.+D.+Morley&title=rDock%3A+A+fast%2C+versatile+and+open+source+code+for+docking+ligands+to+proteins+and+nucleic+acids&doi=10.1371%2Fjournal.pcbi.1003571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">rDock: a fast, versatile and open source program for docking ligands to proteins and nucleic acids</span></div><div class="casAuthors">Ruiz-Carmona, Sergio; Alvarez-Garcia, Daniel; Foloppe, Nicolas; Garmendia-Doval, A. Beatriz; Juhos, Szilveszter; Schmidtke, Peter; Barril, Xavier; Hubbard, Roderick E.; Morley, S. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Computational Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1003571/1-e1003571/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">PCBLBG</span>;
        ISSN:<span class="NLM_cas:issn">1553-7358</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Identification of chem. compds. with specific biol. activities is an important step in both chem. biol. and drug discovery.  When the structure of the intended target is available, one approach is to use mol. docking programs to assess the chem. complementarity of small mols. with the target; such calcns. provide a qual. measure of affinity that can be used in virtual screening (VS) to rank order a list of compds. according to their potential to be active. rDock is a mol. docking program developed at Vernalis for high-throughput VS (HTVS) applications.  Evolved from RiboDock, the program can be used against proteins and nucleic acids, is designed to be computationally very efficient and allows the user to incorporate addnl. constraints and information as a bias to guide docking.  This article provides an overview of the program structure and features and compares rDock to two ref. programs, AutoDock Vina (open source) and Schrodinger's Glide (com.).  In terms of computational speed for VS, rDock is faster than Vina and comparable to Glide.  For binding mode prediction, rDock and Vina are superior to Glide.  The VS performance of rDock is significantly better than Vina, but inferior to Glide for most systems unless pharmacophore constraints are used; in that case rDock and Glide are of equal performance.  The program is released under the Lesser General Public License and is freely available for download, together with the manuals, example files and the complete test sets, at online.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0qXwzBNIxLVg90H21EOLACvtfcHk0lgp1ZgVqE9XEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGlsL%252FO&md5=e4cb786d6567fdc7f2a46f64955a9992</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pcbi.1003571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pcbi.1003571%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Carmona%26aufirst%3DS.%26aulast%3DAlvarez-Garc%25C3%25ADa%26aufirst%3DD.%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DGarmendia-Doval%26aufirst%3DA.%2BB.%26aulast%3DJuhos%26aufirst%3DS.%26aulast%3DSchmidtke%26aufirst%3DP.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DMorley%26aufirst%3DS.%2BD.%26atitle%3DrDock%253A%2520A%2520fast%252C%2520versatile%2520and%2520open%2520source%2520code%2520for%2520docking%2520ligands%2520to%2520proteins%2520and%2520nucleic%2520acids%26jtitle%3DPLoS%2520Comput.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3De1003571%26doi%3D10.1371%2Fjournal.pcbi.1003571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Kryger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of acetylcholinesterase complexed with E2020 (Aricept): Implications for the design of new anti-Alzheimer drugs</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/S0969-2126(99)80040-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1016%2FS0969-2126%2899%2980040-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10368299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=297-307&author=G.+Krygerauthor=I.+Silmanauthor=J.+L.+Sussman&title=Structure+of+acetylcholinesterase+complexed+with+E2020+%28Aricept%29%3A+Implications+for+the+design+of+new+anti-Alzheimer+drugs&doi=10.1016%2FS0969-2126%2899%2980040-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs</span></div><div class="casAuthors">Kryger, Gitay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: Several cholinesterase inhibitors are either being utilized for symptomatic treatment of Alzheimer's disease or are in advanced clin. trials.  E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized, and evaluated by the Eisai Company in Japan.  These inhibitors were designed on the basis of QSAR studies, prior to elucidation of the 3-dimensional structure of Torpedo californica AChE (TcAChE).  E2020 significantly enhances performance in animal models of cholinergic hypofunction and has a high affinity for AChE, binding to both elec. eel and mouse AChE in the nanomolar range.  Results: The exptl. structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.  It shows that E2020 has an unique orientation along the active-site gorge, extending from the anionic subsite of the active site, at the bottom, to the peripheral anionic site, at the top, via arom. stacking interactions with conserved arom. amino acid residues.  E2020 does not, however, interact directly with either the catalytic triad or the oxyanion hole, but only indirectly via solvent mols.  Conclusions: The study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE vs. butyrylcholinesterase (BChE).  It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgomkZ6v86u7Vg90H21EOLACvtfcHk0lgp1ZgVqE9XEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D&md5=e91e20bdfea0a795ced76fac5aee1205</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2899%2980040-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252899%252980040-9%26sid%3Dliteratum%253Aachs%26aulast%3DKryger%26aufirst%3DG.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520acetylcholinesterase%2520complexed%2520with%2520E2020%2520%2528Aricept%2529%253A%2520Implications%2520for%2520the%2520design%2520of%2520new%2520anti-Alzheimer%2520drugs%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D297%26epage%3D307%26doi%3D10.1016%2FS0969-2126%2899%2980040-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Bourne, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchot, P.</span><span> </span><span class="NLM_article-title">Structural insights into ligand interactions at the acetycholinesterase peripheral anionic site</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1093/emboj/cdg005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;key=10.1093%2Femboj%2Fcdg005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=1-12&author=Y.+Bourneauthor=P.+Taylorauthor=Z.+Radicauthor=P.+Marchot&title=Structural+insights+into+ligand+interactions+at+the+acetycholinesterase+peripheral+anionic+site&doi=10.1093%2Femboj%2Fcdg005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg005%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DRadic%26aufirst%3DZ.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DStructural%2520insights%2520into%2520ligand%2520interactions%2520at%2520the%2520acetycholinesterase%2520peripheral%2520anionic%2520site%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26spage%3D1%26epage%3D12%26doi%3D10.1093%2Femboj%2Fcdg005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LII" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LII','PDB','3LII'); return false;">PDB: 3LII</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDT','PDB','4BDT'); return false;">PDB: 4BDT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N5R" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1N5R','PDB','1N5R'); return false;">PDB: 1N5R</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2CKM','PDB','2CKM'); return false;">PDB: 2CKM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83','PDB','1Q83'); return false;">PDB: 1Q83</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66','PDB','1E66'); return false;">PDB: 1E66</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE','PDB','1EVE'); return false;">PDB: 1EVE</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00624%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-15" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00624" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679907d73dc82458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
